US20020016624A1 - Apparatus and method for controlled removal of stenotic material from stents - Google Patents
Apparatus and method for controlled removal of stenotic material from stents Download PDFInfo
- Publication number
- US20020016624A1 US20020016624A1 US09/784,625 US78462501A US2002016624A1 US 20020016624 A1 US20020016624 A1 US 20020016624A1 US 78462501 A US78462501 A US 78462501A US 2002016624 A1 US2002016624 A1 US 2002016624A1
- Authority
- US
- United States
- Prior art keywords
- stenotic material
- removal mechanism
- material removal
- stent
- stenotic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000463 material Substances 0.000 title claims abstract description 407
- 230000002966 stenotic effect Effects 0.000 title claims abstract description 388
- 238000000034 method Methods 0.000 title claims abstract description 96
- 230000007246 mechanism Effects 0.000 claims abstract description 263
- 230000003073 embolic effect Effects 0.000 claims abstract description 25
- 238000012544 monitoring process Methods 0.000 claims description 42
- 230000008859 change Effects 0.000 claims description 10
- 238000013459 approach Methods 0.000 claims description 7
- 210000004204 blood vessel Anatomy 0.000 claims description 7
- 239000004020 conductor Substances 0.000 claims 24
- 208000031481 Pathologic Constriction Diseases 0.000 abstract description 92
- 230000036262 stenosis Effects 0.000 abstract description 92
- 208000037804 stenosis Diseases 0.000 abstract description 92
- 208000037803 restenosis Diseases 0.000 abstract description 32
- 210000005166 vasculature Anatomy 0.000 abstract description 17
- 210000004351 coronary vessel Anatomy 0.000 abstract description 14
- 210000001367 artery Anatomy 0.000 abstract description 12
- 230000008569 process Effects 0.000 abstract description 8
- 230000006378 damage Effects 0.000 abstract description 5
- 230000004044 response Effects 0.000 abstract description 2
- 238000011282 treatment Methods 0.000 description 33
- 210000001519 tissue Anatomy 0.000 description 21
- 238000010438 heat treatment Methods 0.000 description 17
- 230000009471 action Effects 0.000 description 15
- 229920000642 polymer Polymers 0.000 description 15
- 238000002399 angioplasty Methods 0.000 description 14
- 239000000126 substance Substances 0.000 description 12
- 230000002792 vascular Effects 0.000 description 12
- 238000002679 ablation Methods 0.000 description 11
- 239000003814 drug Substances 0.000 description 11
- 229940079593 drug Drugs 0.000 description 11
- 230000005865 ionizing radiation Effects 0.000 description 11
- 238000002483 medication Methods 0.000 description 11
- 230000017531 blood circulation Effects 0.000 description 9
- 230000002093 peripheral effect Effects 0.000 description 9
- 239000002245 particle Substances 0.000 description 7
- 238000005482 strain hardening Methods 0.000 description 7
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 6
- 208000027418 Wounds and injury Diseases 0.000 description 6
- 238000002592 echocardiography Methods 0.000 description 5
- 230000003902 lesion Effects 0.000 description 5
- 230000002411 adverse Effects 0.000 description 4
- 239000013307 optical fiber Substances 0.000 description 4
- 239000011148 porous material Substances 0.000 description 4
- 239000010935 stainless steel Substances 0.000 description 4
- 229910001220 stainless steel Inorganic materials 0.000 description 4
- 238000011144 upstream manufacturing Methods 0.000 description 4
- 210000003462 vein Anatomy 0.000 description 4
- 229910000531 Co alloy Inorganic materials 0.000 description 3
- 229910000990 Ni alloy Inorganic materials 0.000 description 3
- 208000007536 Thrombosis Diseases 0.000 description 3
- 229910001069 Ti alloy Inorganic materials 0.000 description 3
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 3
- 239000000560 biocompatible material Substances 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 229910000701 elgiloys (Co-Cr-Ni Alloy) Inorganic materials 0.000 description 3
- 230000010102 embolization Effects 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 238000003384 imaging method Methods 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- 238000010008 shearing Methods 0.000 description 3
- 229910052719 titanium Inorganic materials 0.000 description 3
- 239000010936 titanium Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 2
- 210000002302 brachial artery Anatomy 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 229910003460 diamond Inorganic materials 0.000 description 2
- 239000010432 diamond Substances 0.000 description 2
- 210000001105 femoral artery Anatomy 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000010419 fine particle Substances 0.000 description 2
- 239000006261 foam material Substances 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 206010020718 hyperplasia Diseases 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 230000007433 nerve pathway Effects 0.000 description 2
- 230000001453 nonthrombogenic effect Effects 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 238000002310 reflectometry Methods 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 206010061660 Artery dissection Diseases 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 206010038563 Reocclusion Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 206010000891 acute myocardial infarction Diseases 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000012292 cell migration Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000007887 coronary angioplasty Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000004033 diameter control Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000013013 elastic material Substances 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000011221 initial treatment Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000005022 packaging material Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- -1 polyethylene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 238000007674 radiofrequency ablation Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000008458 response to injury Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 229910001285 shape-memory alloy Inorganic materials 0.000 description 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000013151 thrombectomy Methods 0.000 description 1
- 230000001732 thrombotic effect Effects 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B17/3205—Excision instruments
- A61B17/3207—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B17/221—Gripping devices in the form of loops or baskets for gripping calculi or similar types of obstructions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B17/3205—Excision instruments
- A61B17/3207—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions
- A61B17/320725—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions with radially expandable cutting or abrading elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00017—Electrical control of surgical instruments
- A61B2017/00022—Sensing or detecting at the treatment site
- A61B2017/00026—Conductivity or impedance, e.g. of tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00017—Electrical control of surgical instruments
- A61B2017/00115—Electrical control of surgical instruments with audible or visual output
- A61B2017/00119—Electrical control of surgical instruments with audible or visual output alarm; indicating an abnormal situation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B17/221—Gripping devices in the form of loops or baskets for gripping calculi or similar types of obstructions
- A61B2017/2212—Gripping devices in the form of loops or baskets for gripping calculi or similar types of obstructions having a closed distal end, e.g. a loop
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/36—Image-producing devices or illumination devices not otherwise provided for
- A61B90/37—Surgical systems with images on a monitor during operation
- A61B2090/378—Surgical systems with images on a monitor during operation using ultrasound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2217/00—General characteristics of surgical instruments
- A61B2217/002—Auxiliary appliance
- A61B2217/005—Auxiliary appliance with suction drainage system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
Definitions
- the present invention relates generally to apparatus and methods for removing occluding material from stented regions within blood vessels which have restenosed. More particularly, the present invention relates to apparatus and methods for sensing a stent within the wall of a restenosed blood vessel and removing the occluding material without damaging the stent.
- Percutaneous transluminal angioplasty (PTA) and percutaneous transluminal coronary angioplasty (PTCA) procedures are widely used for treating stenotic atherosclerotic regions of a patient's vasculature to restore adequate blood flow.
- Catheters having an expansible distal end, typically in the form of an inflatable balloon, are positioned in an artery, such as a coronary artery, at a stenotic site. The expansible end is then expanded to dilate the artery in order to restore adequate blood flow to regions beyond the stenosis.
- PTA and PTCA have gained wide acceptance, these angioplasty procedures suffer from two major problems: abrupt closure and restenosis.
- Abrupt closure refers to rapid reocclusion of the vessel within hours of the initial treatment, and often occurs in patients who have recently suffered acute myocardial infarction. Abrupt closure often results from either an intimal dissection or from rapid thrombus formation which occurs in response to injury of the vascular wall from the initial angioplasty procedure. Restenosis refers to a re-narrowing of the artery over the weeks or months following an initially apparently successful angioplasty procedure. Restenosis occurs in up to 50% of all angioplasty patients and results at least in part from smooth muscle cell proliferation and migration.
- Stents are thin-walled tubular scaffolds which are expanded in the arterial lumen following the angioplasty procedure.
- the stents are formed from a malleable material, such as stainless steel, and are expanded in situ using a balloon.
- the stents may be formed from a shape memory alloy or other elastic material, in which case they are allowed to self-expand at the angioplasty treatment site. In either case, the stent acts as a mechanical support for the artery wall, inhibiting abrupt closure and reducing the restenosis rate as compared to PTCA.
- stents While stents have been very successful in inhibiting abrupt closure and reasonably successful in inhibiting restenosis, a significant portion of the treated patient population still experiences restenosis over time.
- Most stent structures comprise an open lattice, typically in a diamond or spiral pattern, and cell proliferation (also referred to as intimal hyperplasia) can intrude through the interstices between the support elements of the lattice.
- cell proliferation also referred to as intimal hyperplasia
- the stent instead of forming a barrier to hyperplasia and restenosis, the stent can become embedded within an accumulated mass of thrombus and tissue growth, and the treatment site once again becomes occluded.
- the stenosis removal mechanism of the apparatus may advantageously be a directional cutting or debulking device for selectively removing the stenotic material from within a stent or it may be a symmetrical cutting or debulking device for removing the stenotic material uniformly from the entire inner periphery of the stent.
- Atherectomy catheters having ultrasonic imaging transducers are described in U.S. Pat. Nos. 5,000,185 and 5,100,424.
- Rotary ablation catheters having selectively expandable burr components are described in U.S. Pat. Nos. 5,217,474 and 5,308,354.
- a catheter carrying an expandable filter is described in U.S. Pat. No. 4,723,549.
- Thrombectomy and atherectomy catheters having rotating brush and filament structures are described in U.S. Pat. Nos. 5,578,018; 5,535,756; 5,427,115; 5,370,653; 5,009,659; and 4,850,957; WO 95/29626; DE 39 21 071 C2; and Netherlands 9400027.
- the present invention provides apparatus and methods for removing stenotic material from within previously stented regions of a patient's vasculature.
- the present invention is particularly intended for treating regions of restenosis within a stent which result from accumulation of cellular, thrombotic, and other material over the weeks and months following an initially successful stent implant.
- the present invention will also be useful for treating relatively rapid thrombus formation which may sometimes occur during the hours and days following a stent placement procedure.
- Methods according to the present invention comprise operating a stenotic material removal mechanism within a blood vessel, typically a coronary artery or other artery, which has become restenosed or otherwise occluded following the initial stent placement, and sensing the proximity or contact between the stenotic material removal mechanism and the stent within the arterial wall so that the occluded vessel can be effectively recanalized without damaging the stent.
- the sensing means for sensing the proximity or contact between the stenotic material removal mechanism and the stent may be used to indicate an unsafe condition that might lead to stent damage, in response to which, the stenotic material removal mechanism may be manually or automatically deactivated. Alternatively or additionally, the sensing means may be used to indicate an appropriate endpoint for the stenotic material removal process.
- the indication of the proximity or contact between the stenotic material removal mechanism and the stent provided by the sensing means may be used as feedback for controlling the stenotic material removal process in the following ways:
- the sensing means may be used to guide the directional stenotic material removal mechanism either to remove stenotic material from selected portions of the interior of the stent or to remove stenotic material uniformly from the entire inner periphery of the stent.
- the indication from the sensing means may be used as feedback to manually or automatically control the depth of stenotic material removal, preferably to remove stenotic material uniformly from the entire inner periphery of the stent.
- the indication from the sensing means may be used as feedback to manually or automatically control the width or diameter of the blood flow channel created within the stent.
- the feedback from the sensing means may be used to control a combination of the directionality and the depth or diameter of the stenotic material removal process either to remove stenotic material from selected portions of the interior of the stent or to remove stenotic material uniformly from the entire inner periphery of the stent.
- a catheter carrying the stenotic material removal mechanism is positioned on one side of the restenosed stented region.
- the stenotic material removal mechanism is advanced from the catheter and positioned across the stenosis within the stent.
- the stenotic material removal mechanism is then expanded within the stenosis. The expansion may occur passively, as with a resilient stenotic material removal mechanism having one or more resilient members, such as one or more wire-shaped cutting blades, which are released from a tubular sheath and allowed to expand.
- the expansion may occur actively and controllably, such as with a stenotic material removal mechanism having one or more wire-shaped cutting blades which are actively and controllably extended outward to increase the width or diameter of the stenotic material removal mechanism, or such as a stenotic material removal mechanism having a cutter within a housing and an inflatable balloon located on one side of the housing which is inflated to increase the width or diameter of the stenotic material removal mechanism.
- the stenotic material removal mechanism is then activated for removing the stenotic material from within the stent. This is typically done by rotating and/or translating the entire stenotic material removal mechanism or a component of it within the stenosis.
- Medications, chemicals, ionizing radiation or energy such as electrical, magnetic, ultrasonic, hydraulic, pulsed hydraulic, laser or thermal energy may be applied to assist in removal of the stenotic material and/or for denaturing the remaining tissue to discourage further restenosis at the treatment site.
- a sensing means which is located on or adjacent to the stenotic material removal mechanism monitors the proximity or contact between the stenotic material removal mechanism and the stent. When the stenotic material removal mechanism has approached close enough to the stent to indicate effective recanalization of the stenosis, the stenotic material removal mechanism is deactivated. In this way, the sensing means provides an interaction between the stenotic material removal mechanism and the stented vessel to achieve effective recanalization of the stenosis without damaging or dislodging the stent within the vessel wall.
- the catheter carrying the stenotic material removal mechanism is positioned on one side of the restenosed stented region.
- the stenotic material removal mechanism is extended from the catheter and advanced part-way into the stenosis within the stent.
- the stenotic material removal mechanism is then expanded within the stenosis, either passively or actively and controllably as described above, to increase the width or diameter of the stenotic material removal mechanism.
- the stenotic material removal mechanism is then activated for removing the stenotic material from within a portion of the stent. This may be done by rotating and/or translating the entire stenotic material removal mechanism or a component of it within the stenosis.
- Medications, chemicals, ionizing radiation or energy such as electrical, magnetic, ultrasonic, hydraulic, pulsed hydraulic, laser or thermal energy may be applied to assist in removal of the stenotic material and/or for denaturing the remaining tissue to discourage further restenosis at the treatment site.
- a sensing means which is located on or adjacent to the stenotic material removal mechanism monitors the proximity or contact between the stenotic material removal mechanism and the stent. When the stenotic material removal mechanism has approached close enough to the stent to indicate effective recanalization of that portion of the stenosis, the stenotic material removal mechanism is advanced farther into the stenosis.
- the stenotic material removal mechanism may be deactivated and advanced step-wise into the stenosis by contracting or compressing the stenotic material removal mechanism, advancing it a short distance and expanding it again in a new portion of the stent. Otherwise, the stenotic material removal mechanism may be advanced continuously, relying on either the resiliency of the stenotic material removal mechanism or active control for adjusting the width or diameter of the stenotic material removal mechanism as it advances. When the sensing means indicates that the new portion of the stent has been effectively recanalized, the stenotic material removal mechanism is advanced again along the stenosis until the entire stented region has been recanalized.
- the stenotic material removal mechanism may be extended from the catheter and advanced all the way across the stenosis in a contracted or compressed state.
- the stenotic material removal mechanism is then expanded within the far end of the stenosis or within the vessel beyond the stenosis, either passively or actively and controllably as described above, to increase the width or diameter of the stenotic material removal mechanism.
- the stenotic material removal mechanism is then activated for removing the stenotic material while withdrawing the stenotic material removal mechanism toward the catheter to advance it through the stenosis in either a step-wise or continuous fashion.
- Medications, chemicals, ionizing radiation or energy such as electrical, magnetic, ultrasonic, hydraulic, pulsed hydraulic, laser or thermal energy may be applied to assist in removal of the stenotic material and/or for denaturing the remaining tissue to discourage further restenosis at the treatment site.
- the sensing means which is used to monitor the proximity or contact between the stenotic material removal mechanism and the stent in order to control the diameter and/or the rate of advancement of the stenotic material removal mechanism for effective recanalization of the stenosis within the stent.
- the methods of the present invention may include providing a sensing means in the form of one or more open, exposed electrodes which are located on or adjacent to the stenotic material removal mechanism.
- a direct or alternating current reference voltage is applied to a unipolar electrode or applied between two bipolar electrodes, and the current leakage of the electrode or electrodes is monitored. When one or more of the electrodes contacts the metallic stent, the leakage current increases indicating that the stenotic material has been removed down to the stent support members for effective recanalization of the stenosis within that portion of the stent.
- the methods of the present invention may include providing a sensing means in the form of two exposed or insulated bipolar electrodes which are located on or adjacent to the stenotic material removal mechanism.
- An alternating current reference voltage is applied between the bipolar electrodes, and the complex impedance between the electrodes is monitored.
- the capacitive and inductive characteristics of the electrode circuit change, which can be detected as a change in the complex impedance between the electrodes.
- the complex impedance between the electrodes has changed a sufficient amount to indicate effective recanalization of the stenosis within that portion of the stent, the stenotic material removal mechanism may be deactivated or advanced along the stenosis as appropriate.
- the sensing means can be used to control or guide the stenotic material removal mechanism to remove the stenotic material to within a predetermined thickness of the stent support members or the stenotic material can be removed all the way down to the stent support members without fear of damaging the stent. If exposed electrodes are used in this method, monitoring the complex impedance between the electrodes will indicate when the stenotic material removal mechanism is approaching the metallic stent, then when one or more of the electrodes contacts the metallic stent, it will ground to the stent which can be detected as an extreme change in the complex impedance or as a rise in the leakage current. Thus, the sensing means can be used to separately indicate proximity and contact between the stenotic material removal mechanism and the stent. The sensing means can operate with very low voltage and current that will not create any adverse physiological effects on the vascular wall or the tissues and nerve pathways of the heart.
- the heating or ablation electrodes can serve double duty as the sensing means electrodes for monitoring proximity or contact with the metallic stent.
- proximity sensors sensitive to the metallic stent may be used in place of those described.
- optical or ultrasonic sensors may be used in place of the electronic detectors described for detection of both metallic and nonmetallic stents.
- a nonimaging, A mode ultrasonic transducer can be used to detect both metallic and nonmetallic stents and to measure their depth within the arterial wall based on echoes caused by the difference in acoustic impedance between the stent material and the arterial tissue or stenosis.
- the methods of the present invention will optionally further comprise collecting and withdrawing the removed stenotic material from the blood vessel.
- Collection and withdrawal of the removed stenotic material may be accomplished using the same catheter or catheter assembly which carries the stenotic material removal mechanism, typically by aspiration, entrapment, filtering or some combination thereof.
- various catheter assemblies can be put together using coaxially arranged components which may be introduced through a single vascular access point, such as a femoral or brachial artery.
- collection and withdrawal can be accomplished using separate collection apparatus, such as a catheter or catheter assembly, which is introduced through a separate access point.
- embolic filters or occlusion balloons may be placed upstream and downstream of the treatment site.
- the methods of the present invention may optionally further comprise comminution of the removed stenotic material into microscopic particles that will not cause embolization downstream of the treatment site.
- the methods of the present invention will also optionally comprise the use of introducer means, such as introducer needles, guidewires and/or introducer sheaths for introducing the catheter or catheter system into the vascular system and guide means, such as steerable guidewires and selective and/or subselective guiding or delivery catheters for guiding and advancing the catheter or catheter system through the vasculature to the treatment site and supporting it during the treatment.
- introducer means such as introducer needles, guidewires and/or introducer sheaths for introducing the catheter or catheter system into the vascular system
- guide means such as steerable guidewires and selective and/or subselective guiding or delivery catheters for guiding and advancing the catheter or catheter system through the vasculature to the treatment site and supporting it during the treatment.
- the selective and subselective guiding or delivery catheters may also serve the functions of aspiration, collection and withdrawal of the removed stenotic material, as well as for infusion of therapeutic substances.
- Apparatus according to the present invention include catheters, catheter systems, and catheter kits which are specially intended and adapted for performing the methods described above.
- the apparatus are designed to afford percutaneous intravascular placement of a catheter carrying a stenotic material removal mechanism for removing stenotic material from within a previously stented region of the vasculature and a sensing means for sensing when the stenotic material removal mechanism is approaching or contacting the stent within the vascular wall.
- This inventive combination facilitates the effective recanalization of previously placed vascular stents that have become restenosed without risking damaging the stent.
- catheter systems according to the present invention may comprise an inner catheter shaft having a proximal end and a distal end.
- the stenotic material removal mechanism is disposed near the distal end of the inner catheter shaft.
- the inner catheter shaft will preferably include a guidewire lumen for introduction of the catheter system over a steerable guidewire.
- the inner catheter shaft may have additional lumens or actuating mechanisms associated with the stenotic material removal mechanism.
- Various embodiments of the stenotic material removal mechanism will be more fully described below.
- the catheter system may also include a tubular sheath which serves to maintain the stenotic material removal mechanism in a compressed state as it is maneuvered to, and potentially across, the stenosis.
- the catheter system will usually further include an outer catheter tube having a proximal end, a distal end and an inner lumen.
- the outer catheter tube will usually have an aspiration port near its proximal end so that dislodged stenotic material can be aspirated from the vasculature.
- the outer catheter tube may optionally have selective or subselective curves formed near the distal end of the catheter tube for directing and maneuvering the catheter system through the vasculature to the site of the stenosis.
- an outer guiding catheter for example a coronary guiding catheter, may be used for guiding the catheter system into the desired part of the vasculature and supporting it during the treatment.
- the stenotic material removal mechanism which is disposed near the distal end of the inner catheter shaft may take one of several possible forms.
- the stenotic material removal mechanism is in the form of a cutting head having a plurality of longitudinally oriented cutting blades arranged radially about the central axis of the inner catheter.
- the stenotic material removal mechanism is in the form of a cutting head having a plurality of helically configured cutting blades arranged radially about the central axis of the inner catheter.
- each of the cutting blades is preferably shaped like a flattened wire with one or both lateral edges of the wire sharpened into a cutting edge.
- the wire-shaped cutting blades are resilient so that they can expand radially outward from the central axis of the inner catheter.
- the wire-shaped cutting blades maintain an approximately parallel orientation to one another as they expand and contract in the radial direction so that the overall configuration of the cutting head is roughly cylindrical.
- the cutting head can be passively expandable, in which case the resilient wire-shaped cutting blades are treated by coldworking or heat treatment to have an elastic memory that predisposes them to expand outward when they are released from the radial constraint of the tubular sheath.
- the cutting head can be configured to be actively and controllably expandable.
- the resilient wire-shaped cutting blades are attached on their proximal ends to the inner catheter shaft and on their distal ends to an inner actuating member which is coaxially slidably with respect to the inner catheter shaft.
- the resilient wire-shaped cutting blades expand radially outward from the central axis of the inner catheter, and when the inner actuating member is moved distally with respect to the inner catheter shaft, the resilient wire-shaped cutting blades contract radially inward toward the central axis of the inner catheter.
- the resilient wire-shaped cutting blades may be treated by coldworking or heat treatment to have an elastic memory so that they are biased toward the contracted position, the expanded position or an intermediate position, each alternative having various advantages.
- the inner actuating member may be tubular, such as a polymer tube, a hollow flexible cable or a flexible metallic tube, so that the guidewire lumen can pass coaxially through the inner actuating member.
- the inner actuating member may be a thin wire which runs parallel to and alongside the guidewire lumen.
- the stenotic material removal mechanism is operated by rotating the cutting head to remove the stenotic material from within the stent by the cutting action of the longitudinally oriented cutting blades.
- the rotating action of the blades may be accompanied by axially advancing or withdrawing the cutting head through the stenosis and/or by expanding the width or diameter of the cutting head.
- one or more of the longitudinally oriented cutting blades includes a sensing means for sensing the proximity or contact between the cutting blades and the stent.
- the sensing means may be in the form of one or more electrode wires which are positioned on the cutting blades.
- energy such as electrical, ultrasonic or thermal energy may be applied through the cutting blades to assist in removal of the stenotic material and/or for denaturing the remaining tissue to discourage further restenosis at the treatment site.
- electrodes used for heating or ablation can serve double duty as the sensing means electrodes for monitoring proximity or contact with the stent.
- the stenotic material removal mechanism is in the form of a blade which is extendible and retractable from within a cavity or lumen located near the distal end of the inner catheter.
- the blade is actuated to extend radially from the inner catheter by advancing an actuating member which extends through an inner lumen of the catheter to an advancement knob located near the proximal end of the inner catheter.
- the blade maintains an approximately parallel orientation to the inner catheter as it extends and retracts in the radial direction.
- the stenotic material removal mechanism may operate by cutting action, in which case the blade is preferably shaped like a flattened wire with one or both lateral edges of the wire sharpened into a cutting edge, or it may operate by application of electrical or thermal energy, in which case the blade may be flat, round or any convenient shape.
- the stenotic material removal mechanism is operated by advancing the actuating member to extend the blade radially from the inner catheter, then rotating the catheter about its longitudinal axis to remove the stenotic material from within the stent.
- the rotating action of the blades may be accompanied by axially advancing or withdrawing the inner catheter through the stenosis.
- a sensing means for sensing the proximity or contact between the blade and the stent is positioned on the blade of the catheter.
- the sensing means may be in the form of one or more electrode wires which are positioned on the cutting blade. If the stenotic material removal mechanism operates by electrical or thermal heating or ablation, the heating or ablation electrodes can also serve as the sensing means electrodes for monitoring proximity or contact with the stent.
- the sensing means detects sufficient proximity or contact between the blade and the stent to indicate effective recanalization of the stenosis, the cutting blade is deactivated and withdrawn from the stented vessel.
- the stenotic material removal mechanism has a cutter positioned within a housing.
- the housing has a side aperture which exposes the cutter and an inflatable balloon located on the back of the housing opposite the side aperture.
- the balloon can be inflated to increase the width or diameter of the stenotic material removal mechanism and thereby to control the depth of cut and the diameter of the blood flow channel created.
- the cutter may be a cup-shaped rotating blade, a rotating linear or helical blade, a rotating abrasive burr or a reciprocating or axially movable cutting blade.
- medications, chemicals, ionizing radiation or energy such as electrical, magnetic, ultrasonic, hydraulic, pulsed hydraulic, laser or thermal energy may be applied through the cutter to assist in removal of the stenotic material and/or for denaturing the remaining tissue to discourage further restenosis at the treatment site.
- the stenotic material removal mechanism is positioned by advancing the inner catheter so that the side aperture of the housing is situated across the stenosis within the stent and inflating the balloon to press the side aperture against the stenotic material. Then, the cutter is actuated by rotating and/or by axially advancing the cutter within the housing to remove stenotic material from within the stent.
- a sensing means for sensing the proximity or contact between the stenotic material removal mechanism and the stent is positioned on the cutter and/or the housing of the catheter. Again, the sensing means may be in the form of one or more electrode wires which are positioned on the cutter and/or the housing.
- the heating or ablation electrodes can also serve as the sensing means electrodes for monitoring proximity or contact with the stent.
- the sensing means detects sufficient proximity or contact between the cutter and the stent to indicate the desired depth of cut, the cutter is deactivated and withdrawn or directed to another part of the stenosis within the stented portion of the vessel.
- the stenotic material removal mechanism has a rotating cutting head attached to a hollow drive cable which is coaxially and rotatably positioned over a guidewire.
- the rotating cutting head is typically spherical or ovoid in shape and has cutting blades, teeth or abrasive particles on its exterior surface.
- the inner catheter or guidewire may have a bend or a steering mechanism close to its distal end for directing the cutting head against the stenotic material within the stent.
- the cutting head may also have control means for adjusting the outer diameter of the cutting head.
- a sensing means for sensing the proximity or contact between the cutting head and the stent is positioned on the cutting head.
- the sensing means may be in the form of one or more electrodes which are positioned on the cutting head.
- the stenotic material removal mechanism is operated by advancing the inner catheter so that the cutting head is positioned within the stenosis, then rotating the drive cable and the cutting head to remove stenotic material from within the stent.
- the rotating action of the cutting head may be accompanied by axially advancing or withdrawing the cutting head through the stenosis.
- the cutting blades, teeth or abrasive particles on the exterior surface of the cutting head comminute or pulverize the stenotic material into fine particles that will not cause embolization downstream of the treatment site.
- the optional bend or steering mechanism of the inner catheter or guidewire may be used for directing the cutting head against the stenotic material within the stent.
- control means may be used for adjusting the diameter of the cutting head to achieve effective recanalization of the stented artery.
- the sensing means indicates sufficient proximity or contact between the cutting head and the stent, the cutting head is deactivated and withdrawn or directed to another part of the stenosis within the stented portion of the vessel.
- Each embodiment of the apparatus of the present invention will also include a monitoring means which couples to the sensor means of the catheter system through a connection fitting at the proximal end of the inner catheter.
- the monitoring means includes a voltage source that generates a direct or alternating current reference voltage which is applied to a unipolar electrode or applied between two bipolar electrodes positioned on the stenotic material removal mechanism, and an electrical monitor for monitoring the electrical conditions at the sensor electrode or electrodes.
- the electrical monitor may monitor the current leakage at the unipolar or bipolar sensor electrode to detect contact between the sensor electrode and a metallic stent and/or monitor the complex impedance across bipolar electrodes to detect proximity between the sensor electrodes and a metallic stent.
- the monitoring means may optionally include control means for deactivating the stenotic material removal mechanism when an unsafe condition that might lead to stent damage is detected or when the sensing means indicates an appropriate endpoint for the stenotic material removal process has been reached.
- the monitoring means may be an optical sensor that includes an optical fiber which transmits a reference beam to a distal end of the catheter and directs it at the inner surface of the vessel close to the stenotic material removal mechanism.
- a photodetector detects the intensity and/or the wavelength of the light reflected back from the inner surface of the vessel through the optical fiber.
- a difference in reflectivity between the tissue of the vessel wall and the stent material allows the photodetector to detect proximity and/or contact between the stenotic material removal mechanism and the stent.
- the monitoring means may be a nonimaging, A mode ultrasonic scanner which generates a pulsed ultrasonic signal in a transducer mounted on or near the stenotic material removal mechanism.
- the A mode ultrasonic scanner analyzes the amplitude and timing of the echoes detected by the ultrasonic transducer to measure the depth of the stent within the vessel wall.
- each embodiment of the apparatus of the present invention will also include a motor drive unit which attaches at the proximal end of the catheter system.
- the motor drive unit houses a drive motor which is mechanically coupled to the inner catheter or the drive cable of the various embodiments to rotate and/or axially translate the stenotic material removal mechanism.
- the drive motor is preferably a motor or gear motor which operates at relatively low speed for rotating the various cutters at a speed from 500 to 2000 rpm.
- the drive motor is preferably a high speed motor which rotates the cutting head at a speed from 2000 to 150000 rpm for effective comminution of the stenotic material.
- the stenotic material removal mechanism may be operated by hand.
- the apparatus of the present invention may further comprise means for collecting and withdrawing the removed stenotic material from the blood vessel.
- the means for collection and withdrawal of the removed stenotic material may include an irrigation and/or aspiration apparatus attached respectively to the inner and outer catheters of the catheter assembly.
- embolic filters or occlusion balloons may be included in the catheter system for placement upstream and/or downstream of the treatment site. An embolic filters and other stenotic material capture means are described for use in conjunction and/or in a combined apparatus with the stenotic material removal mechanism.
- FIG. 1 is a generalized schematic diagram of the apparatus of the present invention showing the different components of the catheter system.
- FIG. 2 is a side view of the distal portion of a first embodiment of the apparatus of the present invention having a stenotic material removal mechanism having with a plurality of longitudinally oriented cutting blades shown in the contracted position.
- FIG. 3 is a side view of the apparatus of FIG. 2 showing the stenotic material removal mechanism in the expanded position.
- FIG. 4 is a distal end view of the apparatus of FIG. 2 with the stenotic material removal mechanism in the expanded position.
- FIG. 5 is a magnified cutaway view of a cutting blade of the apparatus of FIG. 2 showing the sensor electrodes.
- FIG. 6 is a cross section of the cutting blade of FIG. 5.
- FIG. 7 is a side view of the distal portion of a second embodiment of the apparatus of the present invention having a stenotic material removal mechanism having with a plurality of helically configured cutting blades shown in the expanded position.
- FIG. 8 is an enlarged distal end view of the apparatus of FIG. 7 with the stenotic material removal mechanism in the expanded position.
- FIG. 9 is a magnified cutaway view of a cutting blade of the apparatus of FIG. 7 showing the sensor electrodes.
- FIG. 10 is a cross section of the cutting blade of FIG. 9.
- FIG. 11 is a side view of the distal portion and the proximal portion of a third embodiment of the apparatus of the present invention having a stenotic material removal mechanism with an extendible and retractable blade shown in the retracted position.
- FIG. 12 is a side view of the apparatus of FIG. 11 showing the stenotic material removal mechanism in the extended position.
- FIG. 13 is a magnified cross section of the cutting blade of the apparatus of FIG. 11 showing the sensor electrodes.
- FIG. 14 is a side view of the distal portion of a fourth embodiment of the apparatus of the present invention showing a directional stenotic material removal mechanism with the balloon in the inflated position.
- FIG. 15 is a top view of the apparatus of FIG. 14.
- FIG. 16 is a side view of the distal portion and the proximal portion of a fifth embodiment of the apparatus of the present invention having an abrasive cutting head.
- FIG. 17 is a magnified view of the cutting head of the apparatus of FIG. 16 showing the sensor electrodes.
- FIGS. 18, 19, 20 and 21 are a series of drawings illustrating the method of the present invention using the apparatus of FIG. 2.
- FIGS. 22, 23, 24 and 25 are a series of drawings illustrating an alternate method of the present invention using the apparatus of FIG. 2.
- FIGS. 26, 27, 28 and 29 are a series of drawings illustrating another alternate method of the present invention using the apparatus of FIG. 2.
- FIGS. 30, 31 and 32 are a series of drawings illustrating the operation of an optional embolic filter apparatus which may be used in conjunction with the method of the present invention.
- FIGS. 33, 34, 35 and 36 are a series of drawings illustrating the operation of a combined stenotic material removal mechanism and stenotic material capture mechanism according to the present invention.
- FIGS. 37, 38 and 39 are a series of drawings illustrating the operation of an alternate combined stenotic material removal mechanism and stenotic material capture mechanism according to the present invention.
- FIG. 40 illustrates a kit including a catheter, a package and instructions for use according to the present invention.
- FIG. 1 is a generalized schematic diagram of the apparatus of the present invention.
- the apparatus comprises a catheter system designed to facilitate percutaneous removal of stenotic material from within a previously stented region of the vasculature without damaging or disrupting the implanted stent.
- the catheter system includes an inner catheter shaft 50 having a proximal end and a distal end, with a stenotic material removal mechanism 52 mounted near the distal end of the inner catheter shaft 50 and a sensing means 54 for sensing when the stenotic material removal mechanism 52 is approaching or contacting the stent within the vascular wall.
- the inner catheter shaft 50 will preferably include a guidewire lumen for introduction of the catheter system over a steerable guidewire 56 .
- the inner catheter shaft 50 may have additional lumens or actuating mechanisms associated with the stenotic material removal mechanism 52 .
- Various embodiments of the stenotic material removal mechanism 52 will be more fully described below.
- the catheter system may also include an optional tubular sheath 58 which serves to maintain the stenotic material removal mechanism 52 in a compressed state as it is maneuvered to, and potentially across, the stenosis.
- the tubular sheath 58 may be split or scored along its length so that is can be easily removed from around the inner catheter shaft 50 and discarded after the stenotic material removal mechanism 52 has been maneuvered into place.
- the catheter system will usually further include an outer catheter tube 60 having a proximal end, a distal end and an inner lumen.
- the outer catheter tube will usually have a hemostasis valve 62 and an aspiration port 64 near its proximal end so that dislodged stenotic material can be aspirated from the vasculature.
- the outer catheter tube 60 may optionally have selective or subselective curves formed near the distal end of the outer catheter tube 60 for directing and maneuvering the catheter system through the vasculature to the site of the stenosis.
- an outer guiding catheter 66 for example a coronary guiding catheter, may be used for guiding the catheter system into the desired part of the vasculature and supporting it during the treatment.
- the guiding catheter 66 will have a Y-fitting with a hemostasis valve 68 connected at its proximal end.
- the outer catheter 60 will have an overall length of approximately 60 cm to 120 cm, depending on the location of the vessel to be treated in the patient's body and the point of entry into the vasculature.
- the outer catheter 60 will typically have an overall length of approximately 60 cm to 90 cm.
- the outer catheter 60 will typically have an overall length of approximately 90 cm to 120 cm.
- the inner catheter 50 should have an overall length somewhat longer than the outer catheter 60 so that the stenotic material removal mechanism 52 can be extended out from the distal end of the outer catheter 60 .
- the inner catheter 50 should therefore have an overall length of approximately 80 cm to 150 cm so that it can be extended 20 cm to 30 cm beyond the distal end of the outer catheter 60 .
- the catheter system includes a motor drive unit 70 which attaches at the proximal end of the inner catheter shaft 50 .
- the motor drive unit 70 houses a drive motor 72 which is mechanically coupled to the inner catheter shaft 50 to rotate and/or axially translate the stenotic material removal mechanism 52 for removing stenotic material from within the stented vessel.
- the drive motor 72 may be a low speed motor or gear motor which operates at a speed from 500 to 2000 rpm or a high speed motor or a turbine which operates at a speed from 2000 to 150000 rpm.
- the operating speed of the drive motor 72 will be chosen according to the particular needs of the stenotic material removal mechanism 52 , as will be discussed in more detail below.
- the stenotic material removal mechanism 52 may be operated by hand.
- the catheter system will also include a monitoring means 80 which couples to the sensor means 54 of the catheter system through a connection fitting 82 on the proximal end of the inner catheter shaft 50 .
- the connection fitting 82 will electrically couple to the monitoring means 80 through a commutator 84 which is part of the motor drive unit 70 .
- the monitoring means 80 may be miniaturized and incorporated as an integral part of the motor drive unit 70 .
- the monitoring means 80 may include an audible alarm 85 and a visual alarm 86 to indicate contact between the stenotic material removal mechanism 52 and the stent and/or a visual gauge 88 of the proximity of the stenotic material removal mechanism 52 to the stent.
- the structure and function of the sensor means 54 and the monitoring means 80 will be discussed in further detail below.
- the catheter system may further include an embolic filter 90 which may be coaxially deployed over the same guidewire 56 as the rest of the catheter system.
- embolic filters and/or occlusion balloons may be deployed on separate catheters for placement upstream and/or downstream of the treatment site.
- the stenotic material removal mechanism which is disposed near the distal end of the inner catheter shaft may take one of several possible forms.
- the distal portion of a first illustrative embodiment of an inner catheter according to the apparatus of the present invention is depicted in FIGS. 2 - 6 .
- the stenotic material removal mechanism is in the form of a cutting head 100 having a plurality of longitudinally oriented cutting blades 102 arranged radially about the central axis of the inner catheter shaft 104 .
- the cutting head 100 is shown in a contracted position in FIG. 2 with the cutting blades 102 compressed closely around the central axis of the inner catheter shaft 104 .
- FIG. 3 shows the cutting head 100 in an expanded position with the cutting blades 102 extending radially outward from the central axis of the inner catheter shaft 104 .
- FIG. 4 shows a distal end view of the cutting head 100 in the expanded position.
- Each of the cutting blades 102 is preferably shaped like a flattened wire with one or both lateral edges 110 , 112 of the wire sharpened into a cutting edge, as shown in the cross section of FIG. 6.
- the wire-shaped cutting blades 102 are resilient so that they can expand radially outward from the central axis of the inner catheter shaft 104 .
- the wire-shaped cutting blades 102 maintain an approximately parallel orientation to one another as they expand and contract in the radial direction so that the overall configuration of the cutting head 100 is roughly cylindrical.
- the cutting blades 102 are preferably made of a strong and resilient biocompatible material capable of holding a sharp cutting edge. Suitable materials for the cutting blades 102 include metals, such as stainless steel, titanium and nickel/titanium alloys, and cobalt alloys like Elgiloy and MP35. Composite constructions are also possible for the cutting blades 102 .
- the cutting head 100 can be passively expandable, in which case the resilient wire-shaped cutting blades 102 are treated by coldworking or heat treatment to have an elastic memory that predisposes them to expand outward when they are released from the radial constraint of the tubular sheath 58 which was shown in FIG. 1.
- the cutting head 100 can be configured to be actively and controllably expandable.
- the resilient wire-shaped cutting blades 102 are attached on their proximal ends to the inner catheter shaft 104 and on their distal ends to an inner actuating member 106 which is coaxially slidably with respect to the inner catheter shaft 104 .
- the cutting blades 102 When the inner actuating member 106 is moved proximally with respect to the inner catheter shaft 104 , the cutting blades 102 expand radially outward from the central axis of the inner catheter shaft 104 , and when the inner actuating member 106 is moved distally with respect to the inner catheter shaft 104 , the cutting blades 102 contract radially inward toward the central axis of the inner catheter shaft 104 .
- the cutting blades 102 may be treated by coldworking or heat treatment to have an elastic memory so that they are biased toward the contracted position so that the cutting head 100 will contract easily for advancing it across tight stenotic lesions, or toward a fully expanded position so that the cutting head 100 will be easy to deploy.
- the resilient wire-shaped cutting blades 102 may be treated so that they are biased toward an intermediate position which corresponds with a nominal expanded diameter.
- the inner actuating member 106 may be tubular, such as a polymer tube, a hollow flexible cable or a flexible metallic tube, so that a lumen 108 for a guidewire 56 can pass coaxially through the inner actuating member 106 .
- the inner actuating member may be a thin wire which runs parallel to and alongside the guidewire lumen.
- the inner catheter shaft 104 is a tubular structure with an inner lumen 114 for passing the guidewire 56 and, in some embodiments, the inner actuating member 106 through.
- the inner catheter shaft 104 may be a polymer tube, a braid reinforced polymer tube, a hollow flexible cable, such as a multifilar wound cable, or a flexible metallic tube.
- the inner catheter shaft 104 acts as a flexible drive shaft for transmitting rotation and torque from the drive motor 72 (FIG. 1) to the cutting head 100 .
- the stenotic material removal mechanism is operated by rotating the cutting head 100 to remove the stenotic material from within the stent by the cutting action of the longitudinally oriented cutting blades 102 .
- the rotating action of the blades 102 may be accompanied by axially advancing or withdrawing the cutting head 100 through the stenosis and/or by expanding the width or diameter of the cutting head 100 .
- the cutting head 100 should be expandable over a range of approximately 2 mm to 5 mm for use in stented coronary arteries or as high as 6 mm for use in stented vein grafts and even larger for use in stented peripheral vessels and other stented body structures.
- the cutting head 100 should contract to as small a diameter as possible for passing through tightly stenotic lesions, preferably to a diameter smaller than 2 mm, more preferably to a diameter smaller than 1 mm.
- the effective cutting length of the cutting head 100 is preferably within the range of approximately 10 mm to 40 mm for use in stented coronary arteries and can be longer for use in stented peripheral vessels.
- One or more, or all, of the longitudinally oriented cutting blades 102 includes a sensing means for sensing the proximity or contact between the cutting blades 102 and the stent.
- the sensing means are provided in the form of one or more electrode wires 116 , 118 which are positioned on the cutting blades, as best seen in FIGS. 5 and 6.
- the sensing electrodes 116 , 118 may extend the full length of the cutting blades 102 or only a portion of it, or the sensing electrodes 116 , 118 may be arranged to provide a plurality of sensing locations along the length of the cutting blades 102 .
- one or more open, exposed electrodes 116 , 118 are located on the surface of the cutting blades 102 .
- the cutting blades 102 themselves may serve as the sensor electrodes.
- a direct or alternating current reference voltage is applied to a unipolar electrode or applied between two bipolar electrodes, and the current leakage of the electrode or electrodes is monitored.
- the leakage current increases indicating that the stenotic material has been removed down to the stent support members for effective recanalization of the stenosis within that portion of the stent.
- a second implementation of this embodiment involves two capacitively coupled bipolar electrodes 116 , 118 which are located on the surface of the cutting blades 102 .
- An alternating current reference voltage is applied between the bipolar electrodes 116 , 118 , and the complex impedance between the electrodes is monitored.
- the capacitive and inductive characteristics of the electrode circuit change, which can be detected as a change in the complex impedance between the electrodes.
- the stenotic material removal mechanism may be deactivated or advanced along the stenosis as appropriate.
- the sensing means can be used to separately indicate proximity and contact between the cutting blades 102 and the stent.
- the sensing means can operate with very low voltage and current that will not create any adverse physiological effects on the vascular wall or the tissues and nerve pathways of the heart.
- FIGS. 7 - 10 The distal portion of a second illustrative embodiment of an inner catheter according to the apparatus of the present invention is depicted in FIGS. 7 - 10 .
- the stenotic material removal mechanism is in the form of a cutting head 120 having a plurality of helically configured cutting blades 122 arranged radially about the central axis of the inner catheter shaft 124 , as shown in FIG. 7.
- FIG. 8 shows an enlarged distal end view of the cutting head 120 in the expanded position.
- each of the cutting blades 122 is shaped like a flattened wire with one or both lateral edges 130 , 132 of the wire sharpened into a cutting edge, as shown in the cross section of FIG. 10.
- the helically configured cutting blades 122 maintain an approximately parallel orientation to one another as they expand and contract in the radial direction so that the overall configuration of the cutting head 120 is roughly cylindrical.
- the cutting blades 122 are made of a strong and resilient biocompatible material capable of holding a sharp cutting edge, such as stainless steel, titanium and nickel/titanium alloys, and cobalt alloys like Elgiloy and MP35, or a composite construction.
- the cutting head 120 can be passively expandable or actively and controllably expandable.
- the helically configured cutting blades 122 are attached on their proximal ends to the inner catheter shaft 124 and on their distal ends to an inner actuating member 126 which slides proximally and distally with respect to the inner catheter shaft 124 to expand and contract diameter of the cutting head 120 , respectively.
- the cutting blades 122 may be treated by coldworking or heat treatment to have an elastic memory so that they are biased toward the contracted position, the expanded position or an intermediate position.
- the inner actuating member 126 may be tubular, such as a polymer tube, a hollow flexible cable or a flexible metallic tube, so that a lumen 128 for a guidewire 56 can pass coaxially through the inner actuating member 126 .
- the inner actuating member may be a thin wire which runs parallel to and alongside the guidewire lumen.
- the inner catheter shaft 124 is a tubular structure with an inner lumen 134 for passing the guidewire 56 and, in some cases, the inner actuating member 126 through.
- the inner catheter shaft 124 may be a polymer tube, a braid reinforced polymer tube, a hollow flexible cable, such as a multifilar wound cable, or a flexible metallic tube that serves as a flexible drive shaft for transmitting rotation and torque from the drive motor 72 (FIG. 1) to the cutting head 120 .
- the stenotic material removal mechanism is operated by rotating the cutting head 120 to remove the stenotic material from within the stent by the cutting action of the helically configured cutting blades 122 .
- the rotating action of the blades 122 may be accompanied by axially advancing or withdrawing the cutting head 120 through the stenosis and/or by expanding the width or diameter of the cutting head 120 .
- the cutting head 120 should be expandable over a range of approximately 2 mm to 5 mm for use in stented coronary arteries or as high as 6 mm for use in stented vein grafts and even larger for use in stented peripheral vessels and other stented body structures.
- the cutting head 120 should contract to as small a diameter as possible for passing through tightly stenotic lesions, preferably to a diameter smaller than 2 mm, more preferably to a diameter smaller than 1 mm.
- the effective cutting length of the cutting head 120 is preferably within the range of approximately 10 mm to 40 mm for use in stented coronary arteries and can be longer for use in stented peripheral vessels.
- One or more, or all, of the helically configured cutting blades 122 includes a sensing means for sensing the proximity or contact between the cutting blades 122 and the stent.
- the sensing means may be in the form of one or more electrode wires 136 , 138 which are positioned on the surface of the cutting blades 122 .
- the sensing electrodes 136 , 138 may extend the full length of the cutting blades 122 or only a portion of it, or the sensing electrodes 136 , 138 may be arranged to provide a plurality of sensing locations along the length of the cutting blades 122 .
- the electrodes 136 , 138 may be exposed or insulated and unipolar or bipolar.
- the cutting blades 122 themselves may serve as the sensor electrodes. Contact and/or proximity between the cutting blades 122 and the stent can be monitored by sensing the leakage current and/or the complex impedance of the sensor electrode circuit. When the sensing means detects sufficient proximity or contact between the cutting blades 122 and the stent to indicate effective recanalization of the stenosis within that portion of the stent, the cutting head 120 may be deactivated or advanced along the stenosis as appropriate.
- FIGS. 11 - 13 The distal portion and the proximal portion of a third illustrative embodiment of an inner catheter according to the apparatus of the present invention is depicted in FIGS. 11 - 13 .
- the stenotic material removal mechanism is in the form of a blade 140 which is extendible and retractable from within a cavity 142 located near the distal end of the inner catheter shaft 144 .
- the blade 140 is actuated to extend radially from the inner catheter shaft 144 by advancing an actuating member 146 which extends through an inner lumen 148 of the catheter to an advancement knob 152 which is located on a handle assembly 150 near the proximal end of the inner catheter shaft 144 .
- FIG. 11 is a side view of the inner catheter with the blade 140 on the distal portion of the inner catheter shaft 144 and the advancement knob 152 on the proximal handle assembly 150 in the retracted position.
- FIG. 12 is a side view of the inner catheter with the blade 140 and the advancement knob 152 in the extended position.
- the blade 140 maintains an approximately parallel orientation to the inner catheter shaft 144 as it extends and retracts in the radial direction.
- the blade 140 may be treated by coldworking or heat treatment to have an elastic memory so that it is biased toward the retracted position, in which case the blade 140 will be extended by a compression force applied to the actuating member 146 by the advancement knob 152 on the handle assembly 150 .
- the blade 140 may be treated to be biased toward the extended position, in which case the blade 140 will be self-extending and will be retracted by a tensile force applied to the actuating member 146 by the advancement knob 152 .
- the actuating member 146 may be a thin wire, a flexible cable, or a thin tensile filament.
- the inner catheter shaft 144 is a tubular structure with an inner lumen 162 which extends to the distal end for passing a guidewire 56 through for directing the catheter into and across a stented region in an artery.
- the inner catheter shaft 144 may be a polymer tube, a braid reinforced polymer tube, a hollow flexible cable, such as a multifilar wound cable, or a flexible metallic tube.
- the inner catheter shaft 144 has sufficient torsional rigidity to serve as a flexible drive shaft for transmitting rotation and torque from the proximal handle assembly 150 to the blade 140 on the distal end of the inner catheter shaft 144 .
- the torque may be applied to the proximal handle assembly 150 manually by the operator or the proximal handle assembly 150 may include a drive motor 72 , as in FIG. 1.
- the stenotic material removal mechanism is operated by advancing the actuating member 146 to extend the blade 140 radially from the inner catheter shaft 144 , then rotating the catheter shaft 144 about its longitudinal axis to remove the stenotic material from within the stent.
- the rotating action of the blade 140 may be accompanied by axially advancing or withdrawing the inner catheter through the stenosis.
- the stenotic material removal mechanism of the inner catheter operates by cutting action, in which case the blade 140 is preferably shaped like a flattened wire with one or both lateral edges 154 , 156 of the wire sharpened into a cutting edge, as shown in the magnified cross section of the cutting blade in FIG. 13.
- the cutting blade 140 is made of a strong and resilient biocompatible material capable of holding a sharp cutting edge, such as stainless steel, titanium and nickel/titanium alloys, and cobalt alloys like Elgiloy and MP35, or a composite construction.
- the cutting blade 140 includes a sensing means for sensing the proximity or contact between the cutting blade 140 and the stent. As shown in FIG. 13, the sensing means may be in the form of one or more electrode wires 158 , 160 which are positioned on the surface of the cutting blade 140 .
- the electrodes 158 , 160 may be exposed or insulated and unipolar or bipolar. Alternatively, the cutting blade 140 itself may serve as a unipolar sensor electrode.
- the cutting head 120 may be deactivated or advanced along the stenosis as appropriate.
- energy such as electrical, ultrasonic or thermal energy may be applied through the blade 140 to assist in removal of the stenotic material and/or for denaturing the remaining tissue to discourage further restenosis at the treatment site.
- electrodes used for heating or ablation can also serve as the sensing means electrodes for monitoring proximity or contact with the stent. If the device relies principally on ablation as the stenotic material removal technique, the blade 140 need not be sharpened as shown, but may instead be flat, round or any convenient shape.
- FIGS. 14 - 15 The distal portion of a fourth illustrative embodiment of an inner catheter according to the apparatus of the present invention is depicted in FIGS. 14 - 15 .
- the stenotic material removal mechanism 170 has a cutter 172 positioned within a housing 174 .
- the housing 174 has a side aperture 176 which exposes the cutter 172 and an inflatable balloon 180 located on the back of the housing 174 opposite the side aperture 176 .
- the balloon 180 can be inflated with fluid injected through a balloon lumen 182 to increase the width or diameter of the stenotic material removal mechanism 170 and thereby to control the depth of cut and the diameter of the blood flow channel created.
- the balloon 180 may be made of polyethylene, polyester, nylon or other polymeric materials.
- the cutter 172 may be a cup-shaped rotating blade, a rotating linear or helical blade, a rotating abrasive burr or an axially movable cutting blade, which is rotated and/or translated by a drive shaft 178 that extends proximally through a lumen 186 within the catheter shaft 184 . Additionally or alternatively, medications, chemicals, ionizing radiation or energy, such as electrical, magnetic, ultrasonic, hydraulic, pulsed hydraulic, laser or thermal energy may be applied through the cutter 172 to assist in removal of the stenotic material and/or for denaturing the remaining tissue to discourage further restenosis at the treatment site.
- medications, chemicals, ionizing radiation or energy such as electrical, magnetic, ultrasonic, hydraulic, pulsed hydraulic, laser or thermal energy may be applied through the cutter 172 to assist in removal of the stenotic material and/or for denaturing the remaining tissue to discourage further restenosis at the treatment site.
- the catheter shaft 184 is a tubular structure which includes the balloon lumen 182 and the drive shaft lumen 186 .
- the catheter shaft 184 may be a polymer tube, a braid reinforced polymer tube, a hollow flexible cable, such as a multifilar wound cable, or a flexible metallic tube.
- the catheter shaft 184 has sufficient torsional rigidity to rotate the housing 174 on the distal end of the catheter by rotating the proximal end of the catheter shaft 184 .
- the drive shaft 178 may be a hollow tube with a guidewire lumen 190 which extends to the distal end for passing a guidewire 56 through for directing the catheter into and across a stented region in an artery.
- the drive shaft 178 may be a polymer tube, a braid reinforced polymer tube, a hollow flexible cable, such as a multifilar wound cable, or a flexible metallic tube.
- the drive shaft 178 may be a solid wire, in which case the guidewire lumen 190 could be a separate lumen within the catheter shaft 184 .
- the stenotic material removal mechanism 170 is positioned by advancing and rotating the inner catheter so that the side aperture 176 of the housing 174 is situated across the stenosis within the stent and inflating the balloon 180 to press the side aperture 176 against the stenotic material. Then, the cutter 172 is actuated by rotating and/or by axially advancing the cutter 172 within the housing 174 to remove stenotic material from within the stent.
- a sensing means 188 , 188 ′ for sensing the proximity or contact between the stenotic material removal mechanism 170 and the stent is positioned on the cutter 172 and/or the housing 174 of the catheter.
- the sensing means 188 , 188 ′ may be in the form of one or more electrode wires which are positioned on the cutter 172 and/or the housing 174 . If the stenotic material removal mechanism 170 operates by electrical or thermal heating or ablation, the heating or ablation electrodes can also serve as the sensing means electrodes for monitoring proximity or contact with the stent. When the sensing means detects sufficient proximity or contact between the cutter 172 and the stent to indicate the desired depth of cut, the cutter 172 is deactivated and withdrawn or directed to another part of the stenosis within the stented portion of the vessel.
- FIGS. 16 - 17 The distal portion of a fifth illustrative embodiment of an inner catheter according to the apparatus of the present invention is depicted in FIGS. 16 - 17 .
- the stenotic material removal mechanism is rotatably and slidably received within an inner lumen 212 of the inner catheter shaft 210 .
- the stenotic material removal mechanism has a rotating cutting head 200 attached to a hollow drive cable 202 which is coaxially and rotatably positioned over a guidewire 204 .
- the rotating cutting head 200 is typically spherical or ovoid in shape and has cutting blades, teeth or abrasive particles 206 on its exterior surface. In one preferred embodiment, the cutting head 200 has minute diamond abrasive particles 206 embedded on its exterior surface.
- the hollow drive cable 202 is preferably a multifilar wound cable, but alternatively may be a polymer tube, a braid reinforced polymer tube, a hollow flexible cable or a flexible metallic tube.
- the inner catheter shaft 210 and/or the guidewire 204 may have a bend 214 , 216 or other steering mechanism close to its distal end for directing the cutting head 200 against the stenotic material within the stent.
- the cutting head 200 may also have control means for adjusting the outer diameter of the cutting head 200 . Suitable cutting head diameter control means are described in U.S. Pat. Nos. 5,217,474 and 5,308,354, the specifications of which are hereby incorporated by reference in their entirety.
- a sensing means for sensing the proximity or contact between the cutting head 200 and the stent is positioned on the cutting head 200 .
- the sensing means may be in the form of one or more electrodes 218 , 220 which are positioned on the cutting head 200 .
- One or more electrode lead wires 222 , 224 may be incorporated into the multifilar hollow drive cable 202 .
- the electrodes 218 , 220 may be exposed or insulated and unipolar or bipolar.
- the cutting head 200 itself may serve as a unipolar sensor electrode and the multifilar hollow drive cable 202 may serve as a single electrode lead wire.
- the stenotic material removal mechanism is operated by advancing the inner catheter so that the cutting head 200 is positioned within the stenosis, then rotating the drive cable 202 and the cutting head 200 to remove stenotic material from within the stent.
- the cutting head 200 is rotated with a high speed motor or turbine which rotates the cutting head at a speed from 2000 to 150000 rpm.
- the rotating action of the cutting head 200 may be accompanied by axially advancing or withdrawing the cutting head 200 through the stenosis.
- the cutting blades, teeth or abrasive particles 206 on the exterior surface of the cutting head 200 comminute, or pulverize, the stenotic material into fine particles that will not cause embolization downstream of the treatment site.
- the optional bend 214 , 216 or steering mechanism of the inner catheter 210 or guidewire 204 may be used for directing the cutting head 200 against the stenotic material within the stent.
- the control means may be used for adjusting the diameter of the cutting head 200 to achieve effective recanalization of the stented artery.
- the sensing means indicates sufficient proximity or contact between the cutting head 200 and the stent, the cutting head 200 is deactivated and withdrawn or advanced and directed to another part of the stenosis within the stented portion of the vessel.
- the monitoring means 80 of the catheter system includes a voltage source that generates a direct or alternating current reference voltage which is applied to a unipolar electrode or applied between two bipolar electrodes positioned on the stenotic material removal mechanism, and an electrical monitor for monitoring the electrical conditions at the sensor electrode or electrodes.
- the electrical monitor may monitor the current leakage at the unipolar or bipolar sensor electrode to detect contact between the sensor electrode and a metallic stent and/or monitor the complex impedance across bipolar electrodes to detect proximity between the sensor electrodes and a metallic stent.
- the monitoring means may optionally include control means for deactivating the stenotic material removal mechanism when an unsafe condition that might lead to stent damage is detected or when the sensing means indicates that an appropriate endpoint for the stenotic material removal process has been reached.
- the monitoring means 80 can be designed to monitor each of the multiple electrodes or sensing locations simultaneously, or it can be designed to have an appropriate sampling rate for alternately monitoring each of the electrodes or sensing locations in sequence.
- the monitoring means may be an optical sensor that includes an optical fiber which transmits a reference beam to a distal end of the catheter and directs it at the inner surface of the vessel close to the stenotic material removal mechanism.
- a photodetector detects the intensity and/or the wavelength of the light reflected back from the inner surface of the vessel through the optical fiber.
- a difference in reflectivity between the tissue of the vessel wall and the stent material allows the photodetector to detect proximity and/or contact between the stenotic material removal mechanism and the stent.
- the monitoring means may be a nonimaging, A mode ultrasonic scanner which generates a pulsed ultrasonic signal in a transducer mounted on or near the stenotic material removal mechanism. Differences in the acoustic impedance between the stent material and the arterial tissue or stenosis will cause echoes of the ultrasonic signal back to the transducer.
- the A mode ultrasonic scanner analyzes the amplitude and timing of the echoes detected by the ultrasonic transducer to measure the depth of the stent within the vessel wall.
- a nonimaging, A mode ultrasonic scanner of this type is much more economical than the imaging ultrasonic scanners which have been described in combination with various atherectomy devices.
- the high echogenicity of the stent material will give a reliable measure of the depth of the stent within the vessel wall without the need for expensive imaging equipment.
- FIGS. 18, 19, 20 and 21 are a series of drawings illustrating the method of the present invention. The method is illustrated and described using the apparatus of FIG. 1 with the stenotic material removal mechanism of FIGS. 2 - 6 by way of example. This method may be applied using any of the various apparatus described above with minor modifications to the procedure.
- the catheter system of FIG. 1 is introduced into the patient's vascular system through a peripheral arterial access using the known techniques of an arterial cutdown, the Seldinger technique and/or an introducer sheath.
- the catheter system is maneuvered to the vicinity of a restenosed region within a previously stented region of the vasculature, for example within a coronary artery, using manipulations of the optional guiding catheter 66 and the outer catheter 60 of the catheter system.
- the inner catheter 50 carrying the stenotic material removal mechanism 52 is positioned on one side of the restenosed stented region and the steerable guidewire 56 is maneuvered across the stenosis.
- the cutting head 100 of the stenotic material removal mechanism is advanced from the inner catheter in the contracted position and positioned across the stenosis S within the stent T.
- the cutting head 100 is then expanded within the stenosis S, as shown in FIG. 19.
- the expansion may occur passively, by withdrawing the optional tubular sheath 58 (shown in FIG. 1) and allowing the resilient cutting blades 102 of the cutting head 100 to expand outward.
- the expansion may occur actively and controllably, by withdrawing the inner actuating member 106 to expand the cutting blades 102 outward and increase the width or diameter of the cutting head 100 .
- the stenotic material removal mechanism is then activated by rotating the cutting head 100 to remove the stenotic material M from within the stenosis S.
- the cutting head 100 may be manually rotated by the operator or by a drive motor 72 within a motor drive unit 70 , as shown in FIG. 1.
- Medications, chemicals, ionizing radiation or energy such as electrical, magnetic, ultrasonic, hydraulic, pulsed hydraulic, laser or thermal energy may be applied to assist in removal of the stenotic material M and/or for denaturing the remaining tissue to discourage further restenosis at the treatment site.
- the stenotic material M that is removed may be aspirated out through the aspiration port 64 of the outer catheter 60 (shown in FIG. 1).
- the electrodes 116 , 118 of the sensing means located on the cutting blades 102 monitor the proximity or contact between the cutting head 100 and the stent T.
- the stenotic material removal mechanism is deactivated.
- the catheter system is then withdrawn, leaving the stented region recanalized and open to renewed blood flow, as shown in FIG. 21.
- FIGS. 22, 23, 24 and 25 are a series of drawings illustrating an alternate method of the present invention. As above, the method is illustrated and described using the stenotic material removal mechanism of FIGS. 2 - 6 , but the method may be applied using most of the various apparatus described above with minor modifications to the procedure.
- the catheter carrying the stenotic material removal mechanism is positioned on one side of the restenosed stented region.
- the cutting head 100 of the stenotic material removal mechanism is extended from the catheter and advanced part-way into the stent T and the cutting blades 102 are expanded outward, as shown in FIG. 22.
- the electrodes 116 , 118 of the sensing means located on the cutting blades 102 monitor the proximity or contact between the cutting head 100 and the stent T so that the diameter of the cutting head 100 can be accommodated to the internal diameter of the stent T. If the stenosis S does not extend all of the way to the end of the stent T, the expansion step can be performed while the cutting head 100 is stationary. However, if necessary, the stenotic material removal mechanism can be activated by rotating the cutting head 100 as the cutting blades 102 expand outward to begin removing the stenotic material M while adjusting the diameter of the cutting head 100 to the size of the stent T.
- the stenotic material M is removed from within the stent T by rotating the cutting head 100 and advancing it through the stenosis S, as shown in FIGS. 23 and 24.
- the diameter of the cutting head 100 can be held constant as it is advanced through the stenosis S or it can be adjusted continuously based on feedback from the sensing means.
- Medications, chemicals, ionizing radiation or energy such as electrical, magnetic, ultrasonic, hydraulic, pulsed hydraulic, laser or thermal energy may be applied to assist in removal of the stenotic material M and/or for denaturing the remaining tissue to discourage further restenosis at the treatment site.
- the stenotic material M that is removed may be aspirated out through the aspiration port 64 of the outer catheter 60 (shown in FIG. 1).
- the stenotic material removal mechanism is deactivated and the catheter system is withdrawn, leaving the stented region recanalized and open to renewed blood flow, as shown in FIG. 25.
- This method can be effectively performed in the reverse direction, by advancing the cutting head 100 all the way across the stenosis in a contracted or compressed state.
- the cutting head 100 is then expanded within the far end of the stenosis S or within the vessel beyond the stenosis, using the sensing means to adjust the diameter of the cutting head 100 to the size of the stent T.
- the cutting head 100 is then rotated while withdrawing it toward the catheter to advance it through the stenosis S.
- FIGS. 26, 27, 28 and 29 are a series of drawings illustrating another alternate method of the present invention.
- the method is illustrated and described using the stenotic material removal mechanism of FIGS. 2 - 6 , but the method may be applied using most of the various apparatus described above with minor modifications to the procedure.
- the catheter carrying the stenotic material removal mechanism is positioned on one side of the restenosed stented region.
- the cutting head 100 of the stenotic material removal mechanism is extended from the catheter and advanced part-way into the stenosis S within the stent T, as shown in FIG. 26.
- the cutting blades 102 are then expanded outward within the stenosis S, either passively or actively and controllably as described above, to increase the width or diameter of the cutting head 100 .
- the stenotic material removal mechanism is then activated by rotating the cutting head 100 to begin removing the stenotic material M from within the stenosis S, as shown in FIG. 27.
- Medications, chemicals, ionizing radiation or energy such as electrical, magnetic, ultrasonic, hydraulic, pulsed hydraulic, laser or thermal energy may be applied to assist in removal of the stenotic material M and/or for denaturing the remaining tissue to discourage further restenosis at the treatment site.
- the stenotic material M that is removed may be aspirated out through the aspiration port 64 of the outer catheter 60 (shown in FIG.
- the electrodes 116 , 118 of the sensing means located on the cutting blades 102 monitor the proximity or contact between the cutting head 100 and the stent T.
- the cutting head 100 is advanced farther into the stenosis S, as shown in FIG. 28.
- the stenotic material removal mechanism may be deactivated and advanced step-wise into the stenosis S by contracting or compressing the cutting head 100 , advancing it a short distance and expanding it again in a new portion of the stent T.
- the cutting head 100 may be advanced continuously, relying on either the resiliency of the cutting blades 102 or active control for adjusting the width or diameter of the cutting head 100 as it advances.
- the sensing means indicates that the new portion of the stent T has been effectively recanalized
- the cutting head 100 is advanced again along the stenosis S until the entire stented region has been recanalized, as shown in FIG. 29.
- This method can be effectively performed in the reverse direction, by advancing the cutting head 100 all the way across the stenosis in a contracted or compressed state.
- the cutting head 100 is then expanded within the far end of the stenosis S or within the vessel beyond the stenosis, either passively or actively and controllably as described above, to increase the width or diameter of the cutting head 100 .
- the cutting head 100 is then rotated while withdrawing it toward the catheter to advance it through the stenosis in either a step-wise or continuous fashion.
- Medications, chemicals, ionizing radiation or energy such as electrical, magnetic, ultrasonic, hydraulic, pulsed hydraulic, laser or thermal energy may be applied to assist in removal of the stenotic material and/or for denaturing the remaining tissue to discourage further restenosis at the treatment site.
- the sensing means is used to monitor the proximity or contact between the cutting head 100 and the stent T in order to control the diameter and/or the rate of advancement of the cutting head 100 for effective recanalization of the stenosis S within the stent T.
- FIGS. 30, 31 and 32 are a series of drawings illustrating the operation of an optional embolic filter apparatus 90 which may be used in conjunction with the method of the present invention.
- the embolic filter apparatus 90 may be arranged coaxially as part of the catheter system as shown in FIG. 1 and introduced through a single vascular access point and positioned distally to the treatment site.
- embolic filter apparatus 90 may be arranged on a separate catheter which is introduced through a different vascular access point and positioned proximally or distally to the treatment site.
- the embolic filter 90 is shown in its compacted position within a tubular sheath 92 as it is first introduced into the vasculature and advanced to or across the stenosis.
- the tubular sheath 92 may be the same as the tubular sheath 58 or the inner catheter 50 of the catheter system of FIG. 1.
- the embolic filter 90 may be delivered coaxially over a separate guidewire 56 , or it may be built integrally with a guidewire 56 constructed especially for the purpose.
- the expansion can occur passively, or an actuation member 94 may be used to actively expand the embolic filter 90 .
- the embolic filter 90 should be expandable over a range of approximately 2 mm to 5 mm for use in stented coronary arteries or as high as 6 mm for use in stented vein grafts and even larger for use in stented peripheral vessels and other stented body structures.
- the embolic filter 90 should contract to as small a diameter as possible for passing through tightly stenotic lesions, preferably to a diameter smaller than 2 mm, more preferably to a diameter smaller than 1 mm.
- the embolic filter 90 has a plurality of structural members 96 , which enclose and support a nonthrombogenic expandable filter medium 98 .
- the structural members 96 can be made of a metallic or polymeric material, and may be biased radially outward to assist in expansion of the embolic filter 90 .
- the expandable filter medium 98 may be a porous foam material or it may be a fibrous filter medium such as polyester fiber, which, in its expanded state, has a pore size appropriate for capturing significant emboli which may be dislodged during the stenotic material removal process.
- the pore size of the expandable filter medium 98 may advantageously be in the range of 0.01 to 0.2 mm to capture potential emboli.
- the outer catheter 99 may be the inner catheter 50 or outer catheter 60 of the catheter system of FIG. 1.
- the outer catheter 99 and the embolic filter 90 are then withdrawn from the patient's vasculature.
- embolic filters and/or occlusion balloons may be placed upstream and downstream of the treatment site to isolate or capture potential emboli.
- FIGS. 33, 34, 35 and 36 are a series of drawings illustrating a method and an apparatus according to the present invention that combine a stenotic material removal mechanism with an embolic filter for capturing stenotic material M which is removed from within the stent T.
- the apparatus has a cutting head 300 which is mounted on the distal end of an inner catheter shaft 302 .
- the cutting head 300 has a cutting portion 304 and a filtering or material capturing portion 306 .
- the cutting portion 304 is centrally located on the cutting head 300 and the material capturing portion 306 is located distal to it.
- the cutting head 300 should be expandable over a range of approximately 2 mm to 5 mm for use in stented coronary arteries or as high as 6 mm for use in stented vein grafts and even larger for use in stented peripheral vessels and other stented body structures.
- the cutting head 300 should contract to as small a diameter as possible for passing through tightly stenotic lesions, preferably to a diameter smaller than 2 mm, more preferably to a diameter smaller than 1 mm.
- the effective cutting length of the cutting portion 304 is preferably within the range of approximately 10 mm to 40 mm for use in stented coronary arteries and can be longer for use in stented peripheral vessels.
- the cutting head 300 may also include a second material capturing portion 306 ′ located proximally to the cutting portion 304 .
- the material capturing portion 306 may occupy the entire length of the cutting head 300 .
- the cutting portion 304 of the cutting head 300 may take any one of the different forms described herein in connection with the various embodiments of the invention.
- the cutting portion 304 is shown having a plurality of longitudinally oriented cutting blades 308 , similar to those shown in FIGS. 2 - 6 .
- the cutting blades may be laterally or circumferentially oriented or helically configured, similar to those shown in FIGS. 7 - 10 , or any convenient geometry.
- the cutting blades 308 of the cutting head 300 may be either passively or actively expandable, as described above.
- the material capturing portion 306 preferably contains a nonthrombogenic expandable filter medium 310 .
- the expandable filter medium 310 may be a porous foam material or it may be a fibrous filter medium such as polyester fiber, which, in its expanded state, has a pore size appropriate for capturing significant emboli which may be dislodged during the stenotic material removal process.
- the pore size of the expandable filter medium 310 may advantageously be in the range of 0.01 to 0.2 mm to capture potential emboli.
- the expandable filter medium 310 is enclosed and supported by the cutting blades 308 of the cutting head 300 .
- the expandable filter medium 310 may include a membranous filter material that is attached to and suspended between the cutting blades 308 of the cutting head 300 . Suitable membranous filter materials include flexible woven, nonwoven or knitted filtration fabrics.
- the expandable filter medium 310 occupies a distal portion 306 and/or a proximal portion 306 ′ of the cutting head 300 . Alternatively, the expandable filter medium 310 may occupy the entire length of the cutting head 300 .
- the catheter carrying the stenotic material removal mechanism is positioned on one side of the restenosed stented region.
- the cutting head 300 is extended from the catheter and advanced across the stenosis S in the contracted position, as shown in FIG. 33.
- the expandable filter medium 310 is compressed within the cutting head 300 .
- the cutting head 300 is then expanded within the stenosis S, as shown in FIG. 34. The expansion may occur passively, by withdrawing a surrounding tubular sheath 58 (shown in FIG. 1) and allowing the resilient cutting blades 308 of the cutting head 300 to expand outward.
- the expansion may occur actively and controllably, by operating an actuating mechanism to expand the cutting blades 308 outward and increase the width or diameter of the cutting head 300 , as described above in connection with FIGS. 2 - 6 .
- the filter medium 310 within the material capturing portion 306 of the cutting head 300 expands to a diameter at least as large or larger than the expanded diameter of the cutting portion 304 of the cutting head 300 .
- the stenotic material removal mechanism is then activated by rotating the cutting head 300 to remove the stenotic material M from within the stenosis S.
- the cutting head 300 may be rotated manually by the operator or by a drive motor 72 within a -motor drive unit 70 , as shown in FIG. 1.
- Medications, chemicals, ionizing radiation or energy such as electrical, magnetic, ultrasonic, hydraulic, pulsed hydraulic, laser or thermal energy may be applied to assist in removal of the stenotic material M and/or for denaturing the remaining tissue to discourage further restenosis at the treatment site.
- the stenotic material M that is removed is captured by the filter medium 310 within the material capturing portion 306 of the cutting head 300 , as shown in FIG. 35.
- the cutting head 300 includes a sensing means, such as the sensor electrodes 116 , 118 described above in connection with FIGS. 5 and 6, for sensing the proximity or contact between the cutting blades 308 of the cutting head 300 and the stent T.
- a sensing means such as the sensor electrodes 116 , 118 described above in connection with FIGS. 5 and 6, for sensing the proximity or contact between the cutting blades 308 of the cutting head 300 and the stent T.
- the stenotic material removal mechanism is deactivated.
- the cutting head 300 and all of the stenotic material M captured by the filter medium 310 within the material capturing portion 306 of the cutting head 300 are then withdrawn into the outer catheter 60 , as shown in FIG. 36.
- the catheter system is then withdrawn from the patient, leaving the stented region recanalized and open to renewed blood flow.
- this cutting head 300 with a combined stenotic material removal mechanism and stenotic material capture mechanism may be operated as a simple shearing body without a sensing means.
- the cutting head 300 may be rotated and/or translated within the stenosis S to dislodge stenotic material M from within an interface envelope defined by the stent T embedded within the vessel wall, as shown in FIG. 34.
- the cutting head 300 may be expanded passively or actively to remove all of the stenotic material M from within the stent T.
- the stenotic material M that is removed is captured by the filter medium 310 within the material capturing portion 306 of the cutting head 300 , as shown in FIG. 35.
- the cutting head 300 and all of the stenotic material M captured by the filter medium 310 within the material capturing portion 306 of the cutting head 300 are then withdrawn into the outer catheter 60 , as shown in FIG. 36.
- FIGS. 37, 38 and 39 are a series of drawings illustrating an alternate method and apparatus according to the present invention that also combine a stenotic material removal mechanism with a means for capturing the stenotic material M that is removed from within the stent T.
- the apparatus has a head 350 which is mounted on the distal end of an inner catheter shaft 352 .
- the head 350 is a cage-like structure of counterwound or interwoven helical elements 356 .
- the helical elements 356 may comprise round filaments, ribbon filaments, or the like, made of a metallic or polymeric material.
- the helical elements 356 are attached to a distal ring 358 and to a proximal ring 360 which is free to slide over the inner catheter shaft 352 .
- the helical elements 356 may be treated by coldworking or heat treatment to have an elastic memory so that they are biased toward the expanded position, allowing the head 350 to be passively expanded.
- the proximal ring 360 may optionally be attached to a rod, sleeve, or other means 362 for axially translating the proximal ring 360 to actively and controllably adjust the radius of the head 350 .
- the cage-like structure of counterwound or interwoven helical elements 356 serves to capture dislodged stenotic material M that passes through the interstices between the helical elements 356 .
- the catheter 60 carrying the stenotic material removal mechanism is positioned on one side of the restenosed stented region.
- the head 350 is extended from the catheter and advanced across the stenosis S in a contracted position, as shown in FIG. 37.
- the head 350 is then expanded within the stenosis S, either passively or actively and controllably as described above.
- the stenotic material removal mechanism is then activated by rotating and/or translating the head 350 within the stenosis S to remove stenotic material M from within the stent T, as shown in FIG. 38.
- the head 350 may be rotated manually by the operator or by a drive motor 72 within a motor drive unit 70 , as shown in FIG. 1.
- the head 350 may operate by cutting action, abrasive action or shearing action.
- medications, chemicals, ionizing radiation or energy such as electrical, magnetic, ultrasonic, hydraulic, pulsed hydraulic, laser or thermal energy may be applied to assist in removal of the stenotic material M and/or for denaturing the remaining tissue to discourage further restenosis at the treatment site.
- the stenotic material M that is dislodged passes through the interstices between the helical elements 356 and is captured within the cage-like structure of the head 350 .
- the head 350 includes a sensing means for sensing the proximity or contact between the helical elements 356 of the head 350 and the stent T.
- the sensing means may take the form of one or more sensor electrode wires 366 , 368 interwoven among the helical elements 356 of the head 350 .
- the helical elements 356 of the head 350 may serve as sensor electrodes themselves.
- the head 350 and all of the stenotic material M captured within the cage-like structure of the helical elements 356 are then withdrawn into the outer catheter 60 , as shown in FIG. 39.
- the interstices between the helical elements 356 of the head 350 contract as the head 350 is drawn into the catheter 60 , helping to assure that the particles of dislodged stenotic material M remain captured within the catheter.
- the catheter system is then withdrawn from the patient, leaving the stented region recanalized and open to renewed blood flow.
- the head 350 of this apparatus may be operated as a simple shearing body without a sensing means.
- the head 350 may be rotated and/or translated within the stenosis S to dislodge stenotic material M from within an interface envelope defined by the stent T embedded within the vessel wall, as shown in FIG. 38.
- the head 350 may be expanded passively or actively to remove all of the stenotic material M from within the stent T.
- the stenotic material M that is dislodged passes through the interstices between the helical elements 356 and is captured within the cage-like structure of the head 350 .
- the head 350 and all of the stenotic material M captured within it are then withdrawn into the outer catheter 60 , as shown in FIG. 39.
- a catheter kit according to the present invention comprises a catheter or catheter system 370 , often mounted on a board or in a tray 372 , instructions for use (IFU) 374 , and a pouch 376 or other conventional package.
- a motor drive unit 70 (FIG. 1) may be packaged together with the catheter kit or separately.
- the instructions for use (IFU) 374 are typically part of a separate sheet or booklet which together with the catheter 370 , is packaged within the pouch 376 or other packaging material.
- the packaging and its contents will preferably be sterile or sterilizable.
- the instructions for use (IFU) 374 will set forth method steps comprising the method(s) as described above.
Landscapes
- Health & Medical Sciences (AREA)
- Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medical Informatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Surgical Instruments (AREA)
Abstract
Apparatus and methods for treating in-stent restenosis are described for removing stenotic material from within previously stented regions of a patient's vasculature. The apparatus includes a catheter system having a stenotic material removal mechanism mounted on a distal portion of an elongated inner catheter. A sensing means, such as one or more sensing electrodes, are positioned on an outer surface of the apparatus. In addition, the apparatus optionally includes control means for diametrically expanding the stenotic material removal mechanism for effective recanalization of the stent. A coaxial outer catheter is provided for aspirating stenotic material which is removed from within the stent. In addition, embolic filter apparatus are described for collecting the stenotic material removed from within the stent. The methods comprise operating the stenotic material removal mechanism within a body vessel, typically a coronary artery or other artery, which has become restenosed or otherwise occluded following the initial stent placement, and sensing the proximity or contact between the stenotic material removal mechanism and the stent within the arterial wall so that the stenosis can be effectively recanalized without damaging the stent. The sensing means may be used to indicate an unsafe condition that might lead to stent damage, in response to which, the stenotic material removal mechanism may be manually or automatically deactivated. Alternatively or additionally, the sensing means may be used to indicate an appropriate endpoint for the stenotic material removal process.
Description
- This patent application is a division of application Ser. No. 08/857,659, filed May 16, 1997, which is a continuation-in-part of co-owned, copending patent application, Ser. No. 08/798,722, filed Feb. 12, 1997, the entire disclosures of which are incorporated herein by reference.
- 1. Field of the Invention
- The present invention relates generally to apparatus and methods for removing occluding material from stented regions within blood vessels which have restenosed. More particularly, the present invention relates to apparatus and methods for sensing a stent within the wall of a restenosed blood vessel and removing the occluding material without damaging the stent.
- Percutaneous transluminal angioplasty (PTA) and percutaneous transluminal coronary angioplasty (PTCA) procedures are widely used for treating stenotic atherosclerotic regions of a patient's vasculature to restore adequate blood flow. Catheters having an expansible distal end, typically in the form of an inflatable balloon, are positioned in an artery, such as a coronary artery, at a stenotic site. The expansible end is then expanded to dilate the artery in order to restore adequate blood flow to regions beyond the stenosis. While PTA and PTCA have gained wide acceptance, these angioplasty procedures suffer from two major problems: abrupt closure and restenosis.
- Abrupt closure refers to rapid reocclusion of the vessel within hours of the initial treatment, and often occurs in patients who have recently suffered acute myocardial infarction. Abrupt closure often results from either an intimal dissection or from rapid thrombus formation which occurs in response to injury of the vascular wall from the initial angioplasty procedure. Restenosis refers to a re-narrowing of the artery over the weeks or months following an initially apparently successful angioplasty procedure. Restenosis occurs in up to 50% of all angioplasty patients and results at least in part from smooth muscle cell proliferation and migration.
- Many different strategies have been proposed to ameliorate abrupt closure and reduce the rate of restenosis. Of particular interest to the present invention, the implantation of vascular stents following angioplasty has become widespread. Stents are thin-walled tubular scaffolds which are expanded in the arterial lumen following the angioplasty procedure. Most commonly, the stents are formed from a malleable material, such as stainless steel, and are expanded in situ using a balloon. Alternatively, the stents may be formed from a shape memory alloy or other elastic material, in which case they are allowed to self-expand at the angioplasty treatment site. In either case, the stent acts as a mechanical support for the artery wall, inhibiting abrupt closure and reducing the restenosis rate as compared to PTCA.
- While stents have been very successful in inhibiting abrupt closure and reasonably successful in inhibiting restenosis, a significant portion of the treated patient population still experiences restenosis over time. Most stent structures comprise an open lattice, typically in a diamond or spiral pattern, and cell proliferation (also referred to as intimal hyperplasia) can intrude through the interstices between the support elements of the lattice. As a result, instead of forming a barrier to hyperplasia and restenosis, the stent can become embedded within an accumulated mass of thrombus and tissue growth, and the treatment site once again becomes occluded.
- To date, proposed treatments for restenosis within previously stented regions of the coronary and other arteries have included both follow-up balloon angioplasty and directional atherectomy, e.g. using the Simpson directional atherectomy catheter available from Guidant Corporation, Santa Clara, Calif. Neither approach has been wholly successful. Balloon angioplasty can temporarily open the arterial lumen, but rarely provides long-term patency. Directional atherectomy can successfully debulk the lumen within the stent, but typically does not fully restore the stented lumen to its previous diameter because the catheter removes the stenotic material in an asymmetric pattern. Moreover, it has been found that the atherectomy cutting blades can damage the implanted stent. Such adverse effects were reported by Bowerman et al. in Disruption of a coronary stent during atherectomy for restenosis in the December 1991 issue of Catheterization and Cardiovascular Diagnosis and by Meyer et al. in Stent wire cutting during coronary directional atherectomy in the May 1993 issue of Clinical Cardiology. The possibility of such adverse outcomes is likely to limit the application of atherectomy as a treatment for stent restenosis and will probably result in more tentative use of the atherectomy cutter within the stented region when it is applied, leading to less complete removal of the stenosis.
- For these reasons, it would be desirable to provide improved methods for treating restenosis within regions of the vasculature which have previously been implanted with stents. More particularly, it would be desirable to provide an apparatus for removal of stenotic material from within a stent which includes a sensing means for sensing when the stenosis removal mechanism is approaching or contacting the stent within the arterial wall so that the occluded artery can be effectively recanalized without damaging the stent. The stenosis removal mechanism of the apparatus may advantageously be a directional cutting or debulking device for selectively removing the stenotic material from within a stent or it may be a symmetrical cutting or debulking device for removing the stenotic material uniformly from the entire inner periphery of the stent.
- 2. Description of the Background Art
- Post-angioplasty restenosis is discussed in the following publications: Khanolkar (1996) Indian Heart J. 48:281-282; Ghannem et al. (1996) Ann. Cardiol. Angeiol. 45:287-290; Macander et al. (1994) Cathet. Cardiovasc. Diagn. 32:125-131; Strauss et al. (1992) J. Am. Coll. Cardiol. 20:1465-1473; Bowerman et al. (1991) Cathet. Cardiovasc. Diagn. 24:248-251; Moris et al. (1996) Am. Heart. J. 131:834-836; Schomig et al. (1994) J. Am. Coll. Cardiol. 23:1053-1060; Haude et al., “Treatment of In-Stent Restenosis,” in ______,
Chapter 52, pages 357-365; Gordon et al. (1993) J. Am. Coll. Cardiol. 21:1166-1174; and Baim et al. (1993) Am. J. Cardiol. 71:364366. These publications include descriptions of follow-up angioplasty and atherectomy as possible treatments for restenosis. - Atherectomy catheters having ultrasonic imaging transducers are described in U.S. Pat. Nos. 5,000,185 and 5,100,424. Rotary ablation catheters having selectively expandable burr components are described in U.S. Pat. Nos. 5,217,474 and 5,308,354. A catheter carrying an expandable filter is described in U.S. Pat. No. 4,723,549.
- Thrombectomy and atherectomy catheters having rotating brush and filament structures are described in U.S. Pat. Nos. 5,578,018; 5,535,756; 5,427,115; 5,370,653; 5,009,659; and 4,850,957; WO 95/29626; DE 39 21 071 C2; and Netherlands 9400027.
- Representative atherectomy catheters are described in U.S. Pat. Nos. 4,273,128; 4,445,509; 4,653,496; 4,696,667; 4,706,671; 4,728,319; 4,732,154; 4,762,130; 4,790,812; 4,819,634; 4,842,579; 4,857,045; 4,857,046; 4,867,156; 4,883,458; 4,886,061; 4,890,611; 4,894,051; 4,895,560; 4,926,858; 4,966,604; 4,979,939; 4,979,951; 5,011,488; 5,011,489; 5,011,490; 5,041,082; 5,047,040; 5,071,424; 5,078,723; 5,085,662; 5,087,265; 5,116,352; 5,135,483; 5,154,724; 5,158,564; 5,160,342; 5,176,693; 5,192,291; 5,195,954; 5,196,024; 5,209,749; 5,224,945; 5,234,451; 5,269,751; 5,314,438; 5,318,576; 5,320,634; 5,334,211; 5,356,418; 5,360,432; 5,376,100; 5,402,790; 5,443,443; 5,490,859; 5,527,326; 5,540,707; 5,556,405; 5,556,408; and 5,554,163.
- The disclosures of these patent are incorporated herein by reference in their entirety.
- The present invention provides apparatus and methods for removing stenotic material from within previously stented regions of a patient's vasculature. The present invention is particularly intended for treating regions of restenosis within a stent which result from accumulation of cellular, thrombotic, and other material over the weeks and months following an initially successful stent implant. The present invention will also be useful for treating relatively rapid thrombus formation which may sometimes occur during the hours and days following a stent placement procedure.
- Methods according to the present invention comprise operating a stenotic material removal mechanism within a blood vessel, typically a coronary artery or other artery, which has become restenosed or otherwise occluded following the initial stent placement, and sensing the proximity or contact between the stenotic material removal mechanism and the stent within the arterial wall so that the occluded vessel can be effectively recanalized without damaging the stent. The sensing means for sensing the proximity or contact between the stenotic material removal mechanism and the stent may be used to indicate an unsafe condition that might lead to stent damage, in response to which, the stenotic material removal mechanism may be manually or automatically deactivated. Alternatively or additionally, the sensing means may be used to indicate an appropriate endpoint for the stenotic material removal process.
- According to this second aspect, the indication of the proximity or contact between the stenotic material removal mechanism and the stent provided by the sensing means may be used as feedback for controlling the stenotic material removal process in the following ways: When used in conjunction with a directional stenotic material removal mechanism, the sensing means may be used to guide the directional stenotic material removal mechanism either to remove stenotic material from selected portions of the interior of the stent or to remove stenotic material uniformly from the entire inner periphery of the stent. When used in conjunction with a controllable-depth stenotic material removal mechanism, the indication from the sensing means may be used as feedback to manually or automatically control the depth of stenotic material removal, preferably to remove stenotic material uniformly from the entire inner periphery of the stent. When used in conjunction with a controllable-width or diameter stenotic material removal mechanism, the indication from the sensing means may be used as feedback to manually or automatically control the width or diameter of the blood flow channel created within the stent. In certain embodiments of the method, the feedback from the sensing means may be used to control a combination of the directionality and the depth or diameter of the stenotic material removal process either to remove stenotic material from selected portions of the interior of the stent or to remove stenotic material uniformly from the entire inner periphery of the stent.
- In a preferred aspect of the method of the present invention, a catheter carrying the stenotic material removal mechanism is positioned on one side of the restenosed stented region. The stenotic material removal mechanism is advanced from the catheter and positioned across the stenosis within the stent. The stenotic material removal mechanism is then expanded within the stenosis. The expansion may occur passively, as with a resilient stenotic material removal mechanism having one or more resilient members, such as one or more wire-shaped cutting blades, which are released from a tubular sheath and allowed to expand. Otherwise, the expansion may occur actively and controllably, such as with a stenotic material removal mechanism having one or more wire-shaped cutting blades which are actively and controllably extended outward to increase the width or diameter of the stenotic material removal mechanism, or such as a stenotic material removal mechanism having a cutter within a housing and an inflatable balloon located on one side of the housing which is inflated to increase the width or diameter of the stenotic material removal mechanism. The stenotic material removal mechanism is then activated for removing the stenotic material from within the stent. This is typically done by rotating and/or translating the entire stenotic material removal mechanism or a component of it within the stenosis. Medications, chemicals, ionizing radiation or energy, such as electrical, magnetic, ultrasonic, hydraulic, pulsed hydraulic, laser or thermal energy may be applied to assist in removal of the stenotic material and/or for denaturing the remaining tissue to discourage further restenosis at the treatment site. A sensing means which is located on or adjacent to the stenotic material removal mechanism monitors the proximity or contact between the stenotic material removal mechanism and the stent. When the stenotic material removal mechanism has approached close enough to the stent to indicate effective recanalization of the stenosis, the stenotic material removal mechanism is deactivated. In this way, the sensing means provides an interaction between the stenotic material removal mechanism and the stented vessel to achieve effective recanalization of the stenosis without damaging or dislodging the stent within the vessel wall.
- In an alternative aspect of the method of the present invention, the catheter carrying the stenotic material removal mechanism is positioned on one side of the restenosed stented region. The stenotic material removal mechanism is extended from the catheter and advanced part-way into the stenosis within the stent. The stenotic material removal mechanism is then expanded within the stenosis, either passively or actively and controllably as described above, to increase the width or diameter of the stenotic material removal mechanism. The stenotic material removal mechanism is then activated for removing the stenotic material from within a portion of the stent. This may be done by rotating and/or translating the entire stenotic material removal mechanism or a component of it within the stenosis. Medications, chemicals, ionizing radiation or energy, such as electrical, magnetic, ultrasonic, hydraulic, pulsed hydraulic, laser or thermal energy may be applied to assist in removal of the stenotic material and/or for denaturing the remaining tissue to discourage further restenosis at the treatment site. A sensing means which is located on or adjacent to the stenotic material removal mechanism monitors the proximity or contact between the stenotic material removal mechanism and the stent. When the stenotic material removal mechanism has approached close enough to the stent to indicate effective recanalization of that portion of the stenosis, the stenotic material removal mechanism is advanced farther into the stenosis. The stenotic material removal mechanism may be deactivated and advanced step-wise into the stenosis by contracting or compressing the stenotic material removal mechanism, advancing it a short distance and expanding it again in a new portion of the stent. Otherwise, the stenotic material removal mechanism may be advanced continuously, relying on either the resiliency of the stenotic material removal mechanism or active control for adjusting the width or diameter of the stenotic material removal mechanism as it advances. When the sensing means indicates that the new portion of the stent has been effectively recanalized, the stenotic material removal mechanism is advanced again along the stenosis until the entire stented region has been recanalized.
- Alternatively, the stenotic material removal mechanism may be extended from the catheter and advanced all the way across the stenosis in a contracted or compressed state. The stenotic material removal mechanism is then expanded within the far end of the stenosis or within the vessel beyond the stenosis, either passively or actively and controllably as described above, to increase the width or diameter of the stenotic material removal mechanism. The stenotic material removal mechanism is then activated for removing the stenotic material while withdrawing the stenotic material removal mechanism toward the catheter to advance it through the stenosis in either a step-wise or continuous fashion. Medications, chemicals, ionizing radiation or energy, such as electrical, magnetic, ultrasonic, hydraulic, pulsed hydraulic, laser or thermal energy may be applied to assist in removal of the stenotic material and/or for denaturing the remaining tissue to discourage further restenosis at the treatment site. The sensing means which is used to monitor the proximity or contact between the stenotic material removal mechanism and the stent in order to control the diameter and/or the rate of advancement of the stenotic material removal mechanism for effective recanalization of the stenosis within the stent.
- The methods of the present invention may include providing a sensing means in the form of one or more open, exposed electrodes which are located on or adjacent to the stenotic material removal mechanism. A direct or alternating current reference voltage is applied to a unipolar electrode or applied between two bipolar electrodes, and the current leakage of the electrode or electrodes is monitored. When one or more of the electrodes contacts the metallic stent, the leakage current increases indicating that the stenotic material has been removed down to the stent support members for effective recanalization of the stenosis within that portion of the stent. Alternatively, the methods of the present invention may include providing a sensing means in the form of two exposed or insulated bipolar electrodes which are located on or adjacent to the stenotic material removal mechanism. An alternating current reference voltage is applied between the bipolar electrodes, and the complex impedance between the electrodes is monitored. As the electrodes approach the metallic stent, the capacitive and inductive characteristics of the electrode circuit change, which can be detected as a change in the complex impedance between the electrodes. When the complex impedance between the electrodes has changed a sufficient amount to indicate effective recanalization of the stenosis within that portion of the stent, the stenotic material removal mechanism may be deactivated or advanced along the stenosis as appropriate. The sensing means can be used to control or guide the stenotic material removal mechanism to remove the stenotic material to within a predetermined thickness of the stent support members or the stenotic material can be removed all the way down to the stent support members without fear of damaging the stent. If exposed electrodes are used in this method, monitoring the complex impedance between the electrodes will indicate when the stenotic material removal mechanism is approaching the metallic stent, then when one or more of the electrodes contacts the metallic stent, it will ground to the stent which can be detected as an extreme change in the complex impedance or as a rise in the leakage current. Thus, the sensing means can be used to separately indicate proximity and contact between the stenotic material removal mechanism and the stent. The sensing means can operate with very low voltage and current that will not create any adverse physiological effects on the vascular wall or the tissues and nerve pathways of the heart.
- In embodiments where the stenotic material removal mechanism uses direct or alternating current electrical energy to assist in removal of the stenotic material and/or for denaturing the remaining tissue to discourage further restenosis at the treatment site, for example by heating or by radio frequency ablation, the heating or ablation electrodes can serve double duty as the sensing means electrodes for monitoring proximity or contact with the metallic stent.
- Other types of proximity sensors sensitive to the metallic stent may be used in place of those described. Alternatively, optical or ultrasonic sensors may be used in place of the electronic detectors described for detection of both metallic and nonmetallic stents. For example, a nonimaging, A mode ultrasonic transducer can be used to detect both metallic and nonmetallic stents and to measure their depth within the arterial wall based on echoes caused by the difference in acoustic impedance between the stent material and the arterial tissue or stenosis.
- The methods of the present invention will optionally further comprise collecting and withdrawing the removed stenotic material from the blood vessel. Collection and withdrawal of the removed stenotic material may be accomplished using the same catheter or catheter assembly which carries the stenotic material removal mechanism, typically by aspiration, entrapment, filtering or some combination thereof. It will be appreciated that various catheter assemblies can be put together using coaxially arranged components which may be introduced through a single vascular access point, such as a femoral or brachial artery. Alternatively, collection and withdrawal can be accomplished using separate collection apparatus, such as a catheter or catheter assembly, which is introduced through a separate access point. In some instances, it may be desirable to partially or totally isolate the stented region from circulation during recanalization. For example, embolic filters or occlusion balloons may be placed upstream and downstream of the treatment site. Alternatively or additionally, the methods of the present invention may optionally further comprise comminution of the removed stenotic material into microscopic particles that will not cause embolization downstream of the treatment site.
- The methods of the present invention will also optionally comprise the use of introducer means, such as introducer needles, guidewires and/or introducer sheaths for introducing the catheter or catheter system into the vascular system and guide means, such as steerable guidewires and selective and/or subselective guiding or delivery catheters for guiding and advancing the catheter or catheter system through the vasculature to the treatment site and supporting it during the treatment. The selective and subselective guiding or delivery catheters may also serve the functions of aspiration, collection and withdrawal of the removed stenotic material, as well as for infusion of therapeutic substances.
- Apparatus according to the present invention include catheters, catheter systems, and catheter kits which are specially intended and adapted for performing the methods described above. In particular, the apparatus are designed to afford percutaneous intravascular placement of a catheter carrying a stenotic material removal mechanism for removing stenotic material from within a previously stented region of the vasculature and a sensing means for sensing when the stenotic material removal mechanism is approaching or contacting the stent within the vascular wall. This inventive combination facilitates the effective recanalization of previously placed vascular stents that have become restenosed without risking damaging the stent. To that end, catheter systems according to the present invention may comprise an inner catheter shaft having a proximal end and a distal end. The stenotic material removal mechanism is disposed near the distal end of the inner catheter shaft. The inner catheter shaft will preferably include a guidewire lumen for introduction of the catheter system over a steerable guidewire. The inner catheter shaft may have additional lumens or actuating mechanisms associated with the stenotic material removal mechanism. Various embodiments of the stenotic material removal mechanism will be more fully described below. In embodiments where the stenotic material removal mechanism comprises resilient members which are radially compressible, the catheter system may also include a tubular sheath which serves to maintain the stenotic material removal mechanism in a compressed state as it is maneuvered to, and potentially across, the stenosis. The catheter system will usually further include an outer catheter tube having a proximal end, a distal end and an inner lumen. The outer catheter tube will usually have an aspiration port near its proximal end so that dislodged stenotic material can be aspirated from the vasculature. The outer catheter tube may optionally have selective or subselective curves formed near the distal end of the catheter tube for directing and maneuvering the catheter system through the vasculature to the site of the stenosis. In addition, an outer guiding catheter, for example a coronary guiding catheter, may be used for guiding the catheter system into the desired part of the vasculature and supporting it during the treatment.
- The stenotic material removal mechanism which is disposed near the distal end of the inner catheter shaft may take one of several possible forms. In a first illustrative embodiment of the apparatus, the stenotic material removal mechanism is in the form of a cutting head having a plurality of longitudinally oriented cutting blades arranged radially about the central axis of the inner catheter. In a second illustrative embodiment of the apparatus, the stenotic material removal mechanism is in the form of a cutting head having a plurality of helically configured cutting blades arranged radially about the central axis of the inner catheter. In these first and second illustrative embodiments, each of the cutting blades is preferably shaped like a flattened wire with one or both lateral edges of the wire sharpened into a cutting edge. The wire-shaped cutting blades are resilient so that they can expand radially outward from the central axis of the inner catheter. Preferably, the wire-shaped cutting blades maintain an approximately parallel orientation to one another as they expand and contract in the radial direction so that the overall configuration of the cutting head is roughly cylindrical. The cutting head can be passively expandable, in which case the resilient wire-shaped cutting blades are treated by coldworking or heat treatment to have an elastic memory that predisposes them to expand outward when they are released from the radial constraint of the tubular sheath. Alternatively, the cutting head can be configured to be actively and controllably expandable. In this case, the resilient wire-shaped cutting blades are attached on their proximal ends to the inner catheter shaft and on their distal ends to an inner actuating member which is coaxially slidably with respect to the inner catheter shaft. When the inner actuating member is moved proximally with respect to the inner catheter shaft, the resilient wire-shaped cutting blades expand radially outward from the central axis of the inner catheter, and when the inner actuating member is moved distally with respect to the inner catheter shaft, the resilient wire-shaped cutting blades contract radially inward toward the central axis of the inner catheter. The resilient wire-shaped cutting blades may be treated by coldworking or heat treatment to have an elastic memory so that they are biased toward the contracted position, the expanded position or an intermediate position, each alternative having various advantages. The inner actuating member may be tubular, such as a polymer tube, a hollow flexible cable or a flexible metallic tube, so that the guidewire lumen can pass coaxially through the inner actuating member. Alternatively, the inner actuating member may be a thin wire which runs parallel to and alongside the guidewire lumen.
- The stenotic material removal mechanism is operated by rotating the cutting head to remove the stenotic material from within the stent by the cutting action of the longitudinally oriented cutting blades. The rotating action of the blades may be accompanied by axially advancing or withdrawing the cutting head through the stenosis and/or by expanding the width or diameter of the cutting head. In accordance with the methods described above, one or more of the longitudinally oriented cutting blades includes a sensing means for sensing the proximity or contact between the cutting blades and the stent. The sensing means may be in the form of one or more electrode wires which are positioned on the cutting blades. When the sensing means detects sufficient proximity or contact between the cutting blades and the stent to indicate effective recanalization of the stenosis, the cutting head is deactivated and withdrawn from the stented vessel.
- Additionally or alternatively, energy, such as electrical, ultrasonic or thermal energy may be applied through the cutting blades to assist in removal of the stenotic material and/or for denaturing the remaining tissue to discourage further restenosis at the treatment site. In this case, electrodes used for heating or ablation can serve double duty as the sensing means electrodes for monitoring proximity or contact with the stent.
- In a third illustrative embodiment of the apparatus, the stenotic material removal mechanism is in the form of a blade which is extendible and retractable from within a cavity or lumen located near the distal end of the inner catheter. The blade is actuated to extend radially from the inner catheter by advancing an actuating member which extends through an inner lumen of the catheter to an advancement knob located near the proximal end of the inner catheter. Preferably, the blade maintains an approximately parallel orientation to the inner catheter as it extends and retracts in the radial direction. The stenotic material removal mechanism may operate by cutting action, in which case the blade is preferably shaped like a flattened wire with one or both lateral edges of the wire sharpened into a cutting edge, or it may operate by application of electrical or thermal energy, in which case the blade may be flat, round or any convenient shape.
- The stenotic material removal mechanism is operated by advancing the actuating member to extend the blade radially from the inner catheter, then rotating the catheter about its longitudinal axis to remove the stenotic material from within the stent. The rotating action of the blades may be accompanied by axially advancing or withdrawing the inner catheter through the stenosis. A sensing means for sensing the proximity or contact between the blade and the stent is positioned on the blade of the catheter. The sensing means may be in the form of one or more electrode wires which are positioned on the cutting blade. If the stenotic material removal mechanism operates by electrical or thermal heating or ablation, the heating or ablation electrodes can also serve as the sensing means electrodes for monitoring proximity or contact with the stent. When the sensing means detects sufficient proximity or contact between the blade and the stent to indicate effective recanalization of the stenosis, the cutting blade is deactivated and withdrawn from the stented vessel.
- In a fourth illustrative embodiment of the apparatus, the stenotic material removal mechanism has a cutter positioned within a housing. The housing has a side aperture which exposes the cutter and an inflatable balloon located on the back of the housing opposite the side aperture. The balloon can be inflated to increase the width or diameter of the stenotic material removal mechanism and thereby to control the depth of cut and the diameter of the blood flow channel created. The cutter may be a cup-shaped rotating blade, a rotating linear or helical blade, a rotating abrasive burr or a reciprocating or axially movable cutting blade. Additionally or alternatively, medications, chemicals, ionizing radiation or energy, such as electrical, magnetic, ultrasonic, hydraulic, pulsed hydraulic, laser or thermal energy may be applied through the cutter to assist in removal of the stenotic material and/or for denaturing the remaining tissue to discourage further restenosis at the treatment site.
- The stenotic material removal mechanism is positioned by advancing the inner catheter so that the side aperture of the housing is situated across the stenosis within the stent and inflating the balloon to press the side aperture against the stenotic material. Then, the cutter is actuated by rotating and/or by axially advancing the cutter within the housing to remove stenotic material from within the stent. A sensing means for sensing the proximity or contact between the stenotic material removal mechanism and the stent is positioned on the cutter and/or the housing of the catheter. Again, the sensing means may be in the form of one or more electrode wires which are positioned on the cutter and/or the housing. If the stenotic material removal mechanism operates by electrical or thermal heating or ablation, the heating or ablation electrodes can also serve as the sensing means electrodes for monitoring proximity or contact with the stent. When the sensing means detects sufficient proximity or contact between the cutter and the stent to indicate the desired depth of cut, the cutter is deactivated and withdrawn or directed to another part of the stenosis within the stented portion of the vessel.
- In a fifth illustrative embodiment of the apparatus, the stenotic material removal mechanism has a rotating cutting head attached to a hollow drive cable which is coaxially and rotatably positioned over a guidewire. The rotating cutting head is typically spherical or ovoid in shape and has cutting blades, teeth or abrasive particles on its exterior surface. Optionally, the inner catheter or guidewire may have a bend or a steering mechanism close to its distal end for directing the cutting head against the stenotic material within the stent. Alternatively or additionally, the cutting head may also have control means for adjusting the outer diameter of the cutting head. A sensing means for sensing the proximity or contact between the cutting head and the stent is positioned on the cutting head. The sensing means may be in the form of one or more electrodes which are positioned on the cutting head.
- The stenotic material removal mechanism is operated by advancing the inner catheter so that the cutting head is positioned within the stenosis, then rotating the drive cable and the cutting head to remove stenotic material from within the stent. The rotating action of the cutting head may be accompanied by axially advancing or withdrawing the cutting head through the stenosis. The cutting blades, teeth or abrasive particles on the exterior surface of the cutting head comminute or pulverize the stenotic material into fine particles that will not cause embolization downstream of the treatment site. The optional bend or steering mechanism of the inner catheter or guidewire may be used for directing the cutting head against the stenotic material within the stent. Alternatively, the control means may be used for adjusting the diameter of the cutting head to achieve effective recanalization of the stented artery. When the sensing means indicates sufficient proximity or contact between the cutting head and the stent, the cutting head is deactivated and withdrawn or directed to another part of the stenosis within the stented portion of the vessel.
- Each embodiment of the apparatus of the present invention will also include a monitoring means which couples to the sensor means of the catheter system through a connection fitting at the proximal end of the inner catheter. In one preferred embodiment, the monitoring means includes a voltage source that generates a direct or alternating current reference voltage which is applied to a unipolar electrode or applied between two bipolar electrodes positioned on the stenotic material removal mechanism, and an electrical monitor for monitoring the electrical conditions at the sensor electrode or electrodes. The electrical monitor may monitor the current leakage at the unipolar or bipolar sensor electrode to detect contact between the sensor electrode and a metallic stent and/or monitor the complex impedance across bipolar electrodes to detect proximity between the sensor electrodes and a metallic stent. The monitoring means may optionally include control means for deactivating the stenotic material removal mechanism when an unsafe condition that might lead to stent damage is detected or when the sensing means indicates an appropriate endpoint for the stenotic material removal process has been reached.
- In an alternative embodiment, the monitoring means may be an optical sensor that includes an optical fiber which transmits a reference beam to a distal end of the catheter and directs it at the inner surface of the vessel close to the stenotic material removal mechanism. A photodetector detects the intensity and/or the wavelength of the light reflected back from the inner surface of the vessel through the optical fiber. A difference in reflectivity between the tissue of the vessel wall and the stent material allows the photodetector to detect proximity and/or contact between the stenotic material removal mechanism and the stent. In another alternative embodiment, the monitoring means may be a nonimaging, A mode ultrasonic scanner which generates a pulsed ultrasonic signal in a transducer mounted on or near the stenotic material removal mechanism. Differences in the acoustic impedance between the stent material and the arterial tissue or stenosis will cause echoes of the ultrasonic signal back to the transducer. The A mode ultrasonic scanner analyzes the amplitude and timing of the echoes detected by the ultrasonic transducer to measure the depth of the stent within the vessel wall. These two alternative embodiments of the monitoring means are useful for detection of both metallic and nonmetallic stents.
- Preferably, each embodiment of the apparatus of the present invention will also include a motor drive unit which attaches at the proximal end of the catheter system. The motor drive unit houses a drive motor which is mechanically coupled to the inner catheter or the drive cable of the various embodiments to rotate and/or axially translate the stenotic material removal mechanism. For use with the first four embodiments of the apparatus described above, the drive motor is preferably a motor or gear motor which operates at relatively low speed for rotating the various cutters at a speed from 500 to 2000 rpm. For use with the fifth embodiment of the apparatus described above, the drive motor is preferably a high speed motor which rotates the cutting head at a speed from 2000 to 150000 rpm for effective comminution of the stenotic material. Alternatively, the stenotic material removal mechanism may be operated by hand.
- Optionally, the apparatus of the present invention may further comprise means for collecting and withdrawing the removed stenotic material from the blood vessel. The means for collection and withdrawal of the removed stenotic material may include an irrigation and/or aspiration apparatus attached respectively to the inner and outer catheters of the catheter assembly. Additionally, embolic filters or occlusion balloons may be included in the catheter system for placement upstream and/or downstream of the treatment site. An embolic filters and other stenotic material capture means are described for use in conjunction and/or in a combined apparatus with the stenotic material removal mechanism.
- FIG. 1 is a generalized schematic diagram of the apparatus of the present invention showing the different components of the catheter system.
- FIG. 2 is a side view of the distal portion of a first embodiment of the apparatus of the present invention having a stenotic material removal mechanism having with a plurality of longitudinally oriented cutting blades shown in the contracted position.
- FIG. 3 is a side view of the apparatus of FIG. 2 showing the stenotic material removal mechanism in the expanded position.
- FIG. 4 is a distal end view of the apparatus of FIG. 2 with the stenotic material removal mechanism in the expanded position.
- FIG. 5 is a magnified cutaway view of a cutting blade of the apparatus of FIG. 2 showing the sensor electrodes.
- FIG. 6 is a cross section of the cutting blade of FIG. 5.
- FIG. 7 is a side view of the distal portion of a second embodiment of the apparatus of the present invention having a stenotic material removal mechanism having with a plurality of helically configured cutting blades shown in the expanded position.
- FIG. 8 is an enlarged distal end view of the apparatus of FIG. 7 with the stenotic material removal mechanism in the expanded position.
- FIG. 9 is a magnified cutaway view of a cutting blade of the apparatus of FIG. 7 showing the sensor electrodes.
- FIG. 10 is a cross section of the cutting blade of FIG. 9.
- FIG. 11 is a side view of the distal portion and the proximal portion of a third embodiment of the apparatus of the present invention having a stenotic material removal mechanism with an extendible and retractable blade shown in the retracted position.
- FIG. 12 is a side view of the apparatus of FIG. 11 showing the stenotic material removal mechanism in the extended position.
- FIG. 13 is a magnified cross section of the cutting blade of the apparatus of FIG. 11 showing the sensor electrodes.
- FIG. 14 is a side view of the distal portion of a fourth embodiment of the apparatus of the present invention showing a directional stenotic material removal mechanism with the balloon in the inflated position.
- FIG. 15 is a top view of the apparatus of FIG. 14.
- FIG. 16 is a side view of the distal portion and the proximal portion of a fifth embodiment of the apparatus of the present invention having an abrasive cutting head.
- FIG. 17 is a magnified view of the cutting head of the apparatus of FIG. 16 showing the sensor electrodes.
- FIGS. 18, 19,20 and 21 are a series of drawings illustrating the method of the present invention using the apparatus of FIG. 2.
- FIGS. 22, 23,24 and 25 are a series of drawings illustrating an alternate method of the present invention using the apparatus of FIG. 2.
- FIGS. 26, 27,28 and 29 are a series of drawings illustrating another alternate method of the present invention using the apparatus of FIG. 2.
- FIGS. 30, 31 and32 are a series of drawings illustrating the operation of an optional embolic filter apparatus which may be used in conjunction with the method of the present invention.
- FIGS. 33, 34,35 and 36 are a series of drawings illustrating the operation of a combined stenotic material removal mechanism and stenotic material capture mechanism according to the present invention.
- FIGS. 37, 38 and39 are a series of drawings illustrating the operation of an alternate combined stenotic material removal mechanism and stenotic material capture mechanism according to the present invention.
- FIG. 40 illustrates a kit including a catheter, a package and instructions for use according to the present invention.
- FIG. 1 is a generalized schematic diagram of the apparatus of the present invention. The apparatus comprises a catheter system designed to facilitate percutaneous removal of stenotic material from within a previously stented region of the vasculature without damaging or disrupting the implanted stent. In particular, the catheter system includes an
inner catheter shaft 50 having a proximal end and a distal end, with a stenoticmaterial removal mechanism 52 mounted near the distal end of theinner catheter shaft 50 and a sensing means 54 for sensing when the stenoticmaterial removal mechanism 52 is approaching or contacting the stent within the vascular wall. Theinner catheter shaft 50 will preferably include a guidewire lumen for introduction of the catheter system over asteerable guidewire 56. Theinner catheter shaft 50 may have additional lumens or actuating mechanisms associated with the stenoticmaterial removal mechanism 52. Various embodiments of the stenoticmaterial removal mechanism 52 will be more fully described below. In embodiments where the stenoticmaterial removal mechanism 52 comprises resilient members which are radially compressible, the catheter system may also include an optionaltubular sheath 58 which serves to maintain the stenoticmaterial removal mechanism 52 in a compressed state as it is maneuvered to, and potentially across, the stenosis. Thetubular sheath 58 may be split or scored along its length so that is can be easily removed from around theinner catheter shaft 50 and discarded after the stenoticmaterial removal mechanism 52 has been maneuvered into place. The catheter system will usually further include anouter catheter tube 60 having a proximal end, a distal end and an inner lumen. The outer catheter tube will usually have ahemostasis valve 62 and anaspiration port 64 near its proximal end so that dislodged stenotic material can be aspirated from the vasculature. Theouter catheter tube 60 may optionally have selective or subselective curves formed near the distal end of theouter catheter tube 60 for directing and maneuvering the catheter system through the vasculature to the site of the stenosis. In addition, anouter guiding catheter 66, for example a coronary guiding catheter, may be used for guiding the catheter system into the desired part of the vasculature and supporting it during the treatment. The guidingcatheter 66 will have a Y-fitting with ahemostasis valve 68 connected at its proximal end. - Typically, the
outer catheter 60 will have an overall length of approximately 60 cm to 120 cm, depending on the location of the vessel to be treated in the patient's body and the point of entry into the vasculature. For application in peripheral vessels or for application in the coronary arteries via a brachial artery insertion, theouter catheter 60 will typically have an overall length of approximately 60 cm to 90 cm. For application in the coronary arteries via a percutaneous femoral artery insertion, theouter catheter 60 will typically have an overall length of approximately 90 cm to 120 cm. Theinner catheter 50 should have an overall length somewhat longer than theouter catheter 60 so that the stenoticmaterial removal mechanism 52 can be extended out from the distal end of theouter catheter 60. Theinner catheter 50 should therefore have an overall length of approximately 80 cm to 150 cm so that it can be extended 20 cm to 30 cm beyond the distal end of theouter catheter 60. - In a preferred embodiment, the catheter system includes a
motor drive unit 70 which attaches at the proximal end of theinner catheter shaft 50. Themotor drive unit 70 houses a drive motor 72 which is mechanically coupled to theinner catheter shaft 50 to rotate and/or axially translate the stenoticmaterial removal mechanism 52 for removing stenotic material from within the stented vessel. The drive motor 72 may be a low speed motor or gear motor which operates at a speed from 500 to 2000 rpm or a high speed motor or a turbine which operates at a speed from 2000 to 150000 rpm. The operating speed of the drive motor 72 will be chosen according to the particular needs of the stenoticmaterial removal mechanism 52, as will be discussed in more detail below. In alternative embodiments, the stenoticmaterial removal mechanism 52 may be operated by hand. - The catheter system will also include a monitoring means80 which couples to the sensor means 54 of the catheter system through a connection fitting 82 on the proximal end of the
inner catheter shaft 50. Typically, the connection fitting 82 will electrically couple to the monitoring means 80 through acommutator 84 which is part of themotor drive unit 70. Alternatively, the monitoring means 80 may be miniaturized and incorporated as an integral part of themotor drive unit 70. The monitoring means 80 may include anaudible alarm 85 and avisual alarm 86 to indicate contact between the stenoticmaterial removal mechanism 52 and the stent and/or avisual gauge 88 of the proximity of the stenoticmaterial removal mechanism 52 to the stent. The structure and function of the sensor means 54 and the monitoring means 80 will be discussed in further detail below. - Optionally, the catheter system may further include an
embolic filter 90 which may be coaxially deployed over thesame guidewire 56 as the rest of the catheter system. Alternatively, embolic filters and/or occlusion balloons may be deployed on separate catheters for placement upstream and/or downstream of the treatment site. - The stenotic material removal mechanism which is disposed near the distal end of the inner catheter shaft may take one of several possible forms. The distal portion of a first illustrative embodiment of an inner catheter according to the apparatus of the present invention is depicted in FIGS.2-6. In this embodiment, the stenotic material removal mechanism is in the form of a cutting
head 100 having a plurality of longitudinally oriented cuttingblades 102 arranged radially about the central axis of theinner catheter shaft 104. The cuttinghead 100 is shown in a contracted position in FIG. 2 with thecutting blades 102 compressed closely around the central axis of theinner catheter shaft 104. FIG. 3 shows the cuttinghead 100 in an expanded position with thecutting blades 102 extending radially outward from the central axis of theinner catheter shaft 104. FIG. 4 shows a distal end view of the cuttinghead 100 in the expanded position. In variations of this embodiment, there may be two, three, four or more longitudinally oriented cuttingblades 102. Each of thecutting blades 102 is preferably shaped like a flattened wire with one or bothlateral edges cutting blades 102 are resilient so that they can expand radially outward from the central axis of theinner catheter shaft 104. Preferably, the wire-shapedcutting blades 102 maintain an approximately parallel orientation to one another as they expand and contract in the radial direction so that the overall configuration of the cuttinghead 100 is roughly cylindrical. Thecutting blades 102 are preferably made of a strong and resilient biocompatible material capable of holding a sharp cutting edge. Suitable materials for thecutting blades 102 include metals, such as stainless steel, titanium and nickel/titanium alloys, and cobalt alloys like Elgiloy and MP35. Composite constructions are also possible for thecutting blades 102. - The cutting
head 100 can be passively expandable, in which case the resilient wire-shapedcutting blades 102 are treated by coldworking or heat treatment to have an elastic memory that predisposes them to expand outward when they are released from the radial constraint of thetubular sheath 58 which was shown in FIG. 1. Alternatively, the cuttinghead 100 can be configured to be actively and controllably expandable. In this case, the resilient wire-shapedcutting blades 102 are attached on their proximal ends to theinner catheter shaft 104 and on their distal ends to aninner actuating member 106 which is coaxially slidably with respect to theinner catheter shaft 104. When theinner actuating member 106 is moved proximally with respect to theinner catheter shaft 104, thecutting blades 102 expand radially outward from the central axis of theinner catheter shaft 104, and when theinner actuating member 106 is moved distally with respect to theinner catheter shaft 104, thecutting blades 102 contract radially inward toward the central axis of theinner catheter shaft 104. Thecutting blades 102 may be treated by coldworking or heat treatment to have an elastic memory so that they are biased toward the contracted position so that the cuttinghead 100 will contract easily for advancing it across tight stenotic lesions, or toward a fully expanded position so that the cuttinghead 100 will be easy to deploy. Alternatively, the resilient wire-shapedcutting blades 102 may be treated so that they are biased toward an intermediate position which corresponds with a nominal expanded diameter. Theinner actuating member 106 may be tubular, such as a polymer tube, a hollow flexible cable or a flexible metallic tube, so that alumen 108 for aguidewire 56 can pass coaxially through theinner actuating member 106. Alternatively, the inner actuating member may be a thin wire which runs parallel to and alongside the guidewire lumen. - The
inner catheter shaft 104 is a tubular structure with aninner lumen 114 for passing theguidewire 56 and, in some embodiments, theinner actuating member 106 through. Theinner catheter shaft 104 may be a polymer tube, a braid reinforced polymer tube, a hollow flexible cable, such as a multifilar wound cable, or a flexible metallic tube. Theinner catheter shaft 104 acts as a flexible drive shaft for transmitting rotation and torque from the drive motor 72 (FIG. 1) to the cuttinghead 100. The stenotic material removal mechanism is operated by rotating the cuttinghead 100 to remove the stenotic material from within the stent by the cutting action of the longitudinally oriented cuttingblades 102. The rotating action of theblades 102 may be accompanied by axially advancing or withdrawing the cuttinghead 100 through the stenosis and/or by expanding the width or diameter of the cuttinghead 100. The cuttinghead 100 should be expandable over a range of approximately 2 mm to 5 mm for use in stented coronary arteries or as high as 6 mm for use in stented vein grafts and even larger for use in stented peripheral vessels and other stented body structures. The cuttinghead 100 should contract to as small a diameter as possible for passing through tightly stenotic lesions, preferably to a diameter smaller than 2 mm, more preferably to a diameter smaller than 1 mm. The effective cutting length of the cuttinghead 100 is preferably within the range of approximately 10 mm to 40 mm for use in stented coronary arteries and can be longer for use in stented peripheral vessels. - One or more, or all, of the longitudinally oriented cutting
blades 102 includes a sensing means for sensing the proximity or contact between the cuttingblades 102 and the stent. In this illustrative embodiment, the sensing means are provided in the form of one ormore electrode wires sensing electrodes cutting blades 102 or only a portion of it, or thesensing electrodes cutting blades 102. In a first implementation of this embodiment, one or more open, exposedelectrodes cutting blades 102. Alternatively, thecutting blades 102 themselves may serve as the sensor electrodes. A direct or alternating current reference voltage is applied to a unipolar electrode or applied between two bipolar electrodes, and the current leakage of the electrode or electrodes is monitored. When one or more of theelectrodes bipolar electrodes cutting blades 102. An alternating current reference voltage is applied between thebipolar electrodes electrodes bipolar electrodes blades 102 and the stent. The sensing means can operate with very low voltage and current that will not create any adverse physiological effects on the vascular wall or the tissues and nerve pathways of the heart. - The distal portion of a second illustrative embodiment of an inner catheter according to the apparatus of the present invention is depicted in FIGS.7-10. In this embodiment, the stenotic material removal mechanism is in the form of a cutting
head 120 having a plurality of helically configured cuttingblades 122 arranged radially about the central axis of theinner catheter shaft 124, as shown in FIG. 7. FIG. 8 shows an enlarged distal end view of the cuttinghead 120 in the expanded position. In variations of this embodiment, there may be two, three, four or more helically configured cuttingblades 122. Preferably, each of thecutting blades 122 is shaped like a flattened wire with one or bothlateral edges blades 122 maintain an approximately parallel orientation to one another as they expand and contract in the radial direction so that the overall configuration of the cuttinghead 120 is roughly cylindrical. Thecutting blades 122 are made of a strong and resilient biocompatible material capable of holding a sharp cutting edge, such as stainless steel, titanium and nickel/titanium alloys, and cobalt alloys like Elgiloy and MP35, or a composite construction. - As with the first embodiment, the cutting
head 120 can be passively expandable or actively and controllably expandable. In the latter case, the helically configured cuttingblades 122 are attached on their proximal ends to theinner catheter shaft 124 and on their distal ends to aninner actuating member 126 which slides proximally and distally with respect to theinner catheter shaft 124 to expand and contract diameter of the cuttinghead 120, respectively. Thecutting blades 122 may be treated by coldworking or heat treatment to have an elastic memory so that they are biased toward the contracted position, the expanded position or an intermediate position. Theinner actuating member 126 may be tubular, such as a polymer tube, a hollow flexible cable or a flexible metallic tube, so that alumen 128 for aguidewire 56 can pass coaxially through theinner actuating member 126. Alternatively, the inner actuating member may be a thin wire which runs parallel to and alongside the guidewire lumen. - The
inner catheter shaft 124 is a tubular structure with aninner lumen 134 for passing theguidewire 56 and, in some cases, theinner actuating member 126 through. Theinner catheter shaft 124 may be a polymer tube, a braid reinforced polymer tube, a hollow flexible cable, such as a multifilar wound cable, or a flexible metallic tube that serves as a flexible drive shaft for transmitting rotation and torque from the drive motor 72 (FIG. 1) to the cuttinghead 120. The stenotic material removal mechanism is operated by rotating the cuttinghead 120 to remove the stenotic material from within the stent by the cutting action of the helically configured cuttingblades 122. The rotating action of theblades 122 may be accompanied by axially advancing or withdrawing the cuttinghead 120 through the stenosis and/or by expanding the width or diameter of the cuttinghead 120. The cuttinghead 120 should be expandable over a range of approximately 2 mm to 5 mm for use in stented coronary arteries or as high as 6 mm for use in stented vein grafts and even larger for use in stented peripheral vessels and other stented body structures. The cuttinghead 120 should contract to as small a diameter as possible for passing through tightly stenotic lesions, preferably to a diameter smaller than 2 mm, more preferably to a diameter smaller than 1 mm. The effective cutting length of the cuttinghead 120 is preferably within the range of approximately 10 mm to 40 mm for use in stented coronary arteries and can be longer for use in stented peripheral vessels. - One or more, or all, of the helically configured cutting
blades 122 includes a sensing means for sensing the proximity or contact between the cuttingblades 122 and the stent. As shown in FIGS. 9 and 10, the sensing means may be in the form of one ormore electrode wires 136, 138 which are positioned on the surface of thecutting blades 122. Thesensing electrodes 136, 138 may extend the full length of thecutting blades 122 or only a portion of it, or thesensing electrodes 136, 138 may be arranged to provide a plurality of sensing locations along the length of thecutting blades 122. As in the first embodiment described above, theelectrodes 136, 138 may be exposed or insulated and unipolar or bipolar. Alternatively, thecutting blades 122 themselves may serve as the sensor electrodes. Contact and/or proximity between the cuttingblades 122 and the stent can be monitored by sensing the leakage current and/or the complex impedance of the sensor electrode circuit. When the sensing means detects sufficient proximity or contact between the cuttingblades 122 and the stent to indicate effective recanalization of the stenosis within that portion of the stent, the cuttinghead 120 may be deactivated or advanced along the stenosis as appropriate. - The distal portion and the proximal portion of a third illustrative embodiment of an inner catheter according to the apparatus of the present invention is depicted in FIGS.11-13. In this embodiment, the stenotic material removal mechanism is in the form of a
blade 140 which is extendible and retractable from within acavity 142 located near the distal end of theinner catheter shaft 144. Theblade 140 is actuated to extend radially from theinner catheter shaft 144 by advancing an actuatingmember 146 which extends through aninner lumen 148 of the catheter to anadvancement knob 152 which is located on ahandle assembly 150 near the proximal end of theinner catheter shaft 144. FIG. 11 is a side view of the inner catheter with theblade 140 on the distal portion of theinner catheter shaft 144 and theadvancement knob 152 on theproximal handle assembly 150 in the retracted position. FIG. 12 is a side view of the inner catheter with theblade 140 and theadvancement knob 152 in the extended position. Preferably, theblade 140 maintains an approximately parallel orientation to theinner catheter shaft 144 as it extends and retracts in the radial direction. Theblade 140 may be treated by coldworking or heat treatment to have an elastic memory so that it is biased toward the retracted position, in which case theblade 140 will be extended by a compression force applied to the actuatingmember 146 by theadvancement knob 152 on thehandle assembly 150. Alternatively, theblade 140 may be treated to be biased toward the extended position, in which case theblade 140 will be self-extending and will be retracted by a tensile force applied to the actuatingmember 146 by theadvancement knob 152. Accordingly, the actuatingmember 146 may be a thin wire, a flexible cable, or a thin tensile filament. - The
inner catheter shaft 144 is a tubular structure with aninner lumen 162 which extends to the distal end for passing aguidewire 56 through for directing the catheter into and across a stented region in an artery. Theinner catheter shaft 144 may be a polymer tube, a braid reinforced polymer tube, a hollow flexible cable, such as a multifilar wound cable, or a flexible metallic tube. Preferably, theinner catheter shaft 144 has sufficient torsional rigidity to serve as a flexible drive shaft for transmitting rotation and torque from theproximal handle assembly 150 to theblade 140 on the distal end of theinner catheter shaft 144. The torque may be applied to theproximal handle assembly 150 manually by the operator or theproximal handle assembly 150 may include a drive motor 72, as in FIG. 1. - The stenotic material removal mechanism is operated by advancing the actuating
member 146 to extend theblade 140 radially from theinner catheter shaft 144, then rotating thecatheter shaft 144 about its longitudinal axis to remove the stenotic material from within the stent. The rotating action of theblade 140 may be accompanied by axially advancing or withdrawing the inner catheter through the stenosis. In one preferred embodiment, the stenotic material removal mechanism of the inner catheter operates by cutting action, in which case theblade 140 is preferably shaped like a flattened wire with one or bothlateral edges cutting blade 140 is made of a strong and resilient biocompatible material capable of holding a sharp cutting edge, such as stainless steel, titanium and nickel/titanium alloys, and cobalt alloys like Elgiloy and MP35, or a composite construction. Thecutting blade 140 includes a sensing means for sensing the proximity or contact between thecutting blade 140 and the stent. As shown in FIG. 13, the sensing means may be in the form of one ormore electrode wires cutting blade 140. Theelectrodes cutting blade 140 itself may serve as a unipolar sensor electrode. Contact and/or proximity between thecutting blade 140 and the stent can be monitored by sensing the leakage current and/or the complex impedance of the sensor electrode circuit. When the sensing means detects sufficient proximity or contact between thecutting blade 140 and the stent to indicate effective recanalization of the stenosis within that portion of the stent, the cuttinghead 120 may be deactivated or advanced along the stenosis as appropriate. - Additionally or alternatively, energy, such as electrical, ultrasonic or thermal energy may be applied through the
blade 140 to assist in removal of the stenotic material and/or for denaturing the remaining tissue to discourage further restenosis at the treatment site. In this case, electrodes used for heating or ablation can also serve as the sensing means electrodes for monitoring proximity or contact with the stent. If the device relies principally on ablation as the stenotic material removal technique, theblade 140 need not be sharpened as shown, but may instead be flat, round or any convenient shape. - The distal portion of a fourth illustrative embodiment of an inner catheter according to the apparatus of the present invention is depicted in FIGS.14-15. In this embodiment, the stenotic
material removal mechanism 170 has acutter 172 positioned within ahousing 174. Thehousing 174 has aside aperture 176 which exposes thecutter 172 and aninflatable balloon 180 located on the back of thehousing 174 opposite theside aperture 176. Theballoon 180 can be inflated with fluid injected through aballoon lumen 182 to increase the width or diameter of the stenoticmaterial removal mechanism 170 and thereby to control the depth of cut and the diameter of the blood flow channel created. Theballoon 180 may be made of polyethylene, polyester, nylon or other polymeric materials. Thecutter 172 may be a cup-shaped rotating blade, a rotating linear or helical blade, a rotating abrasive burr or an axially movable cutting blade, which is rotated and/or translated by adrive shaft 178 that extends proximally through alumen 186 within thecatheter shaft 184. Additionally or alternatively, medications, chemicals, ionizing radiation or energy, such as electrical, magnetic, ultrasonic, hydraulic, pulsed hydraulic, laser or thermal energy may be applied through thecutter 172 to assist in removal of the stenotic material and/or for denaturing the remaining tissue to discourage further restenosis at the treatment site. - The
catheter shaft 184 is a tubular structure which includes theballoon lumen 182 and thedrive shaft lumen 186. Thecatheter shaft 184 may be a polymer tube, a braid reinforced polymer tube, a hollow flexible cable, such as a multifilar wound cable, or a flexible metallic tube. Preferably, thecatheter shaft 184 has sufficient torsional rigidity to rotate thehousing 174 on the distal end of the catheter by rotating the proximal end of thecatheter shaft 184. Thedrive shaft 178 may be a hollow tube with aguidewire lumen 190 which extends to the distal end for passing aguidewire 56 through for directing the catheter into and across a stented region in an artery. Thedrive shaft 178 may be a polymer tube, a braid reinforced polymer tube, a hollow flexible cable, such as a multifilar wound cable, or a flexible metallic tube. Alternatively, thedrive shaft 178 may be a solid wire, in which case theguidewire lumen 190 could be a separate lumen within thecatheter shaft 184. - In operation, the stenotic
material removal mechanism 170 is positioned by advancing and rotating the inner catheter so that theside aperture 176 of thehousing 174 is situated across the stenosis within the stent and inflating theballoon 180 to press theside aperture 176 against the stenotic material. Then, thecutter 172 is actuated by rotating and/or by axially advancing thecutter 172 within thehousing 174 to remove stenotic material from within the stent. A sensing means 188, 188′ for sensing the proximity or contact between the stenoticmaterial removal mechanism 170 and the stent is positioned on thecutter 172 and/or thehousing 174 of the catheter. Again, the sensing means 188, 188′ may be in the form of one or more electrode wires which are positioned on thecutter 172 and/or thehousing 174. If the stenoticmaterial removal mechanism 170 operates by electrical or thermal heating or ablation, the heating or ablation electrodes can also serve as the sensing means electrodes for monitoring proximity or contact with the stent. When the sensing means detects sufficient proximity or contact between thecutter 172 and the stent to indicate the desired depth of cut, thecutter 172 is deactivated and withdrawn or directed to another part of the stenosis within the stented portion of the vessel. - The distal portion of a fifth illustrative embodiment of an inner catheter according to the apparatus of the present invention is depicted in FIGS.16-17. In this embodiment, the stenotic material removal mechanism is rotatably and slidably received within an
inner lumen 212 of theinner catheter shaft 210. The stenotic material removal mechanism has arotating cutting head 200 attached to ahollow drive cable 202 which is coaxially and rotatably positioned over aguidewire 204. Therotating cutting head 200 is typically spherical or ovoid in shape and has cutting blades, teeth orabrasive particles 206 on its exterior surface. In one preferred embodiment, the cuttinghead 200 has minute diamondabrasive particles 206 embedded on its exterior surface. Thehollow drive cable 202 is preferably a multifilar wound cable, but alternatively may be a polymer tube, a braid reinforced polymer tube, a hollow flexible cable or a flexible metallic tube. Optionally, theinner catheter shaft 210 and/or theguidewire 204 may have abend head 200 against the stenotic material within the stent. Alternatively or additionally, the cuttinghead 200 may also have control means for adjusting the outer diameter of the cuttinghead 200. Suitable cutting head diameter control means are described in U.S. Pat. Nos. 5,217,474 and 5,308,354, the specifications of which are hereby incorporated by reference in their entirety. - A sensing means for sensing the proximity or contact between the cutting
head 200 and the stent is positioned on the cuttinghead 200. The sensing means may be in the form of one ormore electrodes head 200. One or moreelectrode lead wires hollow drive cable 202. Theelectrodes head 200 itself may serve as a unipolar sensor electrode and the multifilarhollow drive cable 202 may serve as a single electrode lead wire. - The stenotic material removal mechanism is operated by advancing the inner catheter so that the cutting
head 200 is positioned within the stenosis, then rotating thedrive cable 202 and the cuttinghead 200 to remove stenotic material from within the stent. Preferably, the cuttinghead 200 is rotated with a high speed motor or turbine which rotates the cutting head at a speed from 2000 to 150000 rpm. The rotating action of the cuttinghead 200 may be accompanied by axially advancing or withdrawing the cuttinghead 200 through the stenosis. The cutting blades, teeth orabrasive particles 206 on the exterior surface of the cuttinghead 200 comminute, or pulverize, the stenotic material into fine particles that will not cause embolization downstream of the treatment site. Theoptional bend inner catheter 210 orguidewire 204 may be used for directing the cuttinghead 200 against the stenotic material within the stent. Alternatively, the control means may be used for adjusting the diameter of the cuttinghead 200 to achieve effective recanalization of the stented artery. When the sensing means indicates sufficient proximity or contact between the cuttinghead 200 and the stent, the cuttinghead 200 is deactivated and withdrawn or advanced and directed to another part of the stenosis within the stented portion of the vessel. - The function of the monitoring means80 of the catheter system, shown generically in FIG. 1, will be more fully appreciated in light of the foregoing descriptions of the various embodiments of the stenotic material removal mechanism and their related sensing means. In one preferred embodiment, the monitoring means includes a voltage source that generates a direct or alternating current reference voltage which is applied to a unipolar electrode or applied between two bipolar electrodes positioned on the stenotic material removal mechanism, and an electrical monitor for monitoring the electrical conditions at the sensor electrode or electrodes. The electrical monitor may monitor the current leakage at the unipolar or bipolar sensor electrode to detect contact between the sensor electrode and a metallic stent and/or monitor the complex impedance across bipolar electrodes to detect proximity between the sensor electrodes and a metallic stent. The monitoring means may optionally include control means for deactivating the stenotic material removal mechanism when an unsafe condition that might lead to stent damage is detected or when the sensing means indicates that an appropriate endpoint for the stenotic material removal process has been reached.
- In cases where the sensing means provides separate sensing electrodes on the different blades of the stenotic material removal mechanism or where a plurality of sensing locations are provided along the length of the stenotic material removal mechanism, the monitoring means80 can be designed to monitor each of the multiple electrodes or sensing locations simultaneously, or it can be designed to have an appropriate sampling rate for alternately monitoring each of the electrodes or sensing locations in sequence.
- In an alternative embodiment, the monitoring means may be an optical sensor that includes an optical fiber which transmits a reference beam to a distal end of the catheter and directs it at the inner surface of the vessel close to the stenotic material removal mechanism. A photodetector detects the intensity and/or the wavelength of the light reflected back from the inner surface of the vessel through the optical fiber. A difference in reflectivity between the tissue of the vessel wall and the stent material allows the photodetector to detect proximity and/or contact between the stenotic material removal mechanism and the stent.
- In another alternative embodiment, the monitoring means may be a nonimaging, A mode ultrasonic scanner which generates a pulsed ultrasonic signal in a transducer mounted on or near the stenotic material removal mechanism. Differences in the acoustic impedance between the stent material and the arterial tissue or stenosis will cause echoes of the ultrasonic signal back to the transducer. The A mode ultrasonic scanner analyzes the amplitude and timing of the echoes detected by the ultrasonic transducer to measure the depth of the stent within the vessel wall. These two alternative embodiments of the monitoring means are useful for detection of both metallic and nonmetallic stents. A nonimaging, A mode ultrasonic scanner of this type is much more economical than the imaging ultrasonic scanners which have been described in combination with various atherectomy devices. The high echogenicity of the stent material will give a reliable measure of the depth of the stent within the vessel wall without the need for expensive imaging equipment.
- FIGS. 18, 19,20 and 21 are a series of drawings illustrating the method of the present invention. The method is illustrated and described using the apparatus of FIG. 1 with the stenotic material removal mechanism of FIGS. 2-6 by way of example. This method may be applied using any of the various apparatus described above with minor modifications to the procedure. The catheter system of FIG. 1 is introduced into the patient's vascular system through a peripheral arterial access using the known techniques of an arterial cutdown, the Seldinger technique and/or an introducer sheath. The catheter system is maneuvered to the vicinity of a restenosed region within a previously stented region of the vasculature, for example within a coronary artery, using manipulations of the optional guiding
catheter 66 and theouter catheter 60 of the catheter system. Theinner catheter 50 carrying the stenoticmaterial removal mechanism 52 is positioned on one side of the restenosed stented region and thesteerable guidewire 56 is maneuvered across the stenosis. - Referring now to FIG. 18, the cutting
head 100 of the stenotic material removal mechanism is advanced from the inner catheter in the contracted position and positioned across the stenosis S within the stent T. The cuttinghead 100 is then expanded within the stenosis S, as shown in FIG. 19. The expansion may occur passively, by withdrawing the optional tubular sheath 58 (shown in FIG. 1) and allowing theresilient cutting blades 102 of the cuttinghead 100 to expand outward. Alternatively, the expansion may occur actively and controllably, by withdrawing theinner actuating member 106 to expand thecutting blades 102 outward and increase the width or diameter of the cuttinghead 100. The stenotic material removal mechanism is then activated by rotating the cuttinghead 100 to remove the stenotic material M from within the stenosis S. The cuttinghead 100 may be manually rotated by the operator or by a drive motor 72 within amotor drive unit 70, as shown in FIG. 1. Medications, chemicals, ionizing radiation or energy, such as electrical, magnetic, ultrasonic, hydraulic, pulsed hydraulic, laser or thermal energy may be applied to assist in removal of the stenotic material M and/or for denaturing the remaining tissue to discourage further restenosis at the treatment site. The stenotic material M that is removed may be aspirated out through theaspiration port 64 of the outer catheter 60 (shown in FIG. 1). Theelectrodes cutting blades 102 monitor the proximity or contact between the cuttinghead 100 and the stent T. When thecutting blades 102 have approached close enough to the stent T to indicate effective recanalization of the stenosis S, as shown in FIG. 20, the stenotic material removal mechanism is deactivated. The catheter system is then withdrawn, leaving the stented region recanalized and open to renewed blood flow, as shown in FIG. 21. - FIGS. 22, 23,24 and 25 are a series of drawings illustrating an alternate method of the present invention. As above, the method is illustrated and described using the stenotic material removal mechanism of FIGS. 2-6, but the method may be applied using most of the various apparatus described above with minor modifications to the procedure. In this alternative method, the catheter carrying the stenotic material removal mechanism is positioned on one side of the restenosed stented region. The cutting
head 100 of the stenotic material removal mechanism is extended from the catheter and advanced part-way into the stent T and thecutting blades 102 are expanded outward, as shown in FIG. 22. Theelectrodes cutting blades 102 monitor the proximity or contact between the cuttinghead 100 and the stent T so that the diameter of the cuttinghead 100 can be accommodated to the internal diameter of the stent T. If the stenosis S does not extend all of the way to the end of the stent T, the expansion step can be performed while the cuttinghead 100 is stationary. However, if necessary, the stenotic material removal mechanism can be activated by rotating the cuttinghead 100 as thecutting blades 102 expand outward to begin removing the stenotic material M while adjusting the diameter of the cuttinghead 100 to the size of the stent T. - The stenotic material M is removed from within the stent T by rotating the cutting
head 100 and advancing it through the stenosis S, as shown in FIGS. 23 and 24. The diameter of the cuttinghead 100 can be held constant as it is advanced through the stenosis S or it can be adjusted continuously based on feedback from the sensing means. Medications, chemicals, ionizing radiation or energy, such as electrical, magnetic, ultrasonic, hydraulic, pulsed hydraulic, laser or thermal energy may be applied to assist in removal of the stenotic material M and/or for denaturing the remaining tissue to discourage further restenosis at the treatment site. The stenotic material M that is removed may be aspirated out through theaspiration port 64 of the outer catheter 60 (shown in FIG. 1). When the cuttinghead 100 has passed all the way through the stenosis S, the stenotic material removal mechanism is deactivated and the catheter system is withdrawn, leaving the stented region recanalized and open to renewed blood flow, as shown in FIG. 25. - This method can be effectively performed in the reverse direction, by advancing the cutting
head 100 all the way across the stenosis in a contracted or compressed state. The cuttinghead 100 is then expanded within the far end of the stenosis S or within the vessel beyond the stenosis, using the sensing means to adjust the diameter of the cuttinghead 100 to the size of the stent T. The cuttinghead 100 is then rotated while withdrawing it toward the catheter to advance it through the stenosis S. - FIGS. 26, 27,28 and 29 are a series of drawings illustrating another alternate method of the present invention. Once again, the method is illustrated and described using the stenotic material removal mechanism of FIGS. 2-6, but the method may be applied using most of the various apparatus described above with minor modifications to the procedure. In this alternative method, the catheter carrying the stenotic material removal mechanism is positioned on one side of the restenosed stented region. The cutting
head 100 of the stenotic material removal mechanism is extended from the catheter and advanced part-way into the stenosis S within the stent T, as shown in FIG. 26. Thecutting blades 102 are then expanded outward within the stenosis S, either passively or actively and controllably as described above, to increase the width or diameter of the cuttinghead 100. The stenotic material removal mechanism is then activated by rotating the cuttinghead 100 to begin removing the stenotic material M from within the stenosis S, as shown in FIG. 27. Medications, chemicals, ionizing radiation or energy, such as electrical, magnetic, ultrasonic, hydraulic, pulsed hydraulic, laser or thermal energy may be applied to assist in removal of the stenotic material M and/or for denaturing the remaining tissue to discourage further restenosis at the treatment site. The stenotic material M that is removed may be aspirated out through theaspiration port 64 of the outer catheter 60 (shown in FIG. 1). Theelectrodes cutting blades 102 monitor the proximity or contact between the cuttinghead 100 and the stent T. When thecutting blades 102 have approached close enough to the stent T to indicate effective recanalization of that portion of the stenosis S, the cuttinghead 100 is advanced farther into the stenosis S, as shown in FIG. 28. The stenotic material removal mechanism may be deactivated and advanced step-wise into the stenosis S by contracting or compressing the cuttinghead 100, advancing it a short distance and expanding it again in a new portion of the stent T. Otherwise, the cuttinghead 100 may be advanced continuously, relying on either the resiliency of thecutting blades 102 or active control for adjusting the width or diameter of the cuttinghead 100 as it advances. When the sensing means indicates that the new portion of the stent T has been effectively recanalized, the cuttinghead 100 is advanced again along the stenosis S until the entire stented region has been recanalized, as shown in FIG. 29. - This method can be effectively performed in the reverse direction, by advancing the cutting
head 100 all the way across the stenosis in a contracted or compressed state. The cuttinghead 100 is then expanded within the far end of the stenosis S or within the vessel beyond the stenosis, either passively or actively and controllably as described above, to increase the width or diameter of the cuttinghead 100. The cuttinghead 100 is then rotated while withdrawing it toward the catheter to advance it through the stenosis in either a step-wise or continuous fashion. Medications, chemicals, ionizing radiation or energy, such as electrical, magnetic, ultrasonic, hydraulic, pulsed hydraulic, laser or thermal energy may be applied to assist in removal of the stenotic material and/or for denaturing the remaining tissue to discourage further restenosis at the treatment site. The sensing means is used to monitor the proximity or contact between the cuttinghead 100 and the stent T in order to control the diameter and/or the rate of advancement of the cuttinghead 100 for effective recanalization of the stenosis S within the stent T. - The methods of the present invention will optionally further comprise collecting and withdrawing the removed stenotic material from the blood vessel. FIGS. 30, 31 and32 are a series of drawings illustrating the operation of an optional
embolic filter apparatus 90 which may be used in conjunction with the method of the present invention. Theembolic filter apparatus 90 may be arranged coaxially as part of the catheter system as shown in FIG. 1 and introduced through a single vascular access point and positioned distally to the treatment site. Alternatively,embolic filter apparatus 90 may be arranged on a separate catheter which is introduced through a different vascular access point and positioned proximally or distally to the treatment site. - In FIG. 30, the
embolic filter 90 is shown in its compacted position within atubular sheath 92 as it is first introduced into the vasculature and advanced to or across the stenosis. In coaxial arrangements, thetubular sheath 92 may be the same as thetubular sheath 58 or theinner catheter 50 of the catheter system of FIG. 1. Theembolic filter 90 may be delivered coaxially over aseparate guidewire 56, or it may be built integrally with aguidewire 56 constructed especially for the purpose. Once theembolic filter 90 is in position, thetubular sheath 92 is withdrawn and theembolic filter 90 is allowed to expand to the full diameter of the vessel, as shown in FIG. 31. The expansion can occur passively, or anactuation member 94 may be used to actively expand theembolic filter 90. Theembolic filter 90 should be expandable over a range of approximately 2 mm to 5 mm for use in stented coronary arteries or as high as 6 mm for use in stented vein grafts and even larger for use in stented peripheral vessels and other stented body structures. Theembolic filter 90 should contract to as small a diameter as possible for passing through tightly stenotic lesions, preferably to a diameter smaller than 2 mm, more preferably to a diameter smaller than 1 mm. Theembolic filter 90 has a plurality ofstructural members 96, which enclose and support a nonthrombogenicexpandable filter medium 98. Thestructural members 96 can be made of a metallic or polymeric material, and may be biased radially outward to assist in expansion of theembolic filter 90. The expandable filter medium 98 may be a porous foam material or it may be a fibrous filter medium such as polyester fiber, which, in its expanded state, has a pore size appropriate for capturing significant emboli which may be dislodged during the stenotic material removal process. The pore size of the expandable filter medium 98 may advantageously be in the range of 0.01 to 0.2 mm to capture potential emboli. Once the stenotic material removal procedure has been completed, theembolic filter 90 is compressed slightly, by passive or active means, and withdrawn into anouter catheter 99, to capture the emboli without releasing them, as shown in FIG. 32. In coaxial arrangements, theouter catheter 99 may be theinner catheter 50 orouter catheter 60 of the catheter system of FIG. 1. Theouter catheter 99 and theembolic filter 90 are then withdrawn from the patient's vasculature. In other alternative methods, embolic filters and/or occlusion balloons may be placed upstream and downstream of the treatment site to isolate or capture potential emboli. - FIGS. 33, 34,35 and 36 are a series of drawings illustrating a method and an apparatus according to the present invention that combine a stenotic material removal mechanism with an embolic filter for capturing stenotic material M which is removed from within the stent T. The apparatus has a cutting
head 300 which is mounted on the distal end of aninner catheter shaft 302. The cuttinghead 300 has a cuttingportion 304 and a filtering ormaterial capturing portion 306. In this illustrative embodiment, the cuttingportion 304 is centrally located on the cuttinghead 300 and thematerial capturing portion 306 is located distal to it. The cuttinghead 300 should be expandable over a range of approximately 2 mm to 5 mm for use in stented coronary arteries or as high as 6 mm for use in stented vein grafts and even larger for use in stented peripheral vessels and other stented body structures. The cuttinghead 300 should contract to as small a diameter as possible for passing through tightly stenotic lesions, preferably to a diameter smaller than 2 mm, more preferably to a diameter smaller than 1 mm. The effective cutting length of the cuttingportion 304 is preferably within the range of approximately 10 mm to 40 mm for use in stented coronary arteries and can be longer for use in stented peripheral vessels. Additionally or alternatively, the cuttinghead 300 may also include a secondmaterial capturing portion 306′ located proximally to the cuttingportion 304. Alternatively, thematerial capturing portion 306 may occupy the entire length of the cuttinghead 300. The cuttingportion 304 of the cuttinghead 300 may take any one of the different forms described herein in connection with the various embodiments of the invention. For illustrative purposes, the cuttingportion 304 is shown having a plurality of longitudinally oriented cuttingblades 308, similar to those shown in FIGS. 2-6. Alternatively, the cutting blades may be laterally or circumferentially oriented or helically configured, similar to those shown in FIGS. 7-10, or any convenient geometry. Thecutting blades 308 of the cuttinghead 300 may be either passively or actively expandable, as described above. - The
material capturing portion 306 preferably contains a nonthrombogenicexpandable filter medium 310. The expandable filter medium 310 may be a porous foam material or it may be a fibrous filter medium such as polyester fiber, which, in its expanded state, has a pore size appropriate for capturing significant emboli which may be dislodged during the stenotic material removal process. The pore size of the expandable filter medium 310 may advantageously be in the range of 0.01 to 0.2 mm to capture potential emboli. Theexpandable filter medium 310 is enclosed and supported by thecutting blades 308 of the cuttinghead 300. Additionally or alternatively, the expandable filter medium 310 may include a membranous filter material that is attached to and suspended between the cuttingblades 308 of the cuttinghead 300. Suitable membranous filter materials include flexible woven, nonwoven or knitted filtration fabrics. Theexpandable filter medium 310 occupies adistal portion 306 and/or aproximal portion 306′ of the cuttinghead 300. Alternatively, the expandable filter medium 310 may occupy the entire length of the cuttinghead 300. - In use, the catheter carrying the stenotic material removal mechanism is positioned on one side of the restenosed stented region. The cutting
head 300 is extended from the catheter and advanced across the stenosis S in the contracted position, as shown in FIG. 33. Theexpandable filter medium 310 is compressed within the cuttinghead 300. The cuttinghead 300 is then expanded within the stenosis S, as shown in FIG. 34. The expansion may occur passively, by withdrawing a surrounding tubular sheath 58 (shown in FIG. 1) and allowing theresilient cutting blades 308 of the cuttinghead 300 to expand outward. Alternatively, the expansion may occur actively and controllably, by operating an actuating mechanism to expand thecutting blades 308 outward and increase the width or diameter of the cuttinghead 300, as described above in connection with FIGS. 2-6. Preferably, thefilter medium 310 within thematerial capturing portion 306 of the cuttinghead 300 expands to a diameter at least as large or larger than the expanded diameter of the cuttingportion 304 of the cuttinghead 300. The stenotic material removal mechanism is then activated by rotating the cuttinghead 300 to remove the stenotic material M from within the stenosis S. The cuttinghead 300 may be rotated manually by the operator or by a drive motor 72 within a -motor drive unit 70, as shown in FIG. 1. Medications, chemicals, ionizing radiation or energy, such as electrical, magnetic, ultrasonic, hydraulic, pulsed hydraulic, laser or thermal energy may be applied to assist in removal of the stenotic material M and/or for denaturing the remaining tissue to discourage further restenosis at the treatment site. The stenotic material M that is removed is captured by thefilter medium 310 within thematerial capturing portion 306 of the cuttinghead 300, as shown in FIG. 35. - Preferably, the cutting
head 300 includes a sensing means, such as thesensor electrodes blades 308 of the cuttinghead 300 and the stent T. When thecutting blades 308 have approached close enough to the stent T to indicate effective recanalization of the stenosis S, as shown in FIG. 35, the stenotic material removal mechanism is deactivated. The cuttinghead 300 and all of the stenotic material M captured by thefilter medium 310 within thematerial capturing portion 306 of the cuttinghead 300 are then withdrawn into theouter catheter 60, as shown in FIG. 36. The catheter system is then withdrawn from the patient, leaving the stented region recanalized and open to renewed blood flow. - Alternatively, this cutting
head 300 with a combined stenotic material removal mechanism and stenotic material capture mechanism may be operated as a simple shearing body without a sensing means. In this alternative method, the cuttinghead 300 may be rotated and/or translated within the stenosis S to dislodge stenotic material M from within an interface envelope defined by the stent T embedded within the vessel wall, as shown in FIG. 34. The cuttinghead 300 may be expanded passively or actively to remove all of the stenotic material M from within the stent T. The stenotic material M that is removed is captured by thefilter medium 310 within thematerial capturing portion 306 of the cuttinghead 300, as shown in FIG. 35. The cuttinghead 300 and all of the stenotic material M captured by thefilter medium 310 within thematerial capturing portion 306 of the cuttinghead 300 are then withdrawn into theouter catheter 60, as shown in FIG. 36. - FIGS. 37, 38 and39 are a series of drawings illustrating an alternate method and apparatus according to the present invention that also combine a stenotic material removal mechanism with a means for capturing the stenotic material M that is removed from within the stent T. The apparatus has a
head 350 which is mounted on the distal end of aninner catheter shaft 352. Thehead 350 is a cage-like structure of counterwound or interwovenhelical elements 356. Thehelical elements 356 may comprise round filaments, ribbon filaments, or the like, made of a metallic or polymeric material. Thehelical elements 356 are attached to adistal ring 358 and to aproximal ring 360 which is free to slide over theinner catheter shaft 352. Thehelical elements 356 may be treated by coldworking or heat treatment to have an elastic memory so that they are biased toward the expanded position, allowing thehead 350 to be passively expanded. Alternatively, theproximal ring 360 may optionally be attached to a rod, sleeve, orother means 362 for axially translating theproximal ring 360 to actively and controllably adjust the radius of thehead 350. The cage-like structure of counterwound or interwovenhelical elements 356 serves to capture dislodged stenotic material M that passes through the interstices between thehelical elements 356. - In use, the
catheter 60 carrying the stenotic material removal mechanism is positioned on one side of the restenosed stented region. Thehead 350 is extended from the catheter and advanced across the stenosis S in a contracted position, as shown in FIG. 37. Thehead 350 is then expanded within the stenosis S, either passively or actively and controllably as described above. The stenotic material removal mechanism is then activated by rotating and/or translating thehead 350 within the stenosis S to remove stenotic material M from within the stent T, as shown in FIG. 38. Thehead 350 may be rotated manually by the operator or by a drive motor 72 within amotor drive unit 70, as shown in FIG. 1. Thehead 350 may operate by cutting action, abrasive action or shearing action. Alternatively or additionally, medications, chemicals, ionizing radiation or energy, such as electrical, magnetic, ultrasonic, hydraulic, pulsed hydraulic, laser or thermal energy may be applied to assist in removal of the stenotic material M and/or for denaturing the remaining tissue to discourage further restenosis at the treatment site. The stenotic material M that is dislodged passes through the interstices between thehelical elements 356 and is captured within the cage-like structure of thehead 350. - Preferably, the
head 350 includes a sensing means for sensing the proximity or contact between thehelical elements 356 of thehead 350 and the stent T. As shown in FIG. 38, the sensing means may take the form of one or moresensor electrode wires helical elements 356 of thehead 350. Alternatively, thehelical elements 356 of thehead 350 may serve as sensor electrodes themselves. When thehelical elements 356 of thehead 350 have approached close enough to the stent T to indicate effective recanalization of the stenosis S, as shown in FIG. 38, the stenotic material removal mechanism is deactivated. Thehead 350 and all of the stenotic material M captured within the cage-like structure of thehelical elements 356 are then withdrawn into theouter catheter 60, as shown in FIG. 39. The interstices between thehelical elements 356 of thehead 350 contract as thehead 350 is drawn into thecatheter 60, helping to assure that the particles of dislodged stenotic material M remain captured within the catheter. The catheter system is then withdrawn from the patient, leaving the stented region recanalized and open to renewed blood flow. - Alternatively, the
head 350 of this apparatus may be operated as a simple shearing body without a sensing means. In this alternative method, thehead 350 may be rotated and/or translated within the stenosis S to dislodge stenotic material M from within an interface envelope defined by the stent T embedded within the vessel wall, as shown in FIG. 38. Thehead 350 may be expanded passively or actively to remove all of the stenotic material M from within the stent T. The stenotic material M that is dislodged passes through the interstices between thehelical elements 356 and is captured within the cage-like structure of thehead 350. Thehead 350 and all of the stenotic material M captured within it are then withdrawn into theouter catheter 60, as shown in FIG. 39. - Referring now to FIG. 40, a catheter kit according to the present invention comprises a catheter or
catheter system 370, often mounted on a board or in atray 372, instructions for use (IFU) 374, and apouch 376 or other conventional package. A motor drive unit 70 (FIG. 1) may be packaged together with the catheter kit or separately. The instructions for use (IFU) 374 are typically part of a separate sheet or booklet which together with thecatheter 370, is packaged within thepouch 376 or other packaging material. The packaging and its contents will preferably be sterile or sterilizable. The instructions for use (IFU) 374 will set forth method steps comprising the method(s) as described above. - Although the method of the present invention has been described using the example of revascularizing restenosed coronary arteries, it should be noted that the methods and apparatus disclosed may be used for reopening any previously stented body passage which has been subject to restenosis or reclosure. Other body passages where these methods and apparatus may apply include the peripheral blood vessels, the urinary tract, the digestive tract and the respiratory tract.
Claims (70)
1. An apparatus for removing stenotic material from within a stent located within a body vessel, said apparatus comprising:
a stenotic material removal mechanism for removing stenotic material from within the stent,
sensor means associated with said stenotic material removal mechanism for sensing proximity or contact between said stenotic material removal mechanism and the stent,
whereby said sensor means is used to determine an unsafe condition or an appropriate endpoint for removal of stenotic material from within the stent based on the sensed proximity or contact between said stenotic material removal mechanism and the stent for effective recanalization of the body vessel.
2. The apparatus of claim 1 further comprising a control means for controlling a depth to which said stenotic material removal mechanism removes the stenotic material from within the stent.
3. The apparatus of claim 2 wherein said control means comprises a mechanism for diametrically expanding said stenotic material removal mechanism.
4. The apparatus of claim 1 further comprising a means for directing said stenotic material removal mechanism to remove stenotic material from a selected area within the stent.
5. The apparatus of claim 1 further comprising a means for diametrically expanding said stenotic material removal mechanism.
6. The apparatus of claim 1 wherein said stenotic material removal mechanism comprises at least one longitudinally oriented blade.
7. The apparatus of claim 1 wherein said stenotic material removal mechanism comprises a plurality of longitudinally oriented blades.
8. The apparatus of claim 7 wherein said longitudinally oriented blades are resiliently biased to expand radially outward from a central axis of said stenotic material removal mechanism.
9. The apparatus of claim 1 wherein said stenotic material removal mechanism comprises a plurality of helically configured blades.
10. The apparatus of claim 9 wherein said helically configured blades are resiliently biased to expand radially outward from a central axis of said stenotic material removal mechanism.
11. The apparatus of claim 1 wherein said stenotic material removal mechanism comprises a rotating blade.
12. The apparatus of claim 1 wherein said stenotic material removal mechanism comprises a rotating abrasive tool.
13. The apparatus of claim 1 wherein said stenotic material removal mechanism comprises a cage-like network of filaments.
14. The apparatus of claim 1 further comprising a monitoring means associated with said sensor means for monitoring the proximity or contact between said stenotic material removal mechanism and the stent.
15. The apparatus of claim 14 wherein said sensor means comprises at least one electrical conductor on an exterior of said apparatus and said monitoring means comprises a leakage current detector for detecting a leakage current when said at least one electrical conductor contacts said stent.
16. The apparatus of claim 14 wherein said sensor means comprises a first electrical conductor and a second electrical conductor on an exterior of said apparatus and said monitoring means comprises a leakage current detector for detecting a leakage current when said first electrical conductor and said second electrical conductor contacts said stent.
17. The apparatus of claim 14 wherein said sensor means comprises at least one electrical conductor within said apparatus and said monitoring means comprises a means for detecting a change in electrical impedance when said at least one electrical conductor approaches said stent.
18. The apparatus of claim 14 wherein said sensor means comprises a first electrical conductor and a second electrical conductor within said apparatus and said monitoring means comprises a means for detecting a change in electrical impedance when said first electrical conductor and said second electrical conductor approach said stent.
19. The apparatus of claim 14 wherein said monitoring means produces a signal indicative of the proximity or contact between said stenotic material removal mechanism and the stent.
20. The apparatus of claim 14 wherein said monitoring means includes means for deactivating said stenotic material removal mechanism when a predetermined level of proximity or contact between said stenotic material removal mechanism and the stent is detected.
21. The apparatus of claim 1 wherein said stenotic material removal mechanism is positioned at a distal portion of a first elongated catheter shaft.
22. The apparatus of claim 21 wherein said first elongated catheter shaft includes a lumen for passage of a guidewire therethrough.
23. The apparatus of claim 21 further comprising a second elongated catheter shaft positioned coaxially around said first elongated catheter shaft.
24. The apparatus of claim 23 wherein said second elongated catheter shaft includes an internal lumen for aspiration of stenotic material removed from within the stent.
25. The apparatus of claim 1 further comprising a stenotic material collection mechanism for collecting stenotic material removed from within the stent.
26. The apparatus of claim 25 wherein said stenotic material collection mechanism comprises an embolic filter positioned in operative association with said stenotic material removal mechanism.
27. The apparatus of claim 26 wherein said embolic filter is positioned coaxially with said stenotic material removal mechanism.
28. The apparatus of claim 25 wherein said stenotic material collection mechanism is positioned internally to said stenotic material removal mechanism.
29. An apparatus for removing stenotic material from within a stent located within a body vessel, said apparatus comprising:
a catheter shaft having a proximal end and a distal end,
a stenotic material removal mechanism, and
means coupled to the stenotic material removal mechanism for increasing a depth to which the stenotic material removal mechanism removes the stenotic material from within the stent, wherein said means is limited to prevent further increase in depth when or before the stenotic material removal mechanism engages the stent.
30. The apparatus of claim 29 wherein said means deactivates said stenotic material removal mechanism when or before the stenotic material removal mechanism engages the stent.
31. The apparatus of claim 29 wherein said means includes a sensor for sensing contact between said stenotic material removal mechanism and the stent.
32. The apparatus of claim 29 wherein said means includes a sensor for sensing proximity between said stenotic material removal mechanism and the stent.
33. The apparatus of claim 29 wherein said means includes sensor means for sensing contact and proximity between said stenotic material removal mechanism and the stent.
34. The apparatus of claim 29 wherein said means includes a mechanism for diametrically expanding said stenotic material removal mechanism.
35. The apparatus of claim 29 further comprising a means for directing said stenotic material removal mechanism to remove stenotic material from a selected area within the stent.
36. The apparatus of claim 29 wherein said stenotic material removal mechanism comprises at least one longitudinally oriented blade.
37. The apparatus of claim 29 wherein said stenotic material removal mechanism comprises a plurality of longitudinally oriented blades.
38. The apparatus of claim 29 wherein said stenotic material removal mechanism comprises a plurality of helically configured blades.
39. The apparatus of claim 29 wherein said stenotic material removal mechanism comprises a rotating blade.
40. The apparatus of claim 29 wherein said stenotic material removal mechanism comprises a rotating abrasive tool.
41. The apparatus of claim 29 wherein said stenotic material removal mechanism comprises a cage-like network of filaments.
42. An apparatus for removing stenotic material from within a body vessel, said apparatus comprising:
a stenotic material removal mechanism for removing stenotic material from within the body vessel, said stenotic material removal mechanism having a plurality of elongated blades, and
a stenotic material collection mechanism for collecting stenotic material removed from within the body vessel, said stenotic material collection mechanism including an expandable filter medium enclosed and supported by said plurality of elongated blades.
43. The apparatus of claim 42 further comprising a means for diametrically expanding said stenotic material removal mechanism.
44. The apparatus of claim 42 wherein said elongated blades are resiliently biased to expand radially outward from a central axis of said stenotic material removal mechanism.
45. A method for removing stenotic material from within a stent located within a body vessel, said method comprising:
operating a stenotic material removal mechanism to remove stenotic material from within the stent;
sensing proximity or contact between said stenotic material removal mechanism and the stent; and
determining an appropriate endpoint for removal of stenotic material from within the stent based on the sensed proximity or contact between said stenotic material removal mechanism and the stent for effective recanalization of the body vessel.
46. The method of claim 45 further comprising controlling a depth to which said stenotic material removal mechanism removes the stenotic material from within the stent.
47. The method of claim 45 comprising diametrically expanding said stenotic material removal mechanism.
48. The method of claim 45 comprising directing said stenotic material removal mechanism to remove stenotic material from a selected area within the stent.
49. The method of claim 45 further comprising producing a signal indicative of the proximity or contact between said stenotic material removal mechanism and the stent.
50. The method of claim 45 further comprising deactivating said stenotic material removal mechanism when a predetermined level of proximity or contact between said stenotic material removal mechanism and the stent is detected.
51. The method of claim 45 further comprising monitoring the proximity or contact between said stenotic material removal mechanism and the stent.
52. The method of claim 51 wherein said sensor means comprises at least one electrical conductor on an exterior of said stenotic material removal mechanism and wherein the step of monitoring comprises detecting a leakage current when said at least one electrical conductor contacts the stent.
53. The method of claim 51 wherein said sensor means comprises a first electrical conductor and a second electrical conductor on an exterior of said stenotic material removal mechanism and wherein the step of monitoring comprises detecting a leakage current when said first electrical conductor and said second electrical conductor contacts the stent.
54. The method of claim 51 wherein said sensor means comprises at least one electrical conductor positioned on said stenotic material removal mechanism and wherein the step of monitoring comprises detecting a change in electrical impedance when said at least one electrical conductor approaches the stent.
55. The method of claim 51 wherein said sensor means comprises a first electrical conductor and a second electrical conductor positioned on said stenotic material removal mechanism and wherein the step of monitoring comprises detecting a change in electrical impedance when said first electrical conductor and said second electrical conductor approach the stent.
56. The method of claim 45 further comprising aspirating stenotic material removed from within the stent.
57. The method of claim 45 further comprising collecting stenotic material removed from within the stent.
58. The method of claim 45 further comprising inserting said stenotic material removal mechanism into the body vessel on an elongated catheter.
59. The method of claim 58 further comprising introducing said stenotic material removal mechanism on said elongated catheter into the body vessel through a percutaneous puncture.
60. A method for removing stenotic material from within a stent located within a body vessel, said method comprising:
engaging a stenotic material removal mechanism to remove a portion of stenotic material from within the stent;
expanding the stenotic material removal mechanism to remove additional portions of the stenotic material; and
limiting the expansion of the stenotic material removal mechanism when or before the stenotic material removal mechanism engages the stent.
61. The method of claim 60 comprising diametrically expanding said stenotic material removal mechanism.
62. The method of claim 60 further comprising deactivating said stenotic material removal mechanism when or before the stenotic material removal mechanism engages the stent.
63. The method of claim 60 further comprising directing said stenotic material removal mechanism to remove stenotic material from a selected area within the stent.
64. The method of claim 60 further comprising sensing proximity or contact between said stenotic material removal mechanism and the stent.
65. The method of claim 64 further comprising deactivating said stenotic material removal mechanism when a predetermined level of proximity or contact between said stenotic material removal mechanism and the stent is detected.
66. The method of claim 60 further comprising aspirating stenotic material removed from within the stent.
67. The method of claim 60 further comprising collecting stenotic material removed from within the stent.
68. The method of claim 60 further comprising inserting said stenotic material removal mechanism into the body vessel on an elongated catheter.
69. The method of claim 68 further comprising introducing said stenotic material removal mechanism on said elongated catheter into the body vessel through a percutaneous puncture.
70. A catheter kit comprising:
(a) a catheter including:
a catheter shaft having a proximal end and a distal end,
a stenotic material removal mechanism, wherein said removal mechanism is expandable, and
(b) instructions for use setting forth the following steps:
percutaneously introducing the stenotic material removal mechanism into a restenosed stent in a blood vessel;
engaging the stenotic material removal mechanism to remove a portion of stenotic material from within the restenosed stent;
expanding the stenotic material removal mechanism to remove additional portions of the stenotic material; and
limiting the expansion of the stenotic material removal mechanism when or before the stenotic material removal mechanism engages the stent; and
(c) a package holding the catheter and the instructions for use.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/784,625 US20020016624A1 (en) | 1997-02-12 | 2001-02-14 | Apparatus and method for controlled removal of stenotic material from stents |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/798,722 US5882329A (en) | 1997-02-12 | 1997-02-12 | Apparatus and method for removing stenotic material from stents |
US08/857,659 US5941869A (en) | 1997-02-12 | 1997-05-16 | Apparatus and method for controlled removal of stenotic material from stents |
US09/260,935 US6319242B1 (en) | 1997-02-12 | 1999-03-02 | Apparatus and method for controlled removal of stenotic material from stents |
US09/784,625 US20020016624A1 (en) | 1997-02-12 | 2001-02-14 | Apparatus and method for controlled removal of stenotic material from stents |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/260,935 Division US6319242B1 (en) | 1997-02-12 | 1999-03-02 | Apparatus and method for controlled removal of stenotic material from stents |
Publications (1)
Publication Number | Publication Date |
---|---|
US20020016624A1 true US20020016624A1 (en) | 2002-02-07 |
Family
ID=27122026
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/260,935 Expired - Fee Related US6319242B1 (en) | 1997-02-12 | 1999-03-02 | Apparatus and method for controlled removal of stenotic material from stents |
US09/784,625 Abandoned US20020016624A1 (en) | 1997-02-12 | 2001-02-14 | Apparatus and method for controlled removal of stenotic material from stents |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/260,935 Expired - Fee Related US6319242B1 (en) | 1997-02-12 | 1999-03-02 | Apparatus and method for controlled removal of stenotic material from stents |
Country Status (6)
Country | Link |
---|---|
US (2) | US6319242B1 (en) |
EP (1) | EP1007139A4 (en) |
JP (1) | JP2001512334A (en) |
AU (1) | AU6657098A (en) |
CA (1) | CA2280117A1 (en) |
WO (1) | WO1998034673A1 (en) |
Cited By (138)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030078606A1 (en) * | 2001-04-17 | 2003-04-24 | Scimed Life Systems, Inc. | In-stent ablative tool |
US20040162572A1 (en) * | 2003-02-13 | 2004-08-19 | Sauer Jude S. | Instrument for surgically cutting tissue and method of use |
US20040230220A1 (en) * | 2003-02-11 | 2004-11-18 | Cook Incorporated | Removable vena cava filter |
US20050251199A1 (en) * | 2004-04-16 | 2005-11-10 | Osborne Thomas A | Removable vena cava filter with anchoring feature for reduced trauma |
US20050267513A1 (en) * | 2004-04-16 | 2005-12-01 | Osborne Thomas A | Removable vena cava filter having primary struts for enhanced retrieval and delivery |
US20050267512A1 (en) * | 2004-04-16 | 2005-12-01 | Osborne Thomas A | Removable vena cava filter for reduced trauma in collapsed configuration |
US20060069406A1 (en) * | 2004-09-27 | 2006-03-30 | Per Hendriksen | Removable vena cava filter comprising struts having axial bends |
US20060089709A1 (en) * | 2004-10-21 | 2006-04-27 | Helmus Michael N | Medical implant with average surface charge density |
US20070005095A1 (en) * | 2004-04-16 | 2007-01-04 | Osborne Thomas A | Removable vena cava filter having inwardly positioned anchoring hooks in collapsed configuration |
US20070038176A1 (en) * | 2005-07-05 | 2007-02-15 | Jan Weber | Medical devices with machined layers for controlled communications with underlying regions |
WO2007053795A2 (en) * | 2005-10-25 | 2007-05-10 | Massachusetts Institute Of Technology | Converting rotational motion into radial motion |
WO2007078692A2 (en) * | 2005-12-23 | 2007-07-12 | The Board Of Trustees Of The Leland Stanford Junior University | Systems and methods for fixation of bone with an expandable device |
US20070224116A1 (en) * | 2006-03-27 | 2007-09-27 | Chandru Chandrasekaran | Medical devices comprising a porous metal oxide or metal material and a polymer coating for delivering therapeutic agents |
US20070255270A1 (en) * | 2006-04-27 | 2007-11-01 | Medtronic Vascular, Inc. | Intraluminal guidance system using bioelectric impedance |
US20070264303A1 (en) * | 2006-05-12 | 2007-11-15 | Liliana Atanasoska | Coating for medical devices comprising an inorganic or ceramic oxide and a therapeutic agent |
US20070299337A1 (en) * | 2006-06-26 | 2007-12-27 | Boston Scientific Scimed, Inc. | Method for determining size, pathology, and volume of embolic material |
US20080039979A1 (en) * | 2006-08-10 | 2008-02-14 | V2 Green Inc. | Smart Islanding and Power Backup in a Power Aggregation System for Distributed Electric Resources |
US20080040263A1 (en) * | 2006-08-10 | 2008-02-14 | V2 Green, Inc. | Business Methods in a Power Aggregation System for Distributed Electric Resources |
US20080040479A1 (en) * | 2006-08-10 | 2008-02-14 | V2 Green Inc. | Connection Locator in a Power Aggregation System for Distributed Electric Resources |
US20080039989A1 (en) * | 2006-08-10 | 2008-02-14 | V2 Green, Inc. | User Interface and User Control in a Power Aggregation System for Distributed Electric Resources |
US20080039980A1 (en) * | 2006-08-10 | 2008-02-14 | V2 Green Inc. | Scheduling and Control in a Power Aggregation System for Distributed Electric Resources |
US20080040295A1 (en) * | 2006-08-10 | 2008-02-14 | V2 Green, Inc. | Power Aggregation System for Distributed Electric Resources |
US20080040296A1 (en) * | 2006-08-10 | 2008-02-14 | V2 Green Inc. | Electric Resource Power Meter in a Power Aggregation System for Distributed Electric Resources |
US20080040223A1 (en) * | 2006-08-10 | 2008-02-14 | V2 Green Inc. | Electric Resource Module in a Power Aggregation System for Distributed Electric Resources |
US20080052145A1 (en) * | 2006-08-10 | 2008-02-28 | V2 Green, Inc. | Power Aggregation System for Distributed Electric Resources |
US20080077158A1 (en) * | 2006-06-16 | 2008-03-27 | Hani Haider | Method and Apparatus for Computer Aided Surgery |
WO2008143653A2 (en) * | 2006-12-11 | 2008-11-27 | V2Green, Inc. | Transaction management in a power aggregation system for distributed electric resources |
US20080294246A1 (en) * | 2007-05-23 | 2008-11-27 | Boston Scientific Scimed, Inc. | Endoprosthesis with Select Ceramic Morphology |
US20090018639A1 (en) * | 2007-07-11 | 2009-01-15 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US20090043520A1 (en) * | 2006-08-10 | 2009-02-12 | V2Green, Inc. | User Interface and User Control in a Power Aggregation System for Distributed Electric Resources |
US20090043519A1 (en) * | 2006-08-10 | 2009-02-12 | V2Green, Inc. | Electric Resource Power Meter in a Power Aggregation System for Distributed Electric Resources |
US20090040029A1 (en) * | 2006-08-10 | 2009-02-12 | V2Green, Inc. | Transceiver and charging component for a power aggregation system |
US20090063680A1 (en) * | 2006-08-10 | 2009-03-05 | V2Green, Inc. | Connection Locator in a Power Aggregation System for Distributed Electric Resources |
US20090066287A1 (en) * | 2006-08-10 | 2009-03-12 | V2Green, Inc. | Business Methods in a Power Aggregation System for Distributed Electric Resources |
US20090105722A1 (en) * | 2007-10-17 | 2009-04-23 | Mindframe, Inc. | Devices and methods for embolus removal during acute ischemic stroke |
US20090105737A1 (en) * | 2007-10-17 | 2009-04-23 | Mindframe, Inc. | Acute stroke revascularization/recanalization systems processes and products thereby |
US20090118813A1 (en) * | 2007-11-02 | 2009-05-07 | Torsten Scheuermann | Nano-patterned implant surfaces |
US20090125053A1 (en) * | 2007-11-12 | 2009-05-14 | Mindframe, Inc. | Aneurysm neck bridging processes with revascularization systems methods and products thereby |
US20090171441A1 (en) * | 2007-12-27 | 2009-07-02 | Cook Incorporated | Endovascular graft with separately positionable and removable frame units |
US20090192455A1 (en) * | 2008-01-07 | 2009-07-30 | David Ferrera | Novel enhanced ptna rapid exchange type of catheter system |
US20090264771A1 (en) * | 2008-04-22 | 2009-10-22 | Medtronic Vascular, Inc. | Ultrasonic Based Characterization of Plaque in Chronic Total Occlusions |
US20090292297A1 (en) * | 2008-05-19 | 2009-11-26 | David Ferrere | Devices for Restoring Blood Flow and Embolus Removal During Acute Ischemic Stroke |
WO2010011956A1 (en) * | 2008-07-25 | 2010-01-28 | Spine View, Inc. | Systems and methods for cable-based debriders |
US20100087908A1 (en) * | 2007-03-20 | 2010-04-08 | Pierre Hilaire | Apparatus and methods for stent delivery with embolic protection |
US20100100106A1 (en) * | 2008-04-11 | 2010-04-22 | Mindframe, Inc. | Monorail neuro-microcatheter for delivery of medical devices to treat stroke, processes and products thereby |
US20100121373A1 (en) * | 2008-11-10 | 2010-05-13 | Cook Incorporated | Removable vena cava filter with improved leg |
US20100174309A1 (en) * | 2008-05-19 | 2010-07-08 | Mindframe, Inc. | Recanalization/revascularization and embolus addressing systems including expandable tip neuro-microcatheter |
US20100256600A1 (en) * | 2009-04-04 | 2010-10-07 | Ferrera David A | Neurovascular otw pta balloon catheter and delivery system |
US20100318178A1 (en) * | 2009-06-15 | 2010-12-16 | Perflow Medical Ltd. | Method and apparatus for allowing blood flow through an occluded vessel |
US20110054507A1 (en) * | 2009-04-17 | 2011-03-03 | David Batten | Devices and methods for arched roof cutters |
US20110060212A1 (en) * | 2008-02-22 | 2011-03-10 | Micro Therapeutics, Inc. | Methods and apparatus for flow restoration |
US20110087257A1 (en) * | 2009-04-02 | 2011-04-14 | Spine View, Inc. | Minimally invasive discectomy |
US7931683B2 (en) | 2007-07-27 | 2011-04-26 | Boston Scientific Scimed, Inc. | Articles having ceramic coated surfaces |
US7938855B2 (en) | 2007-11-02 | 2011-05-10 | Boston Scientific Scimed, Inc. | Deformable underlayer for stent |
US7942926B2 (en) | 2007-07-11 | 2011-05-17 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US20110160763A1 (en) * | 2007-10-17 | 2011-06-30 | Mindframe, Inc. | Blood flow restoration and thrombus management methods |
US7981150B2 (en) | 2006-11-09 | 2011-07-19 | Boston Scientific Scimed, Inc. | Endoprosthesis with coatings |
US7985252B2 (en) | 2008-07-30 | 2011-07-26 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis |
US7998192B2 (en) | 2008-05-09 | 2011-08-16 | Boston Scientific Scimed, Inc. | Endoprostheses |
US8002821B2 (en) | 2006-09-18 | 2011-08-23 | Boston Scientific Scimed, Inc. | Bioerodible metallic ENDOPROSTHESES |
US8016845B1 (en) | 2003-02-04 | 2011-09-13 | Lsi Solutions, Inc. | Instrument for guiding the surgical cutting of tissue and method of use |
US8029554B2 (en) | 2007-11-02 | 2011-10-04 | Boston Scientific Scimed, Inc. | Stent with embedded material |
US8048150B2 (en) | 2006-04-12 | 2011-11-01 | Boston Scientific Scimed, Inc. | Endoprosthesis having a fiber meshwork disposed thereon |
US8052744B2 (en) | 2006-09-15 | 2011-11-08 | Boston Scientific Scimed, Inc. | Medical devices and methods of making the same |
US8052745B2 (en) | 2007-09-13 | 2011-11-08 | Boston Scientific Scimed, Inc. | Endoprosthesis |
US8052743B2 (en) | 2006-08-02 | 2011-11-08 | Boston Scientific Scimed, Inc. | Endoprosthesis with three-dimensional disintegration control |
US8057534B2 (en) | 2006-09-15 | 2011-11-15 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
US8066763B2 (en) | 1998-04-11 | 2011-11-29 | Boston Scientific Scimed, Inc. | Drug-releasing stent with ceramic-containing layer |
US8067054B2 (en) | 2007-04-05 | 2011-11-29 | Boston Scientific Scimed, Inc. | Stents with ceramic drug reservoir layer and methods of making and using the same |
US8070797B2 (en) | 2007-03-01 | 2011-12-06 | Boston Scientific Scimed, Inc. | Medical device with a porous surface for delivery of a therapeutic agent |
US8071156B2 (en) | 2009-03-04 | 2011-12-06 | Boston Scientific Scimed, Inc. | Endoprostheses |
US8080055B2 (en) | 2006-12-28 | 2011-12-20 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
US8089029B2 (en) | 2006-02-01 | 2012-01-03 | Boston Scientific Scimed, Inc. | Bioabsorbable metal medical device and method of manufacture |
US8128689B2 (en) | 2006-09-15 | 2012-03-06 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis with biostable inorganic layers |
US8216632B2 (en) | 2007-11-02 | 2012-07-10 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US8221822B2 (en) | 2007-07-31 | 2012-07-17 | Boston Scientific Scimed, Inc. | Medical device coating by laser cladding |
US8231980B2 (en) | 2008-12-03 | 2012-07-31 | Boston Scientific Scimed, Inc. | Medical implants including iridium oxide |
US8236046B2 (en) | 2008-06-10 | 2012-08-07 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis |
WO2012114333A1 (en) * | 2011-02-24 | 2012-08-30 | Ilan Ben Oren | Hybrid catheter for vascular intervention |
US8267992B2 (en) | 2009-03-02 | 2012-09-18 | Boston Scientific Scimed, Inc. | Self-buffering medical implants |
US8287937B2 (en) | 2009-04-24 | 2012-10-16 | Boston Scientific Scimed, Inc. | Endoprosthese |
US8303643B2 (en) | 2001-06-27 | 2012-11-06 | Remon Medical Technologies Ltd. | Method and device for electrochemical formation of therapeutic species in vivo |
US8353949B2 (en) | 2006-09-14 | 2013-01-15 | Boston Scientific Scimed, Inc. | Medical devices with drug-eluting coating |
US8382824B2 (en) | 2008-10-03 | 2013-02-26 | Boston Scientific Scimed, Inc. | Medical implant having NANO-crystal grains with barrier layers of metal nitrides or fluorides |
WO2013052590A1 (en) * | 2011-10-04 | 2013-04-11 | Vessix Vascular, Inc. | Apparatus and method for treatment of in-stent restenosis |
US8431149B2 (en) | 2007-03-01 | 2013-04-30 | Boston Scientific Scimed, Inc. | Coated medical devices for abluminal drug delivery |
US8449603B2 (en) | 2008-06-18 | 2013-05-28 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US8574615B2 (en) | 2006-03-24 | 2013-11-05 | Boston Scientific Scimed, Inc. | Medical devices having nanoporous coatings for controlled therapeutic agent delivery |
US8585713B2 (en) | 2007-10-17 | 2013-11-19 | Covidien Lp | Expandable tip assembly for thrombus management |
CN103491905A (en) * | 2011-02-25 | 2014-01-01 | 爱德华兹生命科学公司 | Prosthetic heart valve delivery apparatus |
US20140012363A1 (en) * | 2011-01-17 | 2014-01-09 | Novita Therapeutics, Llc | Ballstent device and methods of use |
US8668732B2 (en) | 2010-03-23 | 2014-03-11 | Boston Scientific Scimed, Inc. | Surface treated bioerodible metal endoprostheses |
US8771343B2 (en) | 2006-06-29 | 2014-07-08 | Boston Scientific Scimed, Inc. | Medical devices with selective titanium oxide coatings |
US8808726B2 (en) | 2006-09-15 | 2014-08-19 | Boston Scientific Scimed. Inc. | Bioerodible endoprostheses and methods of making the same |
US8815273B2 (en) | 2007-07-27 | 2014-08-26 | Boston Scientific Scimed, Inc. | Drug eluting medical devices having porous layers |
US8815275B2 (en) | 2006-06-28 | 2014-08-26 | Boston Scientific Scimed, Inc. | Coatings for medical devices comprising a therapeutic agent and a metallic material |
US8840660B2 (en) | 2006-01-05 | 2014-09-23 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
US8900292B2 (en) | 2007-08-03 | 2014-12-02 | Boston Scientific Scimed, Inc. | Coating for medical device having increased surface area |
US8920491B2 (en) | 2008-04-22 | 2014-12-30 | Boston Scientific Scimed, Inc. | Medical devices having a coating of inorganic material |
US8932346B2 (en) | 2008-04-24 | 2015-01-13 | Boston Scientific Scimed, Inc. | Medical devices having inorganic particle layers |
US20150073400A1 (en) * | 2012-04-18 | 2015-03-12 | CardioSonic Ltd. | Tissue treatment |
US20150080896A1 (en) | 2013-07-19 | 2015-03-19 | Ouroboros Medical, Inc. | Anti-clogging device for a vacuum-assisted, tissue removal system |
US8986248B2 (en) | 2004-06-23 | 2015-03-24 | Boston Scientific Scimed, Inc. | Cutting balloon and process |
KR20150083107A (en) * | 2012-11-08 | 2015-07-16 | 코비디엔 엘피 | Tissue-removing catheter including operational control mechanism |
US9119659B2 (en) | 2011-12-03 | 2015-09-01 | Ouroboros Medical, Inc. | Safe cutting heads and systems for fast removal of a target tissue |
US9284409B2 (en) | 2007-07-19 | 2016-03-15 | Boston Scientific Scimed, Inc. | Endoprosthesis having a non-fouling surface |
US9295393B2 (en) | 2012-11-09 | 2016-03-29 | Elwha Llc | Embolism deflector |
US9498231B2 (en) | 2011-06-27 | 2016-11-22 | Board Of Regents Of The University Of Nebraska | On-board tool tracking system and methods of computer assisted surgery |
WO2017021172A1 (en) * | 2015-08-05 | 2017-02-09 | Koninklijke Philips N.V. | Catheter assembly with low axial sliding friction |
USD802769S1 (en) | 2016-05-16 | 2017-11-14 | Teleflex Medical Incorporated | Thrombectomy handle assembly |
CN108186080A (en) * | 2018-03-02 | 2018-06-22 | 郑州大学第附属医院 | A kind of novel intravascular stirring thrombolysis device |
US10022212B2 (en) | 2011-01-13 | 2018-07-17 | Cook Medical Technologies Llc | Temporary venous filter with anti-coagulant delivery method |
US10080571B2 (en) | 2015-03-06 | 2018-09-25 | Warsaw Orthopedic, Inc. | Surgical instrument and method |
US10105149B2 (en) | 2013-03-15 | 2018-10-23 | Board Of Regents Of The University Of Nebraska | On-board tool tracking system and methods of computer assisted surgery |
US10123803B2 (en) | 2007-10-17 | 2018-11-13 | Covidien Lp | Methods of managing neurovascular obstructions |
WO2019006259A1 (en) * | 2017-06-30 | 2019-01-03 | Onesti Jill | Dissection device |
US10219811B2 (en) | 2011-06-27 | 2019-03-05 | Board Of Regents Of The University Of Nebraska | On-board tool tracking system and methods of computer assisted surgery |
US10376274B2 (en) | 2015-07-16 | 2019-08-13 | Perflow Medical Ltd. | Apparatus and method for vessel occlusion removal |
US10441295B2 (en) | 2013-10-15 | 2019-10-15 | Stryker Corporation | Device for creating a void space in a living tissue, the device including a handle with a control knob that can be set regardless of the orientation of the handle |
US10722255B2 (en) | 2008-12-23 | 2020-07-28 | Covidien Lp | Systems and methods for removing obstructive matter from body lumens and treating vascular defects |
US10933259B2 (en) | 2013-05-23 | 2021-03-02 | CardioSonic Ltd. | Devices and methods for renal denervation and assessment thereof |
US10973570B2 (en) | 2004-09-10 | 2021-04-13 | Boston Scientific Scimed, Inc. | Apparatus and method for treatment of in-stent restenosis |
US11007059B2 (en) * | 2016-05-06 | 2021-05-18 | Transmural Systems Llc | Annuloplasty procedures, related devices and methods |
US11013516B2 (en) | 2011-01-17 | 2021-05-25 | Artio Medical, Inc. | Expandable body device and method of use |
US11033275B2 (en) | 2014-09-17 | 2021-06-15 | Artio Medical, Inc. | Expandable body device and method of use |
US11318331B2 (en) | 2017-03-20 | 2022-05-03 | Sonivie Ltd. | Pulmonary hypertension treatment |
US11337714B2 (en) | 2007-10-17 | 2022-05-24 | Covidien Lp | Restoring blood flow and clot removal during acute ischemic stroke |
US11357447B2 (en) | 2012-05-31 | 2022-06-14 | Sonivie Ltd. | Method and/or apparatus for measuring renal denervation effectiveness |
EP4029459A1 (en) * | 2021-01-15 | 2022-07-20 | Shanghai Sixth People's Hospital | Plaque removal device |
US11484318B2 (en) | 2011-01-17 | 2022-11-01 | Artio Medical, Inc. | Expandable body device and method of use |
US11622781B2 (en) | 2020-01-30 | 2023-04-11 | Julier Medical AG | Apparatus and method for neurovascular endoluminal intervention |
US11684420B2 (en) | 2016-05-05 | 2023-06-27 | Eximo Medical Ltd. | Apparatus and methods for resecting and/or ablating an undesired tissue |
US11730506B2 (en) | 2010-10-18 | 2023-08-22 | Sonivie Ltd. | Ultrasound transducer and uses thereof |
US11737767B2 (en) | 2022-01-21 | 2023-08-29 | Julier Medical AG | Neurovascular catheter and method of use |
WO2023222466A1 (en) * | 2022-05-19 | 2023-11-23 | Koninklijke Philips N.V. | Expandable debulking tool for intravascular procedures |
US11849986B2 (en) | 2019-04-24 | 2023-12-26 | Stryker Corporation | Systems and methods for off-axis augmentation of a vertebral body |
US11911117B2 (en) | 2011-06-27 | 2024-02-27 | Board Of Regents Of The University Of Nebraska | On-board tool tracking system and methods of computer assisted surgery |
US12038322B2 (en) | 2022-06-21 | 2024-07-16 | Eximo Medical Ltd. | Devices and methods for testing ablation systems |
Families Citing this family (245)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030216761A1 (en) * | 1990-03-27 | 2003-11-20 | Samuel Shiber | Guidewire system |
IES81060B2 (en) | 1997-11-07 | 2000-01-12 | Salviac Ltd | An embolic protection device |
US7491216B2 (en) | 1997-11-07 | 2009-02-17 | Salviac Limited | Filter element with retractable guidewire tip |
ATE342697T1 (en) * | 1998-04-02 | 2006-11-15 | Salviac Ltd | IMPLANTATION CATHETER |
US6511492B1 (en) * | 1998-05-01 | 2003-01-28 | Microvention, Inc. | Embolectomy catheters and methods for treating stroke and other small vessel thromboembolic disorders |
US6171327B1 (en) | 1999-02-24 | 2001-01-09 | Scimed Life Systems, Inc. | Intravascular filter and method |
US6918921B2 (en) | 1999-05-07 | 2005-07-19 | Salviac Limited | Support frame for an embolic protection device |
US6964672B2 (en) | 1999-05-07 | 2005-11-15 | Salviac Limited | Support frame for an embolic protection device |
DE10084521T1 (en) | 1999-05-07 | 2002-06-20 | Salviac Ltd | Embolic protection device |
US6530939B1 (en) * | 1999-07-30 | 2003-03-11 | Incept, Llc | Vascular device having articulation region and methods of use |
US6179861B1 (en) | 1999-07-30 | 2001-01-30 | Incept Llc | Vascular device having one or more articulation regions and methods of use |
US6214026B1 (en) | 1999-07-30 | 2001-04-10 | Incept Llc | Delivery system for a vascular device with articulation region |
US6203561B1 (en) | 1999-07-30 | 2001-03-20 | Incept Llc | Integrated vascular device having thrombectomy element and vascular filter and methods of use |
US6544279B1 (en) | 2000-08-09 | 2003-04-08 | Incept, Llc | Vascular device for emboli, thrombus and foreign body removal and methods of use |
US7713279B2 (en) | 2000-12-20 | 2010-05-11 | Fox Hollow Technologies, Inc. | Method and devices for cutting tissue |
US6299622B1 (en) | 1999-08-19 | 2001-10-09 | Fox Hollow Technologies, Inc. | Atherectomy catheter with aligned imager |
US8328829B2 (en) | 1999-08-19 | 2012-12-11 | Covidien Lp | High capacity debulking catheter with razor edge cutting window |
US7708749B2 (en) | 2000-12-20 | 2010-05-04 | Fox Hollow Technologies, Inc. | Debulking catheters and methods |
US6217589B1 (en) | 1999-10-27 | 2001-04-17 | Scimed Life Systems, Inc. | Retrieval device made of precursor alloy cable and method of manufacturing |
US6660021B1 (en) | 1999-12-23 | 2003-12-09 | Advanced Cardiovascular Systems, Inc. | Intravascular device and system |
US6575997B1 (en) | 1999-12-23 | 2003-06-10 | Endovascular Technologies, Inc. | Embolic basket |
US6402771B1 (en) | 1999-12-23 | 2002-06-11 | Guidant Endovascular Solutions | Snare |
US6540722B1 (en) | 1999-12-30 | 2003-04-01 | Advanced Cardiovascular Systems, Inc. | Embolic protection devices |
US6695813B1 (en) | 1999-12-30 | 2004-02-24 | Advanced Cardiovascular Systems, Inc. | Embolic protection devices |
US7918820B2 (en) | 1999-12-30 | 2011-04-05 | Advanced Cardiovascular Systems, Inc. | Device for, and method of, blocking emboli in vessels such as blood arteries |
US6629953B1 (en) | 2000-02-18 | 2003-10-07 | Fox Hollow Technologies, Inc. | Methods and devices for removing material from a vascular site |
US20010031981A1 (en) | 2000-03-31 | 2001-10-18 | Evans Michael A. | Method and device for locating guidewire and treating chronic total occlusions |
GB2369575A (en) | 2000-04-20 | 2002-06-05 | Salviac Ltd | An embolic protection system |
US6508784B1 (en) * | 2000-05-19 | 2003-01-21 | Yan-Ho Shu | Balloon catheter having adjustable centering capabilities and methods thereof |
DE10191982T1 (en) * | 2000-06-23 | 2003-11-06 | Salviac Ltd | Filter element for embolic protection device |
US6565591B2 (en) | 2000-06-23 | 2003-05-20 | Salviac Limited | Medical device |
US6964670B1 (en) | 2000-07-13 | 2005-11-15 | Advanced Cardiovascular Systems, Inc. | Embolic protection guide wire |
US6558405B1 (en) | 2000-08-29 | 2003-05-06 | Advanced Cardiovascular Systems, Inc. | Embolic filter |
JP2002136537A (en) * | 2000-11-01 | 2002-05-14 | Aloka Co Ltd | Blood vessel treatment apparatus and blood vessel treatment system |
US6416540B1 (en) * | 2000-11-01 | 2002-07-09 | Sandip V. Mathur | Magnetically actuated cleanable stent and method |
US6506203B1 (en) | 2000-12-19 | 2003-01-14 | Advanced Cardiovascular Systems, Inc. | Low profile sheathless embolic protection system |
ATE499054T1 (en) * | 2000-12-20 | 2011-03-15 | Fox Hollow Technologies Inc | REDUCTION CATHETER |
US6663651B2 (en) | 2001-01-16 | 2003-12-16 | Incept Llc | Systems and methods for vascular filter retrieval |
US6491660B2 (en) * | 2001-01-23 | 2002-12-10 | Scimed Life Systems, Inc. | Frontal infusion system for intravenous burrs |
US6599307B1 (en) | 2001-06-29 | 2003-07-29 | Advanced Cardiovascular Systems, Inc. | Filter device for embolic protection systems |
US7338510B2 (en) | 2001-06-29 | 2008-03-04 | Advanced Cardiovascular Systems, Inc. | Variable thickness embolic filtering devices and method of manufacturing the same |
US6951570B2 (en) * | 2001-07-02 | 2005-10-04 | Rubicon Medical, Inc. | Methods, systems, and devices for deploying a filter from a filter device |
US6632231B2 (en) * | 2001-08-23 | 2003-10-14 | Scimed Life Systems, Inc. | Segmented balloon catheter blade |
US6638294B1 (en) | 2001-08-30 | 2003-10-28 | Advanced Cardiovascular Systems, Inc. | Self furling umbrella frame for carotid filter |
US6592606B2 (en) | 2001-08-31 | 2003-07-15 | Advanced Cardiovascular Systems, Inc. | Hinged short cage for an embolic protection device |
US8262689B2 (en) | 2001-09-28 | 2012-09-11 | Advanced Cardiovascular Systems, Inc. | Embolic filtering devices |
US7749243B2 (en) * | 2001-10-19 | 2010-07-06 | Boston Scientific Scimed, Inc. | Embolus extractor |
US6887257B2 (en) | 2001-10-19 | 2005-05-03 | Incept Llc | Vascular embolic filter exchange devices and methods of use thereof |
EP1441669B1 (en) | 2001-11-09 | 2009-03-25 | AngioScore, Inc. | Baloon catheter with non-deployable stent |
US20040111108A1 (en) | 2001-11-09 | 2004-06-10 | Farnan Robert C. | Balloon catheter with non-deployable stent |
CA2466037C (en) | 2001-11-09 | 2010-12-21 | Rubicon Medical, Inc. | Stent delivery device with embolic protection |
US7241304B2 (en) | 2001-12-21 | 2007-07-10 | Advanced Cardiovascular Systems, Inc. | Flexible and conformable embolic filtering devices |
AU2002351156A1 (en) | 2001-12-21 | 2003-07-15 | Salviac Limited | A support frame for an embolic protection device |
US7048756B2 (en) * | 2002-01-18 | 2006-05-23 | Apasara Medical Corporation | System, method and apparatus for evaluating tissue temperature |
US6850804B2 (en) | 2002-01-18 | 2005-02-01 | Calfacior Corporation | System method and apparatus for localized heating of tissue |
US7756583B2 (en) | 2002-04-08 | 2010-07-13 | Ardian, Inc. | Methods and apparatus for intravascularly-induced neuromodulation |
US8347891B2 (en) | 2002-04-08 | 2013-01-08 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen |
US7331973B2 (en) | 2002-09-30 | 2008-02-19 | Avdanced Cardiovascular Systems, Inc. | Guide wire with embolic filtering attachment |
US7252675B2 (en) | 2002-09-30 | 2007-08-07 | Advanced Cardiovascular, Inc. | Embolic filtering devices |
US8468678B2 (en) | 2002-10-02 | 2013-06-25 | Boston Scientific Scimed, Inc. | Expandable retrieval device |
US7037319B2 (en) * | 2002-10-15 | 2006-05-02 | Scimed Life Systems, Inc. | Nanotube paper-based medical device |
US20040088000A1 (en) | 2002-10-31 | 2004-05-06 | Muller Paul F. | Single-wire expandable cages for embolic filtering devices |
US7776042B2 (en) | 2002-12-03 | 2010-08-17 | Trans1 Inc. | Methods and apparatus for provision of therapy to adjacent motion segments |
US8080026B2 (en) | 2003-01-21 | 2011-12-20 | Angioscore, Inc. | Apparatus and methods for treating hardened vascular lesions |
US6878291B2 (en) | 2003-02-24 | 2005-04-12 | Scimed Life Systems, Inc. | Flexible tube for cartridge filter |
US7740644B2 (en) | 2003-02-24 | 2010-06-22 | Boston Scientific Scimed, Inc. | Embolic protection filtering device that can be adapted to be advanced over a guidewire |
US8591540B2 (en) | 2003-02-27 | 2013-11-26 | Abbott Cardiovascular Systems Inc. | Embolic filtering devices |
AU2004228053A1 (en) * | 2003-04-04 | 2004-10-21 | Minnesota Medtec, Inc. | Introduction apparatus |
CA2521432A1 (en) * | 2003-04-04 | 2004-10-21 | Minnesota Medtec, Inc. | Guide catheter and method of making same |
US20100145313A1 (en) * | 2003-04-04 | 2010-06-10 | Packard Brian M | System and method for treating septal defects |
US8246640B2 (en) | 2003-04-22 | 2012-08-21 | Tyco Healthcare Group Lp | Methods and devices for cutting tissue at a vascular location |
US7780611B2 (en) | 2003-05-01 | 2010-08-24 | Boston Scientific Scimed, Inc. | Medical instrument with controlled torque transmission |
WO2004100772A2 (en) * | 2003-05-12 | 2004-11-25 | University Of Florida | Devices and methods for disruption and removal of luninal occlusions |
US20050027309A1 (en) * | 2003-06-17 | 2005-02-03 | Samuel Shiber | Guidewire system |
US20050143768A1 (en) * | 2003-06-17 | 2005-06-30 | Samuel Shiber | Sleeved guidewire system method of use |
US20050177073A1 (en) * | 2003-06-17 | 2005-08-11 | Samuel Shiber | Guidewire system with a deflectable distal tip |
US9301829B2 (en) | 2003-07-30 | 2016-04-05 | Boston Scientific Scimed, Inc. | Embolic protection aspirator |
DE202004021951U1 (en) | 2003-09-12 | 2013-06-19 | Vessix Vascular, Inc. | Selectable eccentric remodeling and / or ablation of atherosclerotic material |
US7740633B2 (en) * | 2003-10-23 | 2010-06-22 | Trans1 Inc. | Guide pin for guiding instrumentation along a soft tissue tract to a point on the spine |
US7892251B1 (en) | 2003-11-12 | 2011-02-22 | Advanced Cardiovascular Systems, Inc. | Component for delivering and locking a medical device to a guide wire |
US7678129B1 (en) | 2004-03-19 | 2010-03-16 | Advanced Cardiovascular Systems, Inc. | Locking component for an embolic filter assembly |
US9713730B2 (en) | 2004-09-10 | 2017-07-25 | Boston Scientific Scimed, Inc. | Apparatus and method for treatment of in-stent restenosis |
US8396548B2 (en) | 2008-11-14 | 2013-03-12 | Vessix Vascular, Inc. | Selective drug delivery in a lumen |
US7621904B2 (en) | 2004-10-21 | 2009-11-24 | Boston Scientific Scimed, Inc. | Catheter with a pre-shaped distal tip |
US8038691B2 (en) | 2004-11-12 | 2011-10-18 | Boston Scientific Scimed, Inc. | Cutting balloon catheter having flexible atherotomes |
EP1830915B1 (en) * | 2004-12-30 | 2008-11-05 | Cook Incorporated | Catheter assembly with plaque cutting balloon |
US8480629B2 (en) | 2005-01-28 | 2013-07-09 | Boston Scientific Scimed, Inc. | Universal utility board for use with medical devices and methods of use |
US20060184191A1 (en) | 2005-02-11 | 2006-08-17 | Boston Scientific Scimed, Inc. | Cutting balloon catheter having increased flexibility regions |
EP2438877B1 (en) | 2005-03-28 | 2016-02-17 | Vessix Vascular, Inc. | Intraluminal electrical tissue characterization and tuned RF energy for selective treatment of atheroma and other target tissues |
US9259305B2 (en) | 2005-03-31 | 2016-02-16 | Abbott Cardiovascular Systems Inc. | Guide wire locking mechanism for rapid exchange and other catheter systems |
US7935075B2 (en) * | 2005-04-26 | 2011-05-03 | Cardiac Pacemakers, Inc. | Self-deploying vascular occlusion device |
US10076641B2 (en) * | 2005-05-11 | 2018-09-18 | The Spectranetics Corporation | Methods and systems for delivering substances into luminal walls |
US8019438B2 (en) * | 2005-06-28 | 2011-09-13 | Cardiac Pacemakers, Inc. | Anchor for electrode delivery system |
US20070106320A1 (en) * | 2005-11-10 | 2007-05-10 | John Blix | Balloon catheter for distal protection compatability |
WO2007075986A2 (en) * | 2005-12-20 | 2007-07-05 | Medical Components, Inc. | Cutting balloon catheter assembly |
JP5164861B2 (en) * | 2006-02-01 | 2013-03-21 | ザ クリーブランド クリニック ファウンデーション | Method and apparatus for increasing blood flow through a blocked blood vessel |
US8019435B2 (en) | 2006-05-02 | 2011-09-13 | Boston Scientific Scimed, Inc. | Control of arterial smooth muscle tone |
US20090018566A1 (en) | 2006-06-30 | 2009-01-15 | Artheromed, Inc. | Atherectomy devices, systems, and methods |
US8361094B2 (en) | 2006-06-30 | 2013-01-29 | Atheromed, Inc. | Atherectomy devices and methods |
US7981128B2 (en) * | 2006-06-30 | 2011-07-19 | Atheromed, Inc. | Atherectomy devices and methods |
US9314263B2 (en) | 2006-06-30 | 2016-04-19 | Atheromed, Inc. | Atherectomy devices, systems, and methods |
US8628549B2 (en) | 2006-06-30 | 2014-01-14 | Atheromed, Inc. | Atherectomy devices, systems, and methods |
JP5220007B2 (en) | 2006-06-30 | 2013-06-26 | アセロメッド, インコーポレイテッド | Apparatus and method for atherectomy |
US9492192B2 (en) | 2006-06-30 | 2016-11-15 | Atheromed, Inc. | Atherectomy devices, systems, and methods |
US20080045986A1 (en) | 2006-06-30 | 2008-02-21 | Atheromed, Inc. | Atherectomy devices and methods |
US8007506B2 (en) | 2006-06-30 | 2011-08-30 | Atheromed, Inc. | Atherectomy devices and methods |
US8876754B2 (en) | 2006-08-31 | 2014-11-04 | Bayer Medical Care Inc. | Catheter with filtering and sensing elements |
AU2007310986B2 (en) | 2006-10-18 | 2013-07-04 | Boston Scientific Scimed, Inc. | Inducing desirable temperature effects on body tissue |
EP2455036B1 (en) | 2006-10-18 | 2015-07-15 | Vessix Vascular, Inc. | Tuned RF energy and electrical tissue characterization for selective treatment of target tissues |
JP5559539B2 (en) | 2006-10-18 | 2014-07-23 | べシックス・バスキュラー・インコーポレイテッド | System that induces desirable temperature effects on body tissue |
US20080269774A1 (en) | 2006-10-26 | 2008-10-30 | Chestnut Medical Technologies, Inc. | Intracorporeal Grasping Device |
US8496653B2 (en) | 2007-04-23 | 2013-07-30 | Boston Scientific Scimed, Inc. | Thrombus removal |
US8216209B2 (en) | 2007-05-31 | 2012-07-10 | Abbott Cardiovascular Systems Inc. | Method and apparatus for delivering an agent to a kidney |
US7867273B2 (en) | 2007-06-27 | 2011-01-11 | Abbott Laboratories | Endoprostheses for peripheral arteries and other body vessels |
WO2009006748A2 (en) * | 2007-07-09 | 2009-01-15 | Sis-Medical Ag | Method and system to detect neointima coverage of a stent |
US8236016B2 (en) | 2007-10-22 | 2012-08-07 | Atheromed, Inc. | Atherectomy devices and methods |
US8070762B2 (en) | 2007-10-22 | 2011-12-06 | Atheromed Inc. | Atherectomy devices and methods |
US8784440B2 (en) | 2008-02-25 | 2014-07-22 | Covidien Lp | Methods and devices for cutting tissue |
US20090248059A1 (en) * | 2008-03-25 | 2009-10-01 | Hesham Morsi | Embolectomy Catheter |
WO2009120205A1 (en) * | 2008-03-28 | 2009-10-01 | Niranjan Seshadri | Device for treating occlusions, and method for treating occluded vessels |
US9101387B2 (en) * | 2008-06-05 | 2015-08-11 | Cardiovascular Systems, Inc. | Directional rotational atherectomy device with offset spinning abrasive element |
US9170199B2 (en) * | 2008-07-24 | 2015-10-27 | Massachusetts Institute Of Technology | Enhanced sensors in three dimensional scanning system |
US9170200B2 (en) | 2008-07-24 | 2015-10-27 | Massachusetts Institute Of Technology | Inflatable membrane with hazard mitigation |
US9140649B2 (en) | 2008-07-24 | 2015-09-22 | Massachusetts Institute Of Technology | Inflatable membrane having non-uniform inflation characteristic |
US9291565B2 (en) | 2008-07-24 | 2016-03-22 | Massachusetts Institute Of Technology | Three dimensional scanning using membrane with optical features |
JP5295698B2 (en) * | 2008-09-22 | 2013-09-18 | テルモ株式会社 | Lancing device |
EP2358282B1 (en) | 2008-10-13 | 2017-12-06 | Covidien LP | Devices for manipulating a catheter shaft |
JP5307900B2 (en) | 2008-11-17 | 2013-10-02 | べシックス・バスキュラー・インコーポレイテッド | Selective energy storage without knowledge of organizational topography |
US8444669B2 (en) | 2008-12-15 | 2013-05-21 | Boston Scientific Scimed, Inc. | Embolic filter delivery system and method |
ES2532407T3 (en) | 2009-04-29 | 2015-03-26 | Covidien Lp | Devices for cutting and scraping tissue |
US8551096B2 (en) | 2009-05-13 | 2013-10-08 | Boston Scientific Scimed, Inc. | Directional delivery of energy and bioactives |
KR101323514B1 (en) | 2009-05-14 | 2013-10-29 | 코비디엔 엘피 | Easily cleaned atherectomy catheters and methods of use |
US8246568B2 (en) * | 2009-08-31 | 2012-08-21 | Cook Medical Technologies Llc | Hemodialysis catheter with thrombus removing device |
CA2781046C (en) | 2009-12-02 | 2014-09-16 | Tyco Healthcare Group Lp | Methods and devices for cutting tissue |
AU2010328078B2 (en) | 2009-12-11 | 2013-07-04 | Covidien Lp | Material removal device having improved material capture efficiency and methods of use |
WO2011112918A2 (en) * | 2010-03-11 | 2011-09-15 | Atlanta Catheter Therapies, Inc. | Atherectomy device |
CA2795229A1 (en) | 2010-04-09 | 2011-10-13 | Vessix Vascular, Inc. | Power generating and control apparatus for the treatment of tissue |
US9192790B2 (en) | 2010-04-14 | 2015-11-24 | Boston Scientific Scimed, Inc. | Focused ultrasonic renal denervation |
EP2380604A1 (en) | 2010-04-19 | 2011-10-26 | InnoRa Gmbh | Improved coating formulations for scoring or cutting balloon catheters |
US9795406B2 (en) | 2010-05-13 | 2017-10-24 | Rex Medical, L.P. | Rotational thrombectomy wire |
US9023070B2 (en) | 2010-05-13 | 2015-05-05 | Rex Medical, L.P. | Rotational thrombectomy wire coupler |
US8764779B2 (en) | 2010-05-13 | 2014-07-01 | Rex Medical, L.P. | Rotational thrombectomy wire |
US8663259B2 (en) | 2010-05-13 | 2014-03-04 | Rex Medical L.P. | Rotational thrombectomy wire |
US8473067B2 (en) | 2010-06-11 | 2013-06-25 | Boston Scientific Scimed, Inc. | Renal denervation and stimulation employing wireless vascular energy transfer arrangement |
JP5690928B2 (en) | 2010-06-14 | 2015-03-25 | コヴィディエン リミテッド パートナーシップ | Substance removal device |
US9155589B2 (en) | 2010-07-30 | 2015-10-13 | Boston Scientific Scimed, Inc. | Sequential activation RF electrode set for renal nerve ablation |
US9408661B2 (en) | 2010-07-30 | 2016-08-09 | Patrick A. Haverkost | RF electrodes on multiple flexible wires for renal nerve ablation |
US9084609B2 (en) | 2010-07-30 | 2015-07-21 | Boston Scientific Scime, Inc. | Spiral balloon catheter for renal nerve ablation |
US9463062B2 (en) | 2010-07-30 | 2016-10-11 | Boston Scientific Scimed, Inc. | Cooled conductive balloon RF catheter for renal nerve ablation |
US9358365B2 (en) | 2010-07-30 | 2016-06-07 | Boston Scientific Scimed, Inc. | Precision electrode movement control for renal nerve ablation |
US8632559B2 (en) | 2010-09-21 | 2014-01-21 | Angioscore, Inc. | Method and system for treating valve stenosis |
US8974451B2 (en) | 2010-10-25 | 2015-03-10 | Boston Scientific Scimed, Inc. | Renal nerve ablation using conductive fluid jet and RF energy |
US9220558B2 (en) | 2010-10-27 | 2015-12-29 | Boston Scientific Scimed, Inc. | RF renal denervation catheter with multiple independent electrodes |
JP5636114B2 (en) | 2010-10-28 | 2014-12-03 | コヴィディエン リミテッド パートナーシップ | Substance removal device and method of use |
RU2553930C2 (en) | 2010-11-11 | 2015-06-20 | Ковидиен Лп | Flexible fragmenting catheters with visualisation and methods of their application and manufacturing |
US9028485B2 (en) | 2010-11-15 | 2015-05-12 | Boston Scientific Scimed, Inc. | Self-expanding cooling electrode for renal nerve ablation |
US9089350B2 (en) | 2010-11-16 | 2015-07-28 | Boston Scientific Scimed, Inc. | Renal denervation catheter with RF electrode and integral contrast dye injection arrangement |
US9668811B2 (en) | 2010-11-16 | 2017-06-06 | Boston Scientific Scimed, Inc. | Minimally invasive access for renal nerve ablation |
US9326751B2 (en) | 2010-11-17 | 2016-05-03 | Boston Scientific Scimed, Inc. | Catheter guidance of external energy for renal denervation |
US9060761B2 (en) | 2010-11-18 | 2015-06-23 | Boston Scientific Scime, Inc. | Catheter-focused magnetic field induced renal nerve ablation |
US8801736B2 (en) | 2010-11-19 | 2014-08-12 | Gil Vardi | Percutaneous thrombus extraction device and method |
US9192435B2 (en) | 2010-11-22 | 2015-11-24 | Boston Scientific Scimed, Inc. | Renal denervation catheter with cooled RF electrode |
US9023034B2 (en) | 2010-11-22 | 2015-05-05 | Boston Scientific Scimed, Inc. | Renal ablation electrode with force-activatable conduction apparatus |
US20120157993A1 (en) | 2010-12-15 | 2012-06-21 | Jenson Mark L | Bipolar Off-Wall Electrode Device for Renal Nerve Ablation |
US9220561B2 (en) | 2011-01-19 | 2015-12-29 | Boston Scientific Scimed, Inc. | Guide-compatible large-electrode catheter for renal nerve ablation with reduced arterial injury |
US20130041454A1 (en) * | 2011-02-09 | 2013-02-14 | Business Expectations Llc | Sensor Actuated Stent |
US8821478B2 (en) | 2011-03-04 | 2014-09-02 | Boston Scientific Scimed, Inc. | Catheter with variable stiffness |
JP5759615B2 (en) | 2011-04-08 | 2015-08-05 | コヴィディエン リミテッド パートナーシップ | Iontophoretic catheter system and method for renal sympathetic denervation and iontophoretic drug delivery |
EP2701623B1 (en) | 2011-04-25 | 2016-08-17 | Medtronic Ardian Luxembourg S.à.r.l. | Apparatus related to constrained deployment of cryogenic balloons for limited cryogenic ablation of vessel walls |
US9227024B2 (en) * | 2011-06-13 | 2016-01-05 | Richard Deutsch | Systems and methods for monitoring contact with patient's catheter assembly |
AU2012283908B2 (en) | 2011-07-20 | 2017-02-16 | Boston Scientific Scimed, Inc. | Percutaneous devices and methods to visualize, target and ablate nerves |
WO2013016203A1 (en) | 2011-07-22 | 2013-01-31 | Boston Scientific Scimed, Inc. | Nerve modulation system with a nerve modulation element positionable in a helical guide |
JP5806407B2 (en) | 2011-09-01 | 2015-11-10 | コヴィディエン リミテッド パートナーシップ | Catheter with helical drive shaft and manufacturing method |
WO2013055826A1 (en) | 2011-10-10 | 2013-04-18 | Boston Scientific Scimed, Inc. | Medical devices including ablation electrodes |
EP2765940B1 (en) | 2011-10-11 | 2015-08-26 | Boston Scientific Scimed, Inc. | Off-wall electrode device for nerve modulation |
US9420955B2 (en) | 2011-10-11 | 2016-08-23 | Boston Scientific Scimed, Inc. | Intravascular temperature monitoring system and method |
US9364284B2 (en) | 2011-10-12 | 2016-06-14 | Boston Scientific Scimed, Inc. | Method of making an off-wall spacer cage |
EP2765930B1 (en) | 2011-10-13 | 2018-09-26 | Atheromed, Inc. | Atherectomy apparatus |
WO2013059202A1 (en) | 2011-10-18 | 2013-04-25 | Boston Scientific Scimed, Inc. | Integrated crossing balloon catheter |
EP2768563B1 (en) | 2011-10-18 | 2016-11-09 | Boston Scientific Scimed, Inc. | Deflectable medical devices |
CN108095821B (en) | 2011-11-08 | 2021-05-25 | 波士顿科学西美德公司 | Orifice renal nerve ablation |
WO2013074813A1 (en) | 2011-11-15 | 2013-05-23 | Boston Scientific Scimed, Inc. | Device and methods for renal nerve modulation monitoring |
US9119632B2 (en) | 2011-11-21 | 2015-09-01 | Boston Scientific Scimed, Inc. | Deflectable renal nerve ablation catheter |
US9265969B2 (en) | 2011-12-21 | 2016-02-23 | Cardiac Pacemakers, Inc. | Methods for modulating cell function |
CN104244810A (en) | 2011-12-23 | 2014-12-24 | 维西克斯血管公司 | Methods and apparatuses for remodeling tissue of or adjacent to a body passage |
WO2013101452A1 (en) | 2011-12-28 | 2013-07-04 | Boston Scientific Scimed, Inc. | Device and methods for nerve modulation using a novel ablation catheter with polymeric ablative elements |
US9050106B2 (en) | 2011-12-29 | 2015-06-09 | Boston Scientific Scimed, Inc. | Off-wall electrode device and methods for nerve modulation |
WO2013105961A1 (en) * | 2012-01-12 | 2013-07-18 | Empire Technology Development Llc | Methods and systems for detecting and removing metallic foreign bodies |
WO2013169927A1 (en) | 2012-05-08 | 2013-11-14 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices |
US9358022B2 (en) | 2012-05-21 | 2016-06-07 | Noha, Llc | Clot removal device and method of using same |
EP2866875A4 (en) * | 2012-06-29 | 2016-06-08 | Univ Washington Ct Commerciali | Catheters for emergency endovascular surgery and associated devices, systems, and methods |
US10321946B2 (en) | 2012-08-24 | 2019-06-18 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices with weeping RF ablation balloons |
US9532844B2 (en) | 2012-09-13 | 2017-01-03 | Covidien Lp | Cleaning device for medical instrument and method of use |
US9173696B2 (en) | 2012-09-17 | 2015-11-03 | Boston Scientific Scimed, Inc. | Self-positioning electrode system and method for renal nerve modulation |
WO2014047411A1 (en) | 2012-09-21 | 2014-03-27 | Boston Scientific Scimed, Inc. | System for nerve modulation and innocuous thermal gradient nerve block |
US10549127B2 (en) | 2012-09-21 | 2020-02-04 | Boston Scientific Scimed, Inc. | Self-cooling ultrasound ablation catheter |
EP2906135A2 (en) | 2012-10-10 | 2015-08-19 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices and methods |
WO2014163987A1 (en) | 2013-03-11 | 2014-10-09 | Boston Scientific Scimed, Inc. | Medical devices for modulating nerves |
WO2014143571A1 (en) | 2013-03-11 | 2014-09-18 | Boston Scientific Scimed, Inc. | Medical devices for modulating nerves |
US9808311B2 (en) | 2013-03-13 | 2017-11-07 | Boston Scientific Scimed, Inc. | Deflectable medical devices |
US10265122B2 (en) | 2013-03-15 | 2019-04-23 | Boston Scientific Scimed, Inc. | Nerve ablation devices and related methods of use |
US9297845B2 (en) | 2013-03-15 | 2016-03-29 | Boston Scientific Scimed, Inc. | Medical devices and methods for treatment of hypertension that utilize impedance compensation |
WO2014150553A1 (en) | 2013-03-15 | 2014-09-25 | Boston Scientific Scimed, Inc. | Methods and apparatuses for remodeling tissue of or adjacent to a body passage |
WO2014205388A1 (en) | 2013-06-21 | 2014-12-24 | Boston Scientific Scimed, Inc. | Renal denervation balloon catheter with ride along electrode support |
CN105473092B (en) | 2013-06-21 | 2019-05-17 | 波士顿科学国际有限公司 | The medical instrument for renal nerve ablation with rotatable shaft |
US9707036B2 (en) | 2013-06-25 | 2017-07-18 | Boston Scientific Scimed, Inc. | Devices and methods for nerve modulation using localized indifferent electrodes |
AU2014284558B2 (en) | 2013-07-01 | 2017-08-17 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation |
CN105377169B (en) | 2013-07-11 | 2019-04-19 | 波士顿科学国际有限公司 | Device and method for neuromodulation |
US10413357B2 (en) | 2013-07-11 | 2019-09-17 | Boston Scientific Scimed, Inc. | Medical device with stretchable electrode assemblies |
CN105682594B (en) | 2013-07-19 | 2018-06-22 | 波士顿科学国际有限公司 | Helical bipolar electrodes renal denervation dominates air bag |
EP3024406B1 (en) | 2013-07-22 | 2019-06-19 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation |
EP3024405A1 (en) | 2013-07-22 | 2016-06-01 | Boston Scientific Scimed, Inc. | Renal nerve ablation catheter having twist balloon |
US10722300B2 (en) | 2013-08-22 | 2020-07-28 | Boston Scientific Scimed, Inc. | Flexible circuit having improved adhesion to a renal nerve modulation balloon |
CN105555218B (en) | 2013-09-04 | 2019-01-15 | 波士顿科学国际有限公司 | With radio frequency (RF) foley's tube rinsed with cooling capacity |
WO2015038947A1 (en) | 2013-09-13 | 2015-03-19 | Boston Scientific Scimed, Inc. | Ablation balloon with vapor deposited cover layer |
US10117668B2 (en) | 2013-10-08 | 2018-11-06 | The Spectranetics Corporation | Balloon catheter with non-deployable stent having improved stability |
US9687166B2 (en) | 2013-10-14 | 2017-06-27 | Boston Scientific Scimed, Inc. | High resolution cardiac mapping electrode array catheter |
US11246654B2 (en) | 2013-10-14 | 2022-02-15 | Boston Scientific Scimed, Inc. | Flexible renal nerve ablation devices and related methods of use and manufacture |
US9770606B2 (en) | 2013-10-15 | 2017-09-26 | Boston Scientific Scimed, Inc. | Ultrasound ablation catheter with cooling infusion and centering basket |
JP6259098B2 (en) | 2013-10-15 | 2018-01-10 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Medical device and method for manufacturing the medical device |
US10945786B2 (en) | 2013-10-18 | 2021-03-16 | Boston Scientific Scimed, Inc. | Balloon catheters with flexible conducting wires and related methods of use and manufacture |
US10271898B2 (en) | 2013-10-25 | 2019-04-30 | Boston Scientific Scimed, Inc. | Embedded thermocouple in denervation flex circuit |
US10219814B2 (en) * | 2013-12-13 | 2019-03-05 | Rex Medical, L.P. | Aspiration system for thrombectomy procedures |
CN105899157B (en) | 2014-01-06 | 2019-08-09 | 波士顿科学国际有限公司 | Tear-proof flexible circuit assembly |
WO2015119890A1 (en) | 2014-02-04 | 2015-08-13 | Boston Scientific Scimed, Inc. | Alternative placement of thermal sensors on bipolar electrode |
US11000679B2 (en) | 2014-02-04 | 2021-05-11 | Boston Scientific Scimed, Inc. | Balloon protection and rewrapping devices and related methods of use |
US9968247B2 (en) | 2014-05-02 | 2018-05-15 | United States Endoscopy, Inc. | Cleaning device for an endoscopic device |
US10709490B2 (en) | 2014-05-07 | 2020-07-14 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter assemblies comprising a direct heating element for renal neuromodulation and associated systems and methods |
WO2015200702A1 (en) | 2014-06-27 | 2015-12-30 | Covidien Lp | Cleaning device for catheter and catheter including the same |
CN107106200B (en) | 2014-12-03 | 2020-04-17 | 帕夫梅德有限公司 | System and method for percutaneous segmentation of fibrous structures |
WO2016092389A1 (en) * | 2014-12-10 | 2016-06-16 | Koninklijke Philips N.V. | Devices, systems, and methods for in-stent restenosis prediction |
WO2016110854A1 (en) | 2015-01-08 | 2016-07-14 | Sinusafe Medical Ltd | Paranasal sinus medical device and uses thereof |
US10314667B2 (en) | 2015-03-25 | 2019-06-11 | Covidien Lp | Cleaning device for cleaning medical instrument |
WO2016186844A1 (en) * | 2015-05-15 | 2016-11-24 | Mayo Foundation For Medical Education And Research | Methods and materials for treating peripheral artery disease |
US10292721B2 (en) | 2015-07-20 | 2019-05-21 | Covidien Lp | Tissue-removing catheter including movable distal tip |
US10314664B2 (en) | 2015-10-07 | 2019-06-11 | Covidien Lp | Tissue-removing catheter and tissue-removing element with depth stop |
JP2019062932A (en) * | 2016-02-23 | 2019-04-25 | テルモ株式会社 | Medical device and treatment method |
JP7083163B2 (en) | 2016-07-03 | 2022-06-10 | サイナセーフ メディカル リミテッド | Medical devices for treating sinuses and / or ears and how to use them |
WO2018136863A1 (en) * | 2017-01-23 | 2018-07-26 | Boston Scientific Scimed, Inc. | Necrosectomy devices and procedures |
WO2018204692A1 (en) | 2017-05-03 | 2018-11-08 | Medtronic Vascular, Inc. | Tissue-removing catheter |
US11690645B2 (en) | 2017-05-03 | 2023-07-04 | Medtronic Vascular, Inc. | Tissue-removing catheter |
EP3880096A1 (en) | 2018-11-16 | 2021-09-22 | Medtronic Vascular Inc. | Tissue-removing catheter |
US11819236B2 (en) | 2019-05-17 | 2023-11-21 | Medtronic Vascular, Inc. | Tissue-removing catheter |
US20210402157A1 (en) * | 2020-06-29 | 2021-12-30 | Neuravi Limited | Intravascular plaque isolation, destabilization, and aspiration |
US11304723B1 (en) | 2020-12-17 | 2022-04-19 | Avantec Vascular Corporation | Atherectomy devices that are self-driving with controlled deflection |
Family Cites Families (82)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4273128A (en) | 1980-01-14 | 1981-06-16 | Lary Banning G | Coronary cutting and dilating instrument |
US4445509A (en) | 1982-02-04 | 1984-05-01 | Auth David C | Method and apparatus for removal of enclosed abnormal deposits |
US4883458A (en) | 1987-02-24 | 1989-11-28 | Surgical Systems & Instruments, Inc. | Atherectomy system and method of using the same |
US4819634A (en) | 1984-05-14 | 1989-04-11 | Surgical Systems & Instruments | Rotary-catheter for atherectomy system |
US4732154A (en) | 1984-05-14 | 1988-03-22 | Surgical Systems & Instruments, Inc. | Rotary catheter system |
US4894051A (en) | 1984-05-14 | 1990-01-16 | Surgical Systems & Instruments, Inc. | Atherectomy system with a biasing sleeve and method of using the same |
US5041082A (en) | 1986-06-16 | 1991-08-20 | Samuel Shiber | Mechanical atherectomy system and method |
US4842579B1 (en) | 1984-05-14 | 1995-10-31 | Surgical Systems & Instr Inc | Atherectomy device |
US5334211A (en) | 1984-05-14 | 1994-08-02 | Surgical System & Instruments, Inc. | Lumen tracking atherectomy system |
US5443443A (en) | 1984-05-14 | 1995-08-22 | Surgical Systems & Instruments, Inc. | Atherectomy system |
US4979939A (en) | 1984-05-14 | 1990-12-25 | Surgical Systems & Instruments, Inc. | Atherectomy system with a guide wire |
US4926858A (en) | 1984-05-30 | 1990-05-22 | Devices For Vascular Intervention, Inc. | Atherectomy device for severe occlusions |
US4979951A (en) | 1984-05-30 | 1990-12-25 | Simpson John B | Atherectomy device and method |
US4653496A (en) | 1985-02-01 | 1987-03-31 | Bundy Mark A | Transluminal lysing system |
US4706671A (en) | 1985-05-02 | 1987-11-17 | Weinrib Harry P | Catheter with coiled tip |
US4790812A (en) | 1985-11-15 | 1988-12-13 | Hawkins Jr Irvin F | Apparatus and method for removing a target object from a body passsageway |
US4794931A (en) | 1986-02-28 | 1989-01-03 | Cardiovascular Imaging Systems, Inc. | Catheter apparatus, system and method for intravascular two-dimensional ultrasonography |
US5000185A (en) | 1986-02-28 | 1991-03-19 | Cardiovascular Imaging Systems, Inc. | Method for intravascular two-dimensional ultrasonography and recanalization |
US4728319A (en) | 1986-03-20 | 1988-03-01 | Helmut Masch | Intravascular catheter |
US4696667A (en) | 1986-03-20 | 1987-09-29 | Helmut Masch | Intravascular catheter and method |
US4723549A (en) | 1986-09-18 | 1988-02-09 | Wholey Mark H | Method and apparatus for dilating blood vessels |
US4762130A (en) | 1987-01-15 | 1988-08-09 | Thomas J. Fogarty | Catheter with corkscrew-like balloon |
US4857045A (en) | 1987-04-30 | 1989-08-15 | Schneider (Usa) Inc., A Pfizer Company | Atherectomy catheter |
US4867156A (en) | 1987-06-25 | 1989-09-19 | Stack Richard S | Percutaneous axial atheroectomy catheter assembly and method of using the same |
US4857046A (en) | 1987-10-21 | 1989-08-15 | Cordis Corporation | Drive catheter having helical pump drive shaft |
US5047040A (en) | 1987-11-05 | 1991-09-10 | Devices For Vascular Intervention, Inc. | Atherectomy device and method |
US4850957A (en) | 1988-01-11 | 1989-07-25 | American Biomed, Inc. | Atherectomy catheter |
US4886061A (en) | 1988-02-09 | 1989-12-12 | Medinnovations, Inc. | Expandable pullback atherectomy catheter system |
US4895560A (en) | 1988-03-31 | 1990-01-23 | Papantonakos Apostolos C | Angioplasty apparatus |
US4890611A (en) | 1988-04-05 | 1990-01-02 | Thomas J. Fogarty | Endarterectomy apparatus and method |
US5269751A (en) | 1988-09-21 | 1993-12-14 | Josef Kaliman | Thrombectomy catheter for enlarging an artery |
US5011488A (en) | 1988-12-07 | 1991-04-30 | Robert Ginsburg | Thrombus extraction system |
US4966604A (en) | 1989-01-23 | 1990-10-30 | Interventional Technologies Inc. | Expandable atherectomy cutter with flexibly bowed blades |
US5087265A (en) | 1989-02-17 | 1992-02-11 | American Biomed, Inc. | Distal atherectomy catheter |
US5078723A (en) | 1989-05-08 | 1992-01-07 | Medtronic, Inc. | Atherectomy device |
DE3921071A1 (en) | 1989-06-28 | 1991-02-28 | Rupprecht Hans Juergen | Removing thrombosis from blood vessel - involves semi-rigid rod with attached bristles, given reciprocating and rotating motion |
US5071424A (en) | 1989-08-18 | 1991-12-10 | Evi Corporation | Catheter atherotome |
US5011489A (en) | 1989-10-05 | 1991-04-30 | University Of South Florida | Endothelium stripper and method of using the same |
US5116352A (en) | 1989-10-06 | 1992-05-26 | Angiomed Ag | Apparatus for removing deposits from vessels |
US5009659A (en) | 1989-10-30 | 1991-04-23 | Schneider (Usa) Inc. | Fiber tip atherectomy catheter |
US5085662A (en) * | 1989-11-13 | 1992-02-04 | Scimed Life Systems, Inc. | Atherectomy catheter and related components |
US5011490A (en) | 1989-12-07 | 1991-04-30 | Medical Innovative Technologies R&D Limited Partnership | Endoluminal tissue excision catheter system and method |
US5158564A (en) | 1990-02-14 | 1992-10-27 | Angiomed Ag | Atherectomy apparatus |
US5209749A (en) | 1990-05-11 | 1993-05-11 | Applied Urology Inc. | Fluoroscopically alignable cutter assembly and method of using the same |
US5154724A (en) | 1990-05-14 | 1992-10-13 | Andrews Winston A | Atherectomy catheter |
US5100424A (en) * | 1990-05-21 | 1992-03-31 | Cardiovascular Imaging Systems, Inc. | Intravascular catheter having combined imaging abrasion head |
US5195954A (en) | 1990-06-26 | 1993-03-23 | Schnepp Pesch Wolfram | Apparatus for the removal of deposits in vessels and organs of animals |
US5196024A (en) | 1990-07-03 | 1993-03-23 | Cedars-Sinai Medical Center | Balloon catheter with cutting edge |
US5320634A (en) | 1990-07-03 | 1994-06-14 | Interventional Technologies, Inc. | Balloon catheter with seated cutting edges |
US5160342A (en) | 1990-08-16 | 1992-11-03 | Evi Corp. | Endovascular filter and method for use thereof |
DE4036570A1 (en) | 1990-11-16 | 1992-05-21 | Osypka Peter | CATHETER FOR REDUCING OR REMOVING CONSTRUCTIONS IN VESSELS |
US5217474A (en) | 1991-07-15 | 1993-06-08 | Zacca Nadim M | Expandable tip atherectomy method and apparatus |
US5135483A (en) | 1991-07-22 | 1992-08-04 | Dow Corning Wright Corporation | Atherectomy device with a removable drive system |
FR2685190B1 (en) | 1991-12-23 | 1998-08-07 | Jean Marie Lefebvre | ROTARY ATHERECTOMY OR THROMBECTOMY DEVICE WITH CENTRIFUGAL TRANSVERSE DEVELOPMENT. |
US5192291A (en) | 1992-01-13 | 1993-03-09 | Interventional Technologies, Inc. | Rotationally expandable atherectomy cutter assembly |
US5224945A (en) * | 1992-01-13 | 1993-07-06 | Interventional Technologies, Inc. | Compressible/expandable atherectomy cutter |
US5176693A (en) | 1992-05-11 | 1993-01-05 | Interventional Technologies, Inc. | Balloon expandable atherectomy cutter |
US5383460A (en) * | 1992-10-05 | 1995-01-24 | Cardiovascular Imaging Systems, Inc. | Method and apparatus for ultrasound imaging and atherectomy |
US5360432A (en) | 1992-10-16 | 1994-11-01 | Shturman Cardiology Systems, Inc. | Abrasive drive shaft device for directional rotational atherectomy |
US5356418A (en) | 1992-10-28 | 1994-10-18 | Shturman Cardiology Systems, Inc. | Apparatus and method for rotational atherectomy |
US5643297A (en) | 1992-11-09 | 1997-07-01 | Endovascular Instruments, Inc. | Intra-artery obstruction clearing apparatus and methods |
US5490859A (en) * | 1992-11-13 | 1996-02-13 | Scimed Life Systems, Inc. | Expandable intravascular occlusion material removal devices and methods of use |
US5540707A (en) | 1992-11-13 | 1996-07-30 | Scimed Life Systems, Inc. | Expandable intravascular occlusion material removal devices and methods of use |
US5318576A (en) | 1992-12-16 | 1994-06-07 | Plassche Jr Walter M | Endovascular surgery systems |
US5527326A (en) | 1992-12-29 | 1996-06-18 | Thomas J. Fogarty | Vessel deposit shearing apparatus |
US5429136A (en) * | 1993-04-21 | 1995-07-04 | Devices For Vascular Intervention, Inc. | Imaging atherectomy apparatus |
US5555405A (en) | 1993-07-06 | 1996-09-10 | Digital Equipment Corporation | Method and apparatus for free space management in a forwarding database having forwarding entry sets and multiple free space segment queues |
US5370653A (en) | 1993-07-22 | 1994-12-06 | Micro Therapeutics, Inc. | Thrombectomy method and apparatus |
US5427115A (en) | 1993-09-13 | 1995-06-27 | Boston Scientific Corporation | Apparatus for stricture diagnosis and treatment |
US5427107A (en) * | 1993-12-07 | 1995-06-27 | Devices For Vascular Intervention, Inc. | Optical encoder for catheter device |
US5535756A (en) | 1994-01-06 | 1996-07-16 | Parasher; Vinod K. | Catheter with simultaneous brush cytology and scrape biopsy capability |
NL9400027A (en) | 1994-01-07 | 1995-08-01 | Sobotka Milan R | Brush catheter |
EP0757539A4 (en) | 1994-04-29 | 1998-08-05 | Boston Scient Corp | Resecting coagulated tissue |
US5554163A (en) | 1995-04-27 | 1996-09-10 | Shturman Cardiology Systems, Inc. | Atherectomy device |
US5556408A (en) | 1995-04-27 | 1996-09-17 | Interventional Technologies Inc. | Expandable and compressible atherectomy cutter |
DE19522310C2 (en) * | 1995-06-20 | 1997-07-03 | A Dr Kreis | Catheter for removing a vasoconstriction with an imaging unit |
US5749848A (en) * | 1995-11-13 | 1998-05-12 | Cardiovascular Imaging Systems, Inc. | Catheter system having imaging, balloon angioplasty, and stent deployment capabilities, and method of use for guided stent deployment |
US5827304A (en) | 1995-11-16 | 1998-10-27 | Applied Medical Resources Corporation | Intraluminal extraction catheter |
US5695506A (en) * | 1996-02-06 | 1997-12-09 | Devices For Vascular Intervention | Catheter device with a flexible housing |
US5733296A (en) * | 1996-02-06 | 1998-03-31 | Devices For Vascular Intervention | Composite atherectomy cutter |
US6036707A (en) * | 1996-03-07 | 2000-03-14 | Devices For Vascular Intervention | Catheter device having a selectively flexible housing |
US5938671A (en) * | 1997-11-14 | 1999-08-17 | Reflow, Inc. | Recanalization apparatus and devices for use therein and method |
-
1998
- 1998-02-11 AU AU66570/98A patent/AU6657098A/en not_active Abandoned
- 1998-02-11 WO PCT/US1998/003018 patent/WO1998034673A1/en not_active Application Discontinuation
- 1998-02-11 CA CA002280117A patent/CA2280117A1/en not_active Abandoned
- 1998-02-11 JP JP53509998A patent/JP2001512334A/en active Pending
- 1998-02-11 EP EP98908567A patent/EP1007139A4/en not_active Withdrawn
-
1999
- 1999-03-02 US US09/260,935 patent/US6319242B1/en not_active Expired - Fee Related
-
2001
- 2001-02-14 US US09/784,625 patent/US20020016624A1/en not_active Abandoned
Cited By (257)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8066763B2 (en) | 1998-04-11 | 2011-11-29 | Boston Scientific Scimed, Inc. | Drug-releasing stent with ceramic-containing layer |
US6808531B2 (en) * | 2001-04-17 | 2004-10-26 | Scimed Life Systems, Inc. | In-stent ablative tool |
USRE46581E1 (en) * | 2001-04-17 | 2017-10-24 | Boston Scientific Scimed, Inc. | Cutting balloon catheter |
US20030078606A1 (en) * | 2001-04-17 | 2003-04-24 | Scimed Life Systems, Inc. | In-stent ablative tool |
US8303643B2 (en) | 2001-06-27 | 2012-11-06 | Remon Medical Technologies Ltd. | Method and device for electrochemical formation of therapeutic species in vivo |
US8016845B1 (en) | 2003-02-04 | 2011-09-13 | Lsi Solutions, Inc. | Instrument for guiding the surgical cutting of tissue and method of use |
US20040230220A1 (en) * | 2003-02-11 | 2004-11-18 | Cook Incorporated | Removable vena cava filter |
US20100160954A1 (en) * | 2003-02-11 | 2010-06-24 | Cook Incorporated | Removable Vena Cava Filter |
US8246650B2 (en) | 2003-02-11 | 2012-08-21 | Cook Medical Technologies Llc | Removable vena cava filter |
US7763045B2 (en) | 2003-02-11 | 2010-07-27 | Cook Incorporated | Removable vena cava filter |
US20040162572A1 (en) * | 2003-02-13 | 2004-08-19 | Sauer Jude S. | Instrument for surgically cutting tissue and method of use |
US8114105B2 (en) | 2003-02-13 | 2012-02-14 | Lsi Solutions, Inc. | Instrument for surgically cutting tissue and method of use |
US7481817B2 (en) | 2003-02-13 | 2009-01-27 | Lsi Soultions, Inc. | Instrument for surgically cutting tissue and method of use |
US20050251199A1 (en) * | 2004-04-16 | 2005-11-10 | Osborne Thomas A | Removable vena cava filter with anchoring feature for reduced trauma |
US8043322B2 (en) | 2004-04-16 | 2011-10-25 | Cook Medical Technologies Llc | Removable vena cava filter having inwardly positioned anchoring hooks in collapsed configuration |
US20100160956A1 (en) * | 2004-04-16 | 2010-06-24 | Cook Incorporated | Removable vena cava filter for reduced trauma in collapsed configuration |
US7699867B2 (en) | 2004-04-16 | 2010-04-20 | Cook Incorporated | Removable vena cava filter for reduced trauma in collapsed configuration |
US7972353B2 (en) | 2004-04-16 | 2011-07-05 | Cook Medical Technologies Llc | Removable vena cava filter with anchoring feature for reduced trauma |
US8105349B2 (en) | 2004-04-16 | 2012-01-31 | Cook Medical Technologies Llc | Removable vena cava filter having primary struts for enhanced retrieval and delivery |
US20070005095A1 (en) * | 2004-04-16 | 2007-01-04 | Osborne Thomas A | Removable vena cava filter having inwardly positioned anchoring hooks in collapsed configuration |
US20050267512A1 (en) * | 2004-04-16 | 2005-12-01 | Osborne Thomas A | Removable vena cava filter for reduced trauma in collapsed configuration |
US20050267513A1 (en) * | 2004-04-16 | 2005-12-01 | Osborne Thomas A | Removable vena cava filter having primary struts for enhanced retrieval and delivery |
US8246651B2 (en) | 2004-04-16 | 2012-08-21 | Cook Medical Technologies Llc | Removable vena cava filter for reduced trauma in collapsed configuration |
US8986248B2 (en) | 2004-06-23 | 2015-03-24 | Boston Scientific Scimed, Inc. | Cutting balloon and process |
US10973570B2 (en) | 2004-09-10 | 2021-04-13 | Boston Scientific Scimed, Inc. | Apparatus and method for treatment of in-stent restenosis |
US8167901B2 (en) | 2004-09-27 | 2012-05-01 | Cook Medical Technologies Llc | Removable vena cava filter comprising struts having axial bends |
US20060069406A1 (en) * | 2004-09-27 | 2006-03-30 | Per Hendriksen | Removable vena cava filter comprising struts having axial bends |
US20060089709A1 (en) * | 2004-10-21 | 2006-04-27 | Helmus Michael N | Medical implant with average surface charge density |
US20070038176A1 (en) * | 2005-07-05 | 2007-02-15 | Jan Weber | Medical devices with machined layers for controlled communications with underlying regions |
WO2007053795A3 (en) * | 2005-10-25 | 2010-01-14 | Massachusetts Institute Of Technology | Converting rotational motion into radial motion |
WO2007053795A2 (en) * | 2005-10-25 | 2007-05-10 | Massachusetts Institute Of Technology | Converting rotational motion into radial motion |
WO2007078692A2 (en) * | 2005-12-23 | 2007-07-12 | The Board Of Trustees Of The Leland Stanford Junior University | Systems and methods for fixation of bone with an expandable device |
US20070173939A1 (en) * | 2005-12-23 | 2007-07-26 | The Board Of Trustees Of The Leland Stanford Junior University | Systems and methods for fixation of bone with an expandable device |
WO2007078692A3 (en) * | 2005-12-23 | 2008-12-18 | Univ Leland Stanford Junior | Systems and methods for fixation of bone with an expandable device |
US8840660B2 (en) | 2006-01-05 | 2014-09-23 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
US8089029B2 (en) | 2006-02-01 | 2012-01-03 | Boston Scientific Scimed, Inc. | Bioabsorbable metal medical device and method of manufacture |
US8574615B2 (en) | 2006-03-24 | 2013-11-05 | Boston Scientific Scimed, Inc. | Medical devices having nanoporous coatings for controlled therapeutic agent delivery |
US8187620B2 (en) | 2006-03-27 | 2012-05-29 | Boston Scientific Scimed, Inc. | Medical devices comprising a porous metal oxide or metal material and a polymer coating for delivering therapeutic agents |
US20070224116A1 (en) * | 2006-03-27 | 2007-09-27 | Chandru Chandrasekaran | Medical devices comprising a porous metal oxide or metal material and a polymer coating for delivering therapeutic agents |
US8048150B2 (en) | 2006-04-12 | 2011-11-01 | Boston Scientific Scimed, Inc. | Endoprosthesis having a fiber meshwork disposed thereon |
US7854740B2 (en) | 2006-04-27 | 2010-12-21 | Medtronic Vascular, Inc. | Intraluminal guidance system using bioelectric impedance |
US20070255270A1 (en) * | 2006-04-27 | 2007-11-01 | Medtronic Vascular, Inc. | Intraluminal guidance system using bioelectric impedance |
US20090192405A1 (en) * | 2006-04-27 | 2009-07-30 | Medtronic Vascular, Inc. | Intraluminal guidance system using bioelectric impedance |
WO2007127530A1 (en) * | 2006-04-27 | 2007-11-08 | Medtronic Vascular, Inc. | Intraluminal guidance system using bioelectric impedance |
US20070264303A1 (en) * | 2006-05-12 | 2007-11-15 | Liliana Atanasoska | Coating for medical devices comprising an inorganic or ceramic oxide and a therapeutic agent |
US20110189377A1 (en) * | 2006-05-12 | 2011-08-04 | Boston Scientific Scimed, Inc. | Coating for Medical Devices Comprising An Inorganic or Ceramic Oxide and a Therapeutic Agent |
US20080077158A1 (en) * | 2006-06-16 | 2008-03-27 | Hani Haider | Method and Apparatus for Computer Aided Surgery |
US11116574B2 (en) | 2006-06-16 | 2021-09-14 | Board Of Regents Of The University Of Nebraska | Method and apparatus for computer aided surgery |
US11857265B2 (en) | 2006-06-16 | 2024-01-02 | Board Of Regents Of The University Of Nebraska | Method and apparatus for computer aided surgery |
US20070299337A1 (en) * | 2006-06-26 | 2007-12-27 | Boston Scientific Scimed, Inc. | Method for determining size, pathology, and volume of embolic material |
US7937133B2 (en) | 2006-06-26 | 2011-05-03 | Boston Scientific Scimed, Inc. | Method for determining size, pathology, and volume of embolic material |
US8815275B2 (en) | 2006-06-28 | 2014-08-26 | Boston Scientific Scimed, Inc. | Coatings for medical devices comprising a therapeutic agent and a metallic material |
US8771343B2 (en) | 2006-06-29 | 2014-07-08 | Boston Scientific Scimed, Inc. | Medical devices with selective titanium oxide coatings |
US8052743B2 (en) | 2006-08-02 | 2011-11-08 | Boston Scientific Scimed, Inc. | Endoprosthesis with three-dimensional disintegration control |
US20080039989A1 (en) * | 2006-08-10 | 2008-02-14 | V2 Green, Inc. | User Interface and User Control in a Power Aggregation System for Distributed Electric Resources |
US7949435B2 (en) | 2006-08-10 | 2011-05-24 | V2Green, Inc. | User interface and user control in a power aggregation system for distributed electric resources |
US20080039979A1 (en) * | 2006-08-10 | 2008-02-14 | V2 Green Inc. | Smart Islanding and Power Backup in a Power Aggregation System for Distributed Electric Resources |
US20080040263A1 (en) * | 2006-08-10 | 2008-02-14 | V2 Green, Inc. | Business Methods in a Power Aggregation System for Distributed Electric Resources |
US8810192B2 (en) | 2006-08-10 | 2014-08-19 | Gridpoint, Inc. | Power aggregation system for distributed electric resources |
US20080040479A1 (en) * | 2006-08-10 | 2008-02-14 | V2 Green Inc. | Connection Locator in a Power Aggregation System for Distributed Electric Resources |
US7747739B2 (en) | 2006-08-10 | 2010-06-29 | Gridpoint, Inc. | Connection locator in a power aggregation system for distributed electric resources |
US20090200988A1 (en) * | 2006-08-10 | 2009-08-13 | V2Green, Inc. | Power Aggregation System for Distributed Electric Resources |
US20080039980A1 (en) * | 2006-08-10 | 2008-02-14 | V2 Green Inc. | Scheduling and Control in a Power Aggregation System for Distributed Electric Resources |
US20080040295A1 (en) * | 2006-08-10 | 2008-02-14 | V2 Green, Inc. | Power Aggregation System for Distributed Electric Resources |
US20080040296A1 (en) * | 2006-08-10 | 2008-02-14 | V2 Green Inc. | Electric Resource Power Meter in a Power Aggregation System for Distributed Electric Resources |
US8898278B2 (en) | 2006-08-10 | 2014-11-25 | Gridpoint, Inc. | Connection locator in a power aggregation system for distributed electric resources |
US7844370B2 (en) | 2006-08-10 | 2010-11-30 | Gridpoint, Inc. | Scheduling and control in a power aggregation system for distributed electric resources |
US20080040223A1 (en) * | 2006-08-10 | 2008-02-14 | V2 Green Inc. | Electric Resource Module in a Power Aggregation System for Distributed Electric Resources |
US20080052145A1 (en) * | 2006-08-10 | 2008-02-28 | V2 Green, Inc. | Power Aggregation System for Distributed Electric Resources |
US20090043520A1 (en) * | 2006-08-10 | 2009-02-12 | V2Green, Inc. | User Interface and User Control in a Power Aggregation System for Distributed Electric Resources |
US10279698B2 (en) | 2006-08-10 | 2019-05-07 | V2Green, Inc. | Power aggregation system for distributed electric resources |
US20090043519A1 (en) * | 2006-08-10 | 2009-02-12 | V2Green, Inc. | Electric Resource Power Meter in a Power Aggregation System for Distributed Electric Resources |
US20090066287A1 (en) * | 2006-08-10 | 2009-03-12 | V2Green, Inc. | Business Methods in a Power Aggregation System for Distributed Electric Resources |
US10892639B2 (en) | 2006-08-10 | 2021-01-12 | V2Green, Inc. | Connection locator in a power aggregation system for distributed electric resources |
US20090063680A1 (en) * | 2006-08-10 | 2009-03-05 | V2Green, Inc. | Connection Locator in a Power Aggregation System for Distributed Electric Resources |
US20090040029A1 (en) * | 2006-08-10 | 2009-02-12 | V2Green, Inc. | Transceiver and charging component for a power aggregation system |
US8353949B2 (en) | 2006-09-14 | 2013-01-15 | Boston Scientific Scimed, Inc. | Medical devices with drug-eluting coating |
US8128689B2 (en) | 2006-09-15 | 2012-03-06 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis with biostable inorganic layers |
US8808726B2 (en) | 2006-09-15 | 2014-08-19 | Boston Scientific Scimed. Inc. | Bioerodible endoprostheses and methods of making the same |
US8057534B2 (en) | 2006-09-15 | 2011-11-15 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
US8052744B2 (en) | 2006-09-15 | 2011-11-08 | Boston Scientific Scimed, Inc. | Medical devices and methods of making the same |
US8002821B2 (en) | 2006-09-18 | 2011-08-23 | Boston Scientific Scimed, Inc. | Bioerodible metallic ENDOPROSTHESES |
US7981150B2 (en) | 2006-11-09 | 2011-07-19 | Boston Scientific Scimed, Inc. | Endoprosthesis with coatings |
WO2008143653A2 (en) * | 2006-12-11 | 2008-11-27 | V2Green, Inc. | Transaction management in a power aggregation system for distributed electric resources |
WO2008143653A3 (en) * | 2006-12-11 | 2009-04-16 | V2Green Inc | Transaction management in a power aggregation system for distributed electric resources |
US8715339B2 (en) | 2006-12-28 | 2014-05-06 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
US8080055B2 (en) | 2006-12-28 | 2011-12-20 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
US8070797B2 (en) | 2007-03-01 | 2011-12-06 | Boston Scientific Scimed, Inc. | Medical device with a porous surface for delivery of a therapeutic agent |
US8431149B2 (en) | 2007-03-01 | 2013-04-30 | Boston Scientific Scimed, Inc. | Coated medical devices for abluminal drug delivery |
US20100087908A1 (en) * | 2007-03-20 | 2010-04-08 | Pierre Hilaire | Apparatus and methods for stent delivery with embolic protection |
US8814925B2 (en) * | 2007-03-20 | 2014-08-26 | Minvasys | Apparatus and methods for stent delivery with embolic protection |
US8067054B2 (en) | 2007-04-05 | 2011-11-29 | Boston Scientific Scimed, Inc. | Stents with ceramic drug reservoir layer and methods of making and using the same |
US20080294246A1 (en) * | 2007-05-23 | 2008-11-27 | Boston Scientific Scimed, Inc. | Endoprosthesis with Select Ceramic Morphology |
US7976915B2 (en) | 2007-05-23 | 2011-07-12 | Boston Scientific Scimed, Inc. | Endoprosthesis with select ceramic morphology |
US8002823B2 (en) | 2007-07-11 | 2011-08-23 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US7942926B2 (en) | 2007-07-11 | 2011-05-17 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US20090018639A1 (en) * | 2007-07-11 | 2009-01-15 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US9284409B2 (en) | 2007-07-19 | 2016-03-15 | Boston Scientific Scimed, Inc. | Endoprosthesis having a non-fouling surface |
US8815273B2 (en) | 2007-07-27 | 2014-08-26 | Boston Scientific Scimed, Inc. | Drug eluting medical devices having porous layers |
US7931683B2 (en) | 2007-07-27 | 2011-04-26 | Boston Scientific Scimed, Inc. | Articles having ceramic coated surfaces |
US8221822B2 (en) | 2007-07-31 | 2012-07-17 | Boston Scientific Scimed, Inc. | Medical device coating by laser cladding |
US8900292B2 (en) | 2007-08-03 | 2014-12-02 | Boston Scientific Scimed, Inc. | Coating for medical device having increased surface area |
US8052745B2 (en) | 2007-09-13 | 2011-11-08 | Boston Scientific Scimed, Inc. | Endoprosthesis |
US20090105737A1 (en) * | 2007-10-17 | 2009-04-23 | Mindframe, Inc. | Acute stroke revascularization/recanalization systems processes and products thereby |
US11786254B2 (en) | 2007-10-17 | 2023-10-17 | Covidien Lp | Methods of managing neurovascular obstructions |
US8066757B2 (en) | 2007-10-17 | 2011-11-29 | Mindframe, Inc. | Blood flow restoration and thrombus management methods |
US20090105722A1 (en) * | 2007-10-17 | 2009-04-23 | Mindframe, Inc. | Devices and methods for embolus removal during acute ischemic stroke |
US9198687B2 (en) | 2007-10-17 | 2015-12-01 | Covidien Lp | Acute stroke revascularization/recanalization systems processes and products thereby |
US20110238106A1 (en) * | 2007-10-17 | 2011-09-29 | Mindframe, Inc. | Blood flow restoration and thrombus management methods |
US9220522B2 (en) | 2007-10-17 | 2015-12-29 | Covidien Lp | Embolus removal systems with baskets |
US8945172B2 (en) | 2007-10-17 | 2015-02-03 | Covidien Lp | Devices for restoring blood flow and clot removal during acute ischemic stroke |
US8945143B2 (en) | 2007-10-17 | 2015-02-03 | Covidien Lp | Expandable tip assembly for thrombus management |
US20110160760A1 (en) * | 2007-10-17 | 2011-06-30 | Mindframe, Inc. | System for providing progressive therapy for thrombus management |
US8197493B2 (en) | 2007-10-17 | 2012-06-12 | Mindframe, Inc. | Method for providing progressive therapy for thrombus management |
US9320532B2 (en) | 2007-10-17 | 2016-04-26 | Covidien Lp | Expandable tip assembly for thrombus management |
US20110160757A1 (en) * | 2007-10-17 | 2011-06-30 | Mindframe, Inc. | Expandable tip assembly for thrombus management |
US20110160763A1 (en) * | 2007-10-17 | 2011-06-30 | Mindframe, Inc. | Blood flow restoration and thrombus management methods |
US9387098B2 (en) | 2007-10-17 | 2016-07-12 | Covidien Lp | Revascularization devices |
US10016211B2 (en) | 2007-10-17 | 2018-07-10 | Covidien Lp | Expandable tip assembly for thrombus management |
US8070791B2 (en) | 2007-10-17 | 2011-12-06 | Mindframe, Inc. | Multiple layer embolus removal |
US10835257B2 (en) | 2007-10-17 | 2020-11-17 | Covidien Lp | Methods of managing neurovascular obstructions |
US8585713B2 (en) | 2007-10-17 | 2013-11-19 | Covidien Lp | Expandable tip assembly for thrombus management |
US8574262B2 (en) | 2007-10-17 | 2013-11-05 | Covidien Lp | Revascularization devices |
US10413310B2 (en) | 2007-10-17 | 2019-09-17 | Covidien Lp | Restoring blood flow and clot removal during acute ischemic stroke |
US11337714B2 (en) | 2007-10-17 | 2022-05-24 | Covidien Lp | Restoring blood flow and clot removal during acute ischemic stroke |
US20100318097A1 (en) * | 2007-10-17 | 2010-12-16 | Mindframe, Inc. | Acute stroke revascularization/recanalization systems processes and products thereby |
US10123803B2 (en) | 2007-10-17 | 2018-11-13 | Covidien Lp | Methods of managing neurovascular obstructions |
US7938855B2 (en) | 2007-11-02 | 2011-05-10 | Boston Scientific Scimed, Inc. | Deformable underlayer for stent |
US20090118813A1 (en) * | 2007-11-02 | 2009-05-07 | Torsten Scheuermann | Nano-patterned implant surfaces |
US8029554B2 (en) | 2007-11-02 | 2011-10-04 | Boston Scientific Scimed, Inc. | Stent with embedded material |
US8216632B2 (en) | 2007-11-02 | 2012-07-10 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US20100217187A1 (en) * | 2007-11-12 | 2010-08-26 | Mindframe, Inc. | Rapid perfusion devices and methods |
WO2009114046A3 (en) * | 2007-11-12 | 2009-12-17 | Mindframe, Inc. | Acute stroke revascularization/recanalization systems processes and products thereby |
GB2463592B (en) * | 2007-11-12 | 2010-08-04 | Mindframe Inc | Acute stroke revascularization/recanalization systems processes and products thereby |
US8926680B2 (en) | 2007-11-12 | 2015-01-06 | Covidien Lp | Aneurysm neck bridging processes with revascularization systems methods and products thereby |
US20090125053A1 (en) * | 2007-11-12 | 2009-05-14 | Mindframe, Inc. | Aneurysm neck bridging processes with revascularization systems methods and products thereby |
GB2463592A (en) * | 2007-11-12 | 2010-03-24 | Mindframe Inc | Acute stroke revascularization/recanalization systems processes and products thereby |
US20090171441A1 (en) * | 2007-12-27 | 2009-07-02 | Cook Incorporated | Endovascular graft with separately positionable and removable frame units |
US8246672B2 (en) | 2007-12-27 | 2012-08-21 | Cook Medical Technologies Llc | Endovascular graft with separately positionable and removable frame units |
US20090192455A1 (en) * | 2008-01-07 | 2009-07-30 | David Ferrera | Novel enhanced ptna rapid exchange type of catheter system |
US10456151B2 (en) | 2008-02-22 | 2019-10-29 | Covidien Lp | Methods and apparatus for flow restoration |
US8679142B2 (en) | 2008-02-22 | 2014-03-25 | Covidien Lp | Methods and apparatus for flow restoration |
US9161766B2 (en) | 2008-02-22 | 2015-10-20 | Covidien Lp | Methods and apparatus for flow restoration |
US11529156B2 (en) | 2008-02-22 | 2022-12-20 | Covidien Lp | Methods and apparatus for flow restoration |
US20110060212A1 (en) * | 2008-02-22 | 2011-03-10 | Micro Therapeutics, Inc. | Methods and apparatus for flow restoration |
US8940003B2 (en) | 2008-02-22 | 2015-01-27 | Covidien Lp | Methods and apparatus for flow restoration |
US20100100106A1 (en) * | 2008-04-11 | 2010-04-22 | Mindframe, Inc. | Monorail neuro-microcatheter for delivery of medical devices to treat stroke, processes and products thereby |
US8545514B2 (en) | 2008-04-11 | 2013-10-01 | Covidien Lp | Monorail neuro-microcatheter for delivery of medical devices to treat stroke, processes and products thereby |
US8920491B2 (en) | 2008-04-22 | 2014-12-30 | Boston Scientific Scimed, Inc. | Medical devices having a coating of inorganic material |
US20090264771A1 (en) * | 2008-04-22 | 2009-10-22 | Medtronic Vascular, Inc. | Ultrasonic Based Characterization of Plaque in Chronic Total Occlusions |
US8932346B2 (en) | 2008-04-24 | 2015-01-13 | Boston Scientific Scimed, Inc. | Medical devices having inorganic particle layers |
US7998192B2 (en) | 2008-05-09 | 2011-08-16 | Boston Scientific Scimed, Inc. | Endoprostheses |
US20100174309A1 (en) * | 2008-05-19 | 2010-07-08 | Mindframe, Inc. | Recanalization/revascularization and embolus addressing systems including expandable tip neuro-microcatheter |
US20090292297A1 (en) * | 2008-05-19 | 2009-11-26 | David Ferrere | Devices for Restoring Blood Flow and Embolus Removal During Acute Ischemic Stroke |
US8088140B2 (en) | 2008-05-19 | 2012-01-03 | Mindframe, Inc. | Blood flow restorative and embolus removal methods |
US8236046B2 (en) | 2008-06-10 | 2012-08-07 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis |
US8449603B2 (en) | 2008-06-18 | 2013-05-28 | Boston Scientific Scimed, Inc. | Endoprosthesis coating |
US10039555B2 (en) | 2008-07-25 | 2018-08-07 | Spine View, Inc. | Systems and methods for cable-based tissue removal |
CN107252341A (en) * | 2008-07-25 | 2017-10-17 | 脊柱诊察公司 | System for the remover based on cable |
EP2317940A4 (en) * | 2008-07-25 | 2017-05-24 | Spine View, Inc. | Systems and methods for cable-based debriders |
CN102164550A (en) * | 2008-07-25 | 2011-08-24 | 脊柱诊察公司 | Systems and methods for cable-based debriders |
US8343179B2 (en) | 2008-07-25 | 2013-01-01 | Spine View, Inc. | Systems and methods for cable-based tissue removal |
WO2010011956A1 (en) * | 2008-07-25 | 2010-01-28 | Spine View, Inc. | Systems and methods for cable-based debriders |
US7985252B2 (en) | 2008-07-30 | 2011-07-26 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis |
US8382824B2 (en) | 2008-10-03 | 2013-02-26 | Boston Scientific Scimed, Inc. | Medical implant having NANO-crystal grains with barrier layers of metal nitrides or fluorides |
US20100121373A1 (en) * | 2008-11-10 | 2010-05-13 | Cook Incorporated | Removable vena cava filter with improved leg |
US8246648B2 (en) | 2008-11-10 | 2012-08-21 | Cook Medical Technologies Llc | Removable vena cava filter with improved leg |
US8231980B2 (en) | 2008-12-03 | 2012-07-31 | Boston Scientific Scimed, Inc. | Medical implants including iridium oxide |
US10722255B2 (en) | 2008-12-23 | 2020-07-28 | Covidien Lp | Systems and methods for removing obstructive matter from body lumens and treating vascular defects |
US8267992B2 (en) | 2009-03-02 | 2012-09-18 | Boston Scientific Scimed, Inc. | Self-buffering medical implants |
US8071156B2 (en) | 2009-03-04 | 2011-12-06 | Boston Scientific Scimed, Inc. | Endoprostheses |
US9168047B2 (en) | 2009-04-02 | 2015-10-27 | John T. To | Minimally invasive discectomy |
US20110087257A1 (en) * | 2009-04-02 | 2011-04-14 | Spine View, Inc. | Minimally invasive discectomy |
US20100256600A1 (en) * | 2009-04-04 | 2010-10-07 | Ferrera David A | Neurovascular otw pta balloon catheter and delivery system |
US8801739B2 (en) | 2009-04-17 | 2014-08-12 | Spine View, Inc. | Devices and methods for arched roof cutters |
US9788849B2 (en) | 2009-04-17 | 2017-10-17 | Spine View, Inc. | Devices and methods for arched roof cutters |
US8808320B2 (en) | 2009-04-17 | 2014-08-19 | Spine View, Inc. | Devices and methods for arched roof cutters |
US8702739B2 (en) | 2009-04-17 | 2014-04-22 | David Batten | Devices and methods for arched roof cutters |
US20110054507A1 (en) * | 2009-04-17 | 2011-03-03 | David Batten | Devices and methods for arched roof cutters |
US8287937B2 (en) | 2009-04-24 | 2012-10-16 | Boston Scientific Scimed, Inc. | Endoprosthese |
US9278201B2 (en) * | 2009-06-15 | 2016-03-08 | Perflow Medical Ltd. | Method and apparatus for allowing blood flow through an occluded vessel |
US9510855B2 (en) | 2009-06-15 | 2016-12-06 | Perflow Medical Ltd. | Method and apparatus for allowing blood flow through an occluded vessel |
US20100318178A1 (en) * | 2009-06-15 | 2010-12-16 | Perflow Medical Ltd. | Method and apparatus for allowing blood flow through an occluded vessel |
US11179253B2 (en) | 2009-06-15 | 2021-11-23 | Perflow Medieal Ltd. | Method and apparatus for allowing blood flow through an occluded vessel |
US8668732B2 (en) | 2010-03-23 | 2014-03-11 | Boston Scientific Scimed, Inc. | Surface treated bioerodible metal endoprostheses |
US11730506B2 (en) | 2010-10-18 | 2023-08-22 | Sonivie Ltd. | Ultrasound transducer and uses thereof |
US10022212B2 (en) | 2011-01-13 | 2018-07-17 | Cook Medical Technologies Llc | Temporary venous filter with anti-coagulant delivery method |
US11090176B2 (en) | 2011-01-17 | 2021-08-17 | Artio Medical, Inc. | Detachable metal balloon delivery device and method |
US9572697B2 (en) * | 2011-01-17 | 2017-02-21 | Metactive Medical, Inc. | Blockstent device and methods of use |
US9572698B2 (en) * | 2011-01-17 | 2017-02-21 | Metactive Medical, Inc. | Ballstent device and methods of use |
US11013516B2 (en) | 2011-01-17 | 2021-05-25 | Artio Medical, Inc. | Expandable body device and method of use |
CN110464402A (en) * | 2011-01-17 | 2019-11-19 | 美它克医药公司 | Medical external member and the method for forming balloon-stent |
US20140018838A1 (en) * | 2011-01-17 | 2014-01-16 | Novita Therapeutics, Llc | Blockstent device and methods of use |
US10537451B2 (en) | 2011-01-17 | 2020-01-21 | Metactive Medical, Inc. | Ballstent device and methods of use |
US11484318B2 (en) | 2011-01-17 | 2022-11-01 | Artio Medical, Inc. | Expandable body device and method of use |
US20140012363A1 (en) * | 2011-01-17 | 2014-01-09 | Novita Therapeutics, Llc | Ballstent device and methods of use |
US10543115B2 (en) | 2011-01-17 | 2020-01-28 | Metactive Medical, Inc. | Blockstent device and methods of use |
US10258409B2 (en) | 2011-02-24 | 2019-04-16 | Eximo Medical Ltd. | Hybrid catheter for endoluminal intervention |
US11576724B2 (en) | 2011-02-24 | 2023-02-14 | Eximo Medical Ltd. | Hybrid catheter for vascular intervention |
US12042223B2 (en) | 2011-02-24 | 2024-07-23 | Eximo Medical Ltd. | Hybrid catheter for vascular intervention |
WO2012114333A1 (en) * | 2011-02-24 | 2012-08-30 | Ilan Ben Oren | Hybrid catheter for vascular intervention |
US10363099B2 (en) | 2011-02-24 | 2019-07-30 | Eximo Medical Ltd. | Hybrid catheter for vascular intervention |
US9730756B2 (en) | 2011-02-24 | 2017-08-15 | Eximo Medical Ltd. | Hybrid catheter for vascular intervention |
US9763735B2 (en) | 2011-02-24 | 2017-09-19 | Eximo Medical Ltd. | Hybrid catheter for endoluminal intervention |
US11737868B2 (en) | 2011-02-25 | 2023-08-29 | Edwards Lifesciences Corporation | Prosthetic heart valve delivery apparatus |
US11737871B2 (en) | 2011-02-25 | 2023-08-29 | Edwards Lifesciences Corporation | Prosthetic heart valve |
US11399934B2 (en) | 2011-02-25 | 2022-08-02 | Edwards Lifesciences Corporation | Prosthetic heart valve |
CN103491905A (en) * | 2011-02-25 | 2014-01-01 | 爱德华兹生命科学公司 | Prosthetic heart valve delivery apparatus |
US11801132B2 (en) | 2011-02-25 | 2023-10-31 | Edwards Lifesciences Corporation | Prosthetic heart valve |
CN105287052A (en) * | 2011-02-25 | 2016-02-03 | 爱德华兹生命科学公司 | Prosthetic heart valve delivery apparatus |
US11129713B2 (en) | 2011-02-25 | 2021-09-28 | Edwards Lifesciences Corporation | Prosthetic heart valve delivery apparatus |
US10219811B2 (en) | 2011-06-27 | 2019-03-05 | Board Of Regents Of The University Of Nebraska | On-board tool tracking system and methods of computer assisted surgery |
US9498231B2 (en) | 2011-06-27 | 2016-11-22 | Board Of Regents Of The University Of Nebraska | On-board tool tracking system and methods of computer assisted surgery |
US10080617B2 (en) | 2011-06-27 | 2018-09-25 | Board Of Regents Of The University Of Nebraska | On-board tool tracking system and methods of computer assisted surgery |
US11911117B2 (en) | 2011-06-27 | 2024-02-27 | Board Of Regents Of The University Of Nebraska | On-board tool tracking system and methods of computer assisted surgery |
CN104125815A (en) * | 2011-10-04 | 2014-10-29 | 维西克斯血管公司 | Apparatus and method for treatment of in-stent restenosis |
WO2013052590A1 (en) * | 2011-10-04 | 2013-04-11 | Vessix Vascular, Inc. | Apparatus and method for treatment of in-stent restenosis |
AU2012318647B2 (en) * | 2011-10-04 | 2017-06-01 | Boston Scientific Scimed, Inc. | Apparatus and method for treatment of in-stent restenosis |
US10448967B2 (en) | 2011-12-03 | 2019-10-22 | DePuy Synthes Products, Inc. | Discectomy kits with an obturator, guard cannula |
US9265521B2 (en) | 2011-12-03 | 2016-02-23 | Ouroboros Medical, Inc. | Tissue removal systems with articulating cutting heads |
US9119659B2 (en) | 2011-12-03 | 2015-09-01 | Ouroboros Medical, Inc. | Safe cutting heads and systems for fast removal of a target tissue |
US20150073400A1 (en) * | 2012-04-18 | 2015-03-12 | CardioSonic Ltd. | Tissue treatment |
US10357304B2 (en) * | 2012-04-18 | 2019-07-23 | CardioSonic Ltd. | Tissue treatment |
US11357447B2 (en) | 2012-05-31 | 2022-06-14 | Sonivie Ltd. | Method and/or apparatus for measuring renal denervation effectiveness |
KR20150083107A (en) * | 2012-11-08 | 2015-07-16 | 코비디엔 엘피 | Tissue-removing catheter including operational control mechanism |
KR101717387B1 (en) * | 2012-11-08 | 2017-03-16 | 코비디엔 엘피 | Tissue-removing catheter including operational control mechanism |
CN104869923A (en) * | 2012-11-08 | 2015-08-26 | 柯惠有限合伙公司 | Tissue-removing catheter including operational control mechanism |
US9414752B2 (en) | 2012-11-09 | 2016-08-16 | Elwha Llc | Embolism deflector |
US9295393B2 (en) | 2012-11-09 | 2016-03-29 | Elwha Llc | Embolism deflector |
US10105149B2 (en) | 2013-03-15 | 2018-10-23 | Board Of Regents Of The University Of Nebraska | On-board tool tracking system and methods of computer assisted surgery |
US10933259B2 (en) | 2013-05-23 | 2021-03-02 | CardioSonic Ltd. | Devices and methods for renal denervation and assessment thereof |
US10342563B2 (en) | 2013-07-19 | 2019-07-09 | DePuy Synthes Products, Inc. | Anti-clogging device for a vacuum-assisted, tissue removal system |
US20150080896A1 (en) | 2013-07-19 | 2015-03-19 | Ouroboros Medical, Inc. | Anti-clogging device for a vacuum-assisted, tissue removal system |
US10441295B2 (en) | 2013-10-15 | 2019-10-15 | Stryker Corporation | Device for creating a void space in a living tissue, the device including a handle with a control knob that can be set regardless of the orientation of the handle |
US11259818B2 (en) | 2013-10-15 | 2022-03-01 | Stryker Corporation | Methods for creating a void within a bone |
US11033275B2 (en) | 2014-09-17 | 2021-06-15 | Artio Medical, Inc. | Expandable body device and method of use |
US10667827B2 (en) | 2015-03-06 | 2020-06-02 | Warsaw Orthopedic, Inc. | Surgical instrument and method |
US10080571B2 (en) | 2015-03-06 | 2018-09-25 | Warsaw Orthopedic, Inc. | Surgical instrument and method |
US11653934B2 (en) | 2015-03-06 | 2023-05-23 | Warsaw Orthopedic, Inc. | Surgical instrument and method |
US11129631B2 (en) | 2015-07-16 | 2021-09-28 | Perflow Medical Ltd. | Apparatus and method for vessel occlusion removal |
US10376274B2 (en) | 2015-07-16 | 2019-08-13 | Perflow Medical Ltd. | Apparatus and method for vessel occlusion removal |
WO2017021172A1 (en) * | 2015-08-05 | 2017-02-09 | Koninklijke Philips N.V. | Catheter assembly with low axial sliding friction |
US11684420B2 (en) | 2016-05-05 | 2023-06-27 | Eximo Medical Ltd. | Apparatus and methods for resecting and/or ablating an undesired tissue |
US11007059B2 (en) * | 2016-05-06 | 2021-05-18 | Transmural Systems Llc | Annuloplasty procedures, related devices and methods |
USD802769S1 (en) | 2016-05-16 | 2017-11-14 | Teleflex Medical Incorporated | Thrombectomy handle assembly |
US11318331B2 (en) | 2017-03-20 | 2022-05-03 | Sonivie Ltd. | Pulmonary hypertension treatment |
WO2019006259A1 (en) * | 2017-06-30 | 2019-01-03 | Onesti Jill | Dissection device |
CN108186080A (en) * | 2018-03-02 | 2018-06-22 | 郑州大学第附属医院 | A kind of novel intravascular stirring thrombolysis device |
US11849986B2 (en) | 2019-04-24 | 2023-12-26 | Stryker Corporation | Systems and methods for off-axis augmentation of a vertebral body |
US11766272B2 (en) | 2020-01-30 | 2023-09-26 | Julier Medical AG | Apparatus and methods for neurovascular endoluminal intervention |
US11622781B2 (en) | 2020-01-30 | 2023-04-11 | Julier Medical AG | Apparatus and method for neurovascular endoluminal intervention |
US11911057B2 (en) | 2020-01-30 | 2024-02-27 | Julier Medical AG | Catheter apparatus and methods for endoluminal intervention |
EP4029459A1 (en) * | 2021-01-15 | 2022-07-20 | Shanghai Sixth People's Hospital | Plaque removal device |
US11737767B2 (en) | 2022-01-21 | 2023-08-29 | Julier Medical AG | Neurovascular catheter and method of use |
US12004758B2 (en) | 2022-01-21 | 2024-06-11 | Julier Medical AG | Catheter for accessing the vasculature including the neurovasculature, and methods of use |
WO2023222466A1 (en) * | 2022-05-19 | 2023-11-23 | Koninklijke Philips N.V. | Expandable debulking tool for intravascular procedures |
US12038322B2 (en) | 2022-06-21 | 2024-07-16 | Eximo Medical Ltd. | Devices and methods for testing ablation systems |
Also Published As
Publication number | Publication date |
---|---|
US6319242B1 (en) | 2001-11-20 |
WO1998034673A1 (en) | 1998-08-13 |
EP1007139A1 (en) | 2000-06-14 |
JP2001512334A (en) | 2001-08-21 |
AU6657098A (en) | 1998-08-26 |
EP1007139A4 (en) | 2000-06-14 |
CA2280117A1 (en) | 1998-08-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6319242B1 (en) | Apparatus and method for controlled removal of stenotic material from stents | |
US5941869A (en) | Apparatus and method for controlled removal of stenotic material from stents | |
EP1707148B1 (en) | Percutaneous or surgical radiofrequency intravascular thrombectomy catheter system and method | |
US11786269B2 (en) | Atherectomy devices and methods | |
EP2037821B1 (en) | Atherectomy devices | |
US6872204B2 (en) | Tissue cutting catheter and RF cutting method | |
US9675376B2 (en) | Atherectomy devices and methods | |
US5702413A (en) | Curved bristle atherectomy device and method | |
JP2019076741A (en) | Techniques of recanalizing occluded vessels using radiofrequency energy | |
US20070239182A1 (en) | Thrombus removal device | |
JPH02503161A (en) | Expandable pullback acerectomy catheter system | |
KR20110005842A (en) | Atherectomy devices and methods | |
EP3982861B1 (en) | Retrieval of material from corporeal lumens | |
JP2004506454A (en) | Percutaneous and remote endarterectomy method and apparatus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |